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Abstract 
Plants are capable of synthesizing an overwhelming variety of secondary metabolites, many 
of which possess biological activities relevant for the pharmaceutical and chemical industries. 
Furthermore, there is an ever increasing demand for novel compounds, due to, among others, 
the growing drug tolerance and resistance in microorganisms and newly emerging diseases. 
In microorganisms, combinatorial biochemistry is a widely used tool to increase structural 
variation in several classes of (microbial) natural products. Despite the potential importance 
of plant secondary metabolites, only a limited fraction of these molecules is currently used, 
mostly due to their complex structure and the low production levels in planta. Metabolic 
engineering of plants has offered limited help because the molecular mechanisms steering 
plant secondary metabolism remain poorly characterized. Here, we used a functional 
genomics approach to identify candidate genes involved in the saponin biosynthesis of five 
different plants. After targeted metabolite profiling confirmed the induction of triterpene 
saponin biosynthesis by methyl jasmonate treatment, a genome-wide cDNA-AFLP transcript 
profiling was carried out for the five plants. Taking into account the putative functional 
annotation and the expression pattern of the visualized transcript tags, a set of 259 candidate 
genes potentially involved in saponin biosynthesis and its regulation were identified. The 
generated gene list provided the basis for a combinatorial biochemistry platform that targets 
triterpene saponins in plants. Proof of concept of combinatorial biochemistry was achieved 
by heterologous expression of the candidate saponin biosynthesis genes in M. truncatula 
hairy roots. Three of the generated transgenic hairy root lines were found to accumulate novel 
molecules, two of which were shown to be novel triterpene saponins, whereas the third line 
produced a set of novel, non-saponin compounds. Furthermore, the identified transcription 
factors and other regulators were lead candidates for studies investigating the control of the 
saponin biosynthesis in planta. This led to the identification of a RING membrane-anchor E3 
ubiquitin ligase, MAKIBISHI1 (MKB1), that targets 3-hydroxy-3-methylglutaryl-CoA 
reductase (HMGR), the enzyme catalyzing the rate-limiting step in the mevalonate pathway, 
for ubiquitin-mediated proteasomal degradation, thereby controlling saponin biosynthesis. 
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Abstract 
Combinatorial biochemistry, also called combinatorial biosynthesis, comprises a series of 
methods that establish novel enzyme-substrate combinations in vivo, which in turn lead to the 
biosynthesis of new, natural product-derived compounds that can be used in drug discovery 
programs. Plants are an extremely rich source of bioactive natural products and continue to 
possess a huge potential for drug discovery. In this review, we discuss the state-of-the-art in 
combinatorial biosynthesis methods to generate novel molecules from plants. We debate on 
the progress and potential in biotransformation, mutasynthesis, combinatorial metabolism in 
hybrids, activation of silent plant metabolism and synthetic biology in plants and microbes to 
create opportunities for combinatorial biosynthesis of plant-derived natural products, and, 
ultimately, for drug discovery. The therapeutic value of two classes of natural products, the 
terpenoid indole alkaloids and the triterpene saponins is particularly highlighted. 
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1. Introduction 
For already thousands of years, mankind has made use of plant-derived natural products to 
treat diseases and injuries (Ji et al., 2009). Today, these small molecules are still used in a 
variety of therapeutics and play an important role in drug discovery programs (Newman and 
Cragg, 2007; Butler, 2008; Cragg et al., 2009; Li and Vederas, 2009). Nonetheless, there is a 
continuous demand for novel molecules with novel or superior pharmaceutical activities, due 
to, among others, newly emerging diseases and the growing drug tolerance and resistance in 
microorganisms. For instance, the methicillin-resistant Staphylococcus aureus (MRSA) 
causes an estimated 19,000 deaths per year in the United States (Klevens et al., 2007; 
Fischbach and Walsh, 2009). 
Recent advancements in functional genomics and the application of multidisciplinary 
approaches allow picking the inherent bioactive molecules from medicinal plants, resulting in 
the discovery and development of new and important drugs, such as the recently approved 
plant-derived drugs elliptinium, galantamine and huperzine (Butler, 2008; Harvey, 2008). 
Chemical synthesis of natural compounds generates a better understanding of how the 
molecules function, and allows targeted design of novel compounds with improved or even 
new functions (Wender and Miller, 2009). Unfortunately, due to their structural complexity, 
it is often commercially unfeasible to chemically synthesize the bioactive plant-derived 
molecules (Chemler and Koffas, 2008). Therefore, development of novel drugs from natural 
plant sources by using the present-day experimental tools remains a rational approach. 
Traditionally, medicinal plant extracts were the only source of plant-derived natural products 
used in pharmacognosy and their bioactive compounds were discovered by traditional 
screening (Kong et al., 2003). For instance, a large-scale screening for antitumor agents, 
conducted by the National Cancer Institute, led to the discovery of paclitaxel from the bark of 
the Pacific Yew tree, Taxus brevifolia (Wani et al., 1971). Yet, such traditional 
pharmacological screenings of medicinal plants are time consuming and expensive, 
drawbacks that may be partially overcome by high-throughput pharmacological screening of 
crude plant extracts (Littleton et al., 2005). Despite the potential of plant natural products, the 
pharmaceutical industry has shifted focus to the high-throughput screening of combinatorial 
chemistry libraries, but, to date, the output in terms of new drugs is far below the initial  
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Scheme 1. Various approaches for combinatorial biosynthesis of plant-derived natural products. A, B, 
C, S1, and S2, enzymes. Coloured symbols represent small molecule scaffolds and modifications 
thereof. 
 
expectations (Ortholand and Ganesan, 2004; Koehn and Carter, 2005; Walsh and Fischbach, 
2010; Welsch et al., 2010). 
An alternative approach to generate new molecules or scaffolds is combinatorial biosynthesis, 
that can be defined as an approach in which gene products from different organisms are 
combined to produce new bioactive compounds. In a broad sense, combinatorial biosynthesis 
can be practically achieved using various approaches, such as (i) biotransformation, where 
the chemical modifications of compounds are carried out by biocatalysts; (ii) mutasynthesis, 
or feeding of compounds to mutant biocatalysts; (iii) combinatorial metabolism in hybrids; 
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(iv) activation of silent metabolism; and (v) synthetic biology or the combinatorial piling up 
of genes in heterologous hosts (Scheme 1). 
In this review, we focus on the potential and the progress made in combinatorial biosynthesis 
in plants. The practical mechanisms available to date are discussed and a possible future 
outline to use plant-based combinatorial biosynthesis platforms for novel drug discovery is 
given. 
2. Combinatorial biosynthesis in microorganisms: setting the exemplar 
When Hopwood and coworkers introduced genes involved in the biosynthesis of the 
antibiotic actinorhodin into a medermycin-producing Streptomyces strain, the transformed 
strain produced a novel antibiotic, mederrhodin A. This compound had a structure similar to 
that of medermycin, but with an additional hydroxyl group typical of actinorhodin (Figure 1) 
(Hopwood et al., 1985). This was the first report that established the feasibility and potential 
of interchanging and combining genes from different organisms as a way to generate hybrid 
pathways that lead to the synthesis of „hybrid‟ or „new-to-nature‟ compounds. Since then, 
combinatorial biosynthesis has become a powerful platform for generating structural diversity 
in microbial natural products (Floss, 2006; Lam, 2007; Menzella and Reeves, 2007; Zhou et 
al., 2008). 
In particular, combinatorial biosynthesis proved to be an excellent approach for the 
development of novel polyketides, a large family of natural products that include many 
pharmaceuticals (Cane et al., 1998; Hutchinson, 1998; Staunton and Weissman, 2001; Rix et 
al., 2002; Weissman and Leadlay, 2005; Floss, 2006; Lam, 2007; Menzella and Reeves, 
2007; Zhou et al., 2008). Polyketides are biosynthesized from acyl-CoA monomers of simple 
carboxylic acids, by large, multifunctional proteins (megasynthases) that comprise several 
active catalytic sites. Each active site or module catalyzes one specific cycle of the polyketide 
chain elongation and the associated modification of the polyketide backbone (Staunton and 
Weissman, 2001; Floss, 2006). The large natural diversity of polyketide structures is obtained 
by combinations of different catalytic modules (incorporation of different acyl-CoA 
residues), in a different sequence and a different number of modules. After the synthesis of 
the polyketide backbone, various cyclization and tailoring enzymes increase the structural 
variability. The tremendous combinatorial biosynthesis potential of polyketides was 
underscored by McDaniel and coworkers. By engineering the multiple biosynthetic steps in a  
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Figure 1. Mederrhodin A, produced by cloning of actinorhodin biosynthesis genes into a medermycin 
producing Streptomyces strain (Floss, 2006). 
 
polyketide synthase that produced the macrolide ring of the widely used antibiotic 
erythromycin, a small combinatorial library of more than 50 novel polyketides was generated 
(McDaniel et al., 1999). Later, the molecular nature of the polyketide synthesis allowed the 
establishment of a modular method, referred to as „Lego-ization of polyketide biosynthesis‟, 
to assemble synthetic polyketide synthases that catalyzed the production of new polyketides 
(Sherman, 2005; Kittendorf and Sherman, 2006). 
Combinatorial biosynthesis in microorganisms has been successfully applied to other classes 
of microbial natural products as well, such as the indolocarbazoles, a class of compounds 
with potential applications in cancer therapy (Sánchez et al., 2006). Characterization of the 
rebeccamycin biosynthetic gene cluster paved the way for its combinatorial stacking with 
selected genes from other indolocarbazole biosynthetic pathways, resulting in the production 
of over 24 novel indolocarbazole derivatives in the microbial host (Sánchez et al., 2005; Salas 
and Méndez, 2009). 
Recent, groundbreaking, technological advances in molecular biology, functional genomics 
and biotechnology will substantially increase the capacity of combinatorial biosynthesis 
(Zhou et al., 2008). For instance, with the emergence of next-generation sequencing 
techniques entire microbial genomes can be sequenced, facilitating the discovery of 
biosynthetic gene clusters that can be applied in combinatorial biosynthesis platforms. 
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Obviously, because these generic technologies are also applicable to plants, they undoubtedly 
will allow the exploitation of the unrivalled complex metabolic arsenal of plants (see below) 
and open a new era for plant-based drug discovery in the near future. 
3. The metabolic power of plants 
3.1.Broad substrate specificity 
Although plants produce a vast array of metabolites with very diverse structures and 
biological activities, a large majority of the plant metabolites are derived from only a limited 
number of chemical scaffolds. For instance, in Catharanthus roseus (Madagascar 
periwinkle), over 120 different terpenoid indole alkaloids (TIAs) are biosynthesized from one 
precursor molecule, i.e. strictosidine. Starting from this precursor, the structural variation is 
obtained via a highly branched pathway, containing tens of specific enzymatic conversions 
and spontaneous chemical reactions (van der Heijden et al., 2004). Similar cases have been 
reported in multiple plant species and various metabolite classes. For example, over 60 
different ginsenosides derived from the ubiquitous precursor 2,3-oxidosqualene have been 
isolated from Panax quinquefolius (American ginseng), and novel structures continue to be 
discovered (Qi et al., 2010, 2011). 
Several factors collectively contribute to the enormous structural diversity of plant 
metabolites. Plants contain a large number of proteins capable of catalyzing regio- and 
stereospecific reactions. Cells from any plant species or organ express over 10,000 genes, of 
which a substantial fraction encode enzymes with a role in metabolism. For instance, in the 
model plant Arabidopsis thaliana, approximately 20% (5,506 out of 27,416) of the annotated 
protein-encoding genes in the genome are currently predicted to catalyze enzymatic reactions 
(TAIR10 Genome release, http://www.arabidopsis.org/ and AraCyc 7.0 Release, 
http://www.plantcyc.org/). Furthermore, alternative reading frames, gene fusions and 
alternative splicing of pre-mRNA can lead to structurally and functionally different proteins 
from a single gene (Reddy, 2001; Schwab, 2003). Also at the protein level, structural 
variation is further enlarged. Multifunctional enzymes can accept a range of substrates, 
catalyze distinct reactions, or form different products (Schwab, 2003). The multi-amyrin 
synthase from Pisum sativum (pea), produces eight different triterpene scaffolds from the 2,3-
oxidosqualene precursor. Consequently, only one enzyme can already account for nearly 10% 
of the natural variation in triterpene skeletons (Morita et al., 2000). Perhaps the most  
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Figure 2. The condensation of tryptophan-derived tryptamine and secologanin to form strictosidine 
by the enzyme strictosidine synthase. 
 
impressive cases reported to date are represented by the sesquiterpene synthases, δ-selinene 
synthase and γ-humulene synthase, from Abies grandis (Grand fir), that are capable of 
producing 34 and 52 different sesquiterpene scaffolds, respectively (Steele et al., 1998). 
Interestingly, directed evolution strategies based on the knowledge of the active sites of these 
promiscuous enzymes allowed the creation of enzymes with altered (new or narrower) 
specificity and activity (Yoshikuni et al., 2006), illustrating the enormous potential of plant 
enzymes for metabolic engineering towards the production of new-to-nature plant-derived 
products. 
Ultimately, the successful development of a combinatorial biosynthesis platform in plants 
will depend on the availability of an arsenal of biosynthetic enzymes to ensure a broad 
substrate tolerance and of a wide range of possible substrates for the substrate-flexible 
enzymes. Then, also unnatural substrates may be incorporated into biosynthetic pathways, as 
illustrated by strictosidine synthase, the enzyme that catalyzes the first committed step in the 
TIA biosynthesis, the condensation of tryptamine and secologanin to form strictosidine 
(Figure 2). Strictosidine synthase tolerates various modifications on the indole ring of 
tryptamine and can incorporate analogs containing benzofuran and benzothiophene 
heterocycles. Furthermore, the resulting unnatural condensation products are accepted by the 
downstream glucosidase, which leads to the production of unnatural analogs of alkaloid 
intermediates (McCoy and O'Connor, 2006; O'Connor and Maresh, 2006). Similarly, by 
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introducing prokaryotic halogenases that chlorinate the indole ring of tryptophan into C. 
roseus hairy roots, chlorinated tryptophan was produced and used by the downstream TIA 
biosynthesis enzymes to form halogenated alkaloids in planta (Runguphan et al., 2010). This 
first example of combinatorial biosynthesis in plants underscores its huge potential. 
In future combinatorial biosynthesis programs, the availability of substrates for the substrate-
flexible enzymes will become key. For instance, the recombinant alcohol acyltransferase of 
Fragaria x ananassa (strawberry) has been shown to accept a broad range of acyl-CoAs as 
precursor to form the volatile esters of strawberry fruit. However, the observed substrate 
tolerance of the recombinant enzyme and the observed volatile esters occurring in 
strawberries did not correspond, indicating that the availability of the precursors rather than 
the substrate specificity of the enzymes governs the volatile ester formation in strawberry 
(Aharoni et al., 2000). 
3.2.Biotransformation 
Biotransformation is defined as the process in which one chemical is transformed into 
another, by means of a biocatalyst. As biocatalyst, whole cells (either from microorganisms, 
animals or plants), cell extracts, or (partially) purified enzymes can be used (Julsing et al., 
2006). As purified enzymes are expensive, difficult to isolate, and need to be externally 
supplied with cofactors during the reaction, whole cells are considered as the preferred 
biocatalysts, because they are relatively cheap, easy to obtain, provide a protective 
environment for the enzymes from shear forces, and provide essential cofactors for the 
biotransformation. However, in whole cells it might be more difficult to avoid alongside side 
reactions and to control or reproduce the cells (de Carvalho and da Fonseca, 2006). 
Because of the dazzling high number of enzymes present in whole plant cells (see above), 
biotransformation can serve as an excellent tool for combinatorial biosynthesis to obtain 
novel compounds. Typically, the biotransformation substrates are cheap and highly available 
products that are transformed into more rare, and, thus, more expensive compounds (Ishihara 
et al., 2003; Zhou and Wu, 2006). Over the last few decades, numerous studies have reported 
on the biotransformation of exogenous substrates by plant cells (for an excellent review from 
1978 to 2003, see Ishihara et al., 2003). The advances in this field after 2003 are summarized 
in Table 1. 
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Table 1. An overview of biotransformations by plant biocatalysts from 2003 onwards. For earlier 
literature on plant-based biotransformation see (Ishihara et al., 2003). 
Substrate Species Reference 
Hydroxylation 
Ingenol-3-angelate 
Hordeum vulgare, Oryza sativa, Panax quinquefolium, Nicotiana 
tabacum 
(Teng et al., 2009) 
Tyrosine Portulaca grandiflora (Rani et al., 2007) 
Benzofuran-2-yl methyl ketone Daucus carota (Ravía et al., 2006) 
Acyclic monoterpene Catharanthus roseus (Matsuki et al., 2006) 
Oxidation of hydroxyl groups 
Taxadienes Ginkgo biloba (Zou et al., 2008) 
1-arylethanols Ocimum basilicum cv. Purpurascens (Itoh et al., 2008) 
α-pinene Psychotria brachyceras, Rauvolfia sellowii, Picea abies 
(Vaněk et al., 2005; 
Limberger et al., 2007) 
Prenyl alcohols Cucurbita maxima (Nagaki et al., 2007) 
Valencene Gynostemma pentaphyllum (Sakamaki et al., 2005) 
Enol acetates Marchantia polymorpha (Shimoda et al., 2004) 
α-ionone and β-ionone Caragana chamlagu (Sakamaki et al., 2004) 
Thujopsene Nicotiana tabacum, Catharanthus roseus (Chai et al., 2004) 
Reduction of carbonyl groups 
Aliphatic and aromatic aldehydes and 
ketones 
Cocos nucifera (Fonseca et al., 2009) 
Cyclic 3-oxo-amines Daucus carota (Lacheretz et al., 2009) 
Substituted fluorenones 
Malus pumila Mill., Musa balbisiana Colla, Citrus reticulata 
Blanco, Solanum tuberosum, Fragaria ananassa Duch., Allium 
fistulosum, Prunus spp., Allium saticum, Allium cepa, Prunus 
pseudocerasus Lindl., Zizyphus jujuba Mill., Jerusalem artichoko, 
Vitis spp. 
(Xie et al., 2009a) 
Aromatic ketones Phaseolus angularis (Xie et al., 2009b) 
Ketones 
Raphanus sativus, Baccharis crispa, Tessaria absinthioides, 
Malus pumila, Daucus carota, Cucumis sativus, Allium cepa, 
Solanum tuberosum, Raphanus sativus, Ipomoea batatas, Arctium 
lappa, Cyanidioschyzon merolae, Cyanidium caldarium 
(Utsukihara et al., 2006b; 
Utsukihara et al., 2006a; 
Matsuo et al., 2008; Orden 
et al., 2008; Yang et al., 
2008) 
Substituted acenaphthenequinones Prunus persica, Daucus carota (Tong et al., 2008) 
Aliphatic and aromatic aldehydes, ketone, 
ester, nitrile and amide 
Saccharum officinarum (Assunção et al., 2007) 
Dydrogesterone Azadirachta indica (Azizuddin et al., 2008) 
Substituted α-tetralones Daucus carota (Ferraz et al., 2008) 
Aldehydes, ketones Passiflora edulis, Manihot esculenta, Manihot dulcis 
(Machado et al., 2006; 
Machado et al., 2008a; 
Machado et al., 2008b) 
Carbonylic and carboxylic groups 
Actinidia chinensis, Allium porro, Convolvulus sepium, Daucus 
carota, Glycine soja, Helianthus annuus, Nicotiana tabacum, 
Philadelphus virginalis, Phytolacca decandra, Polygonum 
persicaria, Rauvolfia manii, Scorzonera hispanica, Solanum 
melanogena, Tagetes patula, Vitis vinifera 
(Villa and Molinari, 2008) 
2-substituted tetrahydropyran-4-ones Daucus carota (Yadav et al., 2008) 
Prochiral ketones Daucus carota 
(Caron et al., 2005; 
Blanchard and de Weghe, 
2006; Yadav et al., 2007) 
Phenolic 1-Benzyl-N-
methyltetrahydroisoquinolines 
Corydalis spp., Macleaya spp. (Cui et al., 2007) 
Nitro-aromatic compounds Arracacia xanthorrhiza, Beta vulgaris (Pacheco et al., 2007) 
Homochiral secondary alcohols 
Brassica oleracea botrytis, Cucurbita maxima, Cucurbita pepo, 
Cynara scolimus, Daucus carota, Foeniculum vulgare, Musa 
sapientum 
(Bruni et al., 2006) 
Xenobiotic diketones Brassica napus (Orden et al., 2006) 
Aromatic γ-nitroketones Daucus carota (Scarpi et al., 2005) 
Aromatic nitro compounds Vitis vinifera (Li et al., 2005a) 
Chinensiolide B Catharanthus roseus (Dai et al., 2005a) 
3-acetylisoxazoles Ocimum basilicum cv. Purpurascens (Itoh et al., 2005) 
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Bromo- and methoxy-acetophenone 
derivatives 
Daucus carota, Apium graveolens 
(Mączka and Mironowicz, 
2004a) 
Hydrogenation of double bonds 
Progesterone Marchantia polymorpha  (Haridy et al.) 
Dihydroartemisinic acid Catharanthus roseus, Panax quinquefolium (Zhu et al.) 
N-substituted maleimides 
Nicotiana tabacum, Catharanthus roseus, Marchantia 
polymorpha, Parthenocissus tricuspidata, Gossypium hirsutum 
(Hirata et al., 2005) 
Glycosylation 
Capsaicin Panax ginseng (Katsuragi et al.) 
Cinnamic acid, p-coumaric acid, caffeic acid 
and ferulic acid 
Eucalyptus perriniana (Katsuragi et al., 2010) 
Naringin and naringenin Eucalyptus perriniana (Shimoda et al., 2010) 
Sesamol Nicotiana tabacum, Eucalyptus perriniana (Shimoda et al., 2009a) 
Fluorophenols Nicotiana tabacum (Shimoda et al., 2009b) 
Farnesol, geraniol  and (S)-perillyl alcohol 
Eucalyptus perriniana, Strophanthus gratus, Phytolacca 
americana 
(Shimoda et al., 2008b) 
Genistein and quercetin Ipomoea batatas, Marchantia polymorpha (Shimoda et al., 2008a) 
Hesperetin Ipomoea batatas, Eucalyptus perriniana 
(Shimoda and Hamada, 
2008) 
p-hydroxybenzyl alcohol Nicotiana tabacum (Peng et al., 2008) 
Daidzein Eucalyptus spp., Various plants 
(Sato et al., 2007; 
Shimoda et al., 2008c) 
β-thujaplicin Nicotiana tabacum (Kwon et al., 2008) 
Cholesterol Dioscorea bulbifera 
(Jyothishwaran and 
Seetharam, 2008) 
Mono-, sesqui- and diterpenes Arabidopsis thaliana (Caputi et al., 2008) 
p-, m-, and o-hydroxybenzoic acids Panax ginseng (Chen et al., 2008) 
Taxifolin and Quercetin Eucalyptus perriniana (Kasai et al., 2007) 
Monoterpene alcohols Eucalyptus perriniana (Sakamoto et al., 2007) 
Capsaicin and 8-nordihydrocapsaicin Catharanthus roseus (Shimoda et al., 2007c) 
Ketone and zingerone Phytolacca americana (Shimoda et al., 2007a) 
Tocopherol Eucalyptus perriniana (Shimoda et al., 2007b) 
Podophyllotoxin Hordeum vulgare (Teng et al., 2007) 
4-hydroxybenzene derivatives Polygonum multiflorum (Yan et al., 2007) 
p-coumaric acid Eucalyptus perriniana (Hirabayasi et al., 2006) 
Thymol, carvacrol, and eugenol Eucalyptus perriniana (Shimoda et al., 2006b) 
Vitamin E, its homologues, and vitamin A Phytolacca americana, Catharanthus roseus (Shimoda et al., 2006a) 
Nitrosobenzene Spinacia oleracea 
(Tatsunami and Yoshioka, 
2006) 
Vitamin E 
Phytolacca americana, Catharanthus roseus, Eucalyptus 
perriniana 
(Kondo et al., 2006) 
Multiple transformations 
Paeonol Panax ginseng (Li et al., 2005b) 
Curcumin Catharanthus roseus (Kaminaga et al., 2003) 
Deoxypodophyllotoxin Linum flavum (Koulman et al., 2003) 
Paeonol Panax quinquefolium (Ma et al., 2010) 
Carbonyl compounds Taxus spp (Sandoval et al., 2009) 
Tryptophan Achillea millefolium (Marioni et al., 2008) 
Valdecoxib 
Catharanthus roseus, Azadirachta indica, Capsicum annuum, 
Ervatamia heyneana, Nicotiana tabacum 
(Molmoori et al., 2008) 
Aldehydes, ketones, α-keto esters, β-keto 
esters 
Various plants (Liu et al., 2008) 
Zerumbone Caragana chamlagu (Sakamaki et al., 2008) 
4(20),11-taxadienes 
Asparagus officinalis, Platycodon grandiflorum, Catharanthus 
roseus, Ginkgo biloba 
(Dai et al., 2005b; Dai et 
al., 2008) 
Bromo- and methoxy-substituted 1-
phenylethanol acetates 
Daucus carota, Apium graveolens 
(Mączka and Mironowicz, 
2007) 
Acetophenone derivatives, (RS)-1-
phenylethanol derivatives 
Allium schoenoprasum, Arctium lappa, Arracacia xanthorrhiza, 
Beta vulgaris, Brassica rapa, Colocasia esculenta, Coriandrum 
sativum, Dioscorea alata, Ipomoea batatas (white), Ipomoea 
batatas (red), Manihot esculenta, Polymnia sonchifolia, Raphanus 
(Andrade et al., 2006) 
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sativus, Solanum tuberosum, Zingiber officinale 
Sesquiterpenoids Marchantia polymorpha (Hegazy et al., 2005) 
α-bromo and α,α'-dibromo alkanone Various plants (Utsukihara et al., 2007a) 
α- and 6 β-santonin 
Asparagus officinalis, Catharanthus roseus, Ginkgo biloba, 
Platycodon grandiflorum, Taxus cuspidata, Phytolacca asinosa 
(Yang et al., 2005; Yang 
et al., 2006) 
Terpenes Various plants 
(de Carvalho and da 
Fonseca, 2006) 
Taxoids, cinobufagin, chinensiolide B, α-
santonin, artemisinin, hydroquinone, 
podophyllotoxin, cantharidin 
Various plants (Zhou and Wu, 2006) 
Hesperedin Daucus carota, Nicotiana tabacum (Frydman et al., 2005) 
Terpenoids Various plants (Ishida, 2005) 
14-deacetoxyl sinenxan A Ginkgo spp (Zhan et al., 2005) 
Steroids, terpenes, shikimic acid derivatives 
Apium graveolens var. rapaceum, Daucus carota, Armoracia 
lapathifolia Gilib. 
(Mączka and Mironowicz, 
2004b) 
Others 
2',4'-dihydroxychalcone Morus nigra (Bolasco et al.) 
Racemic aromatic alcohols Manihot esculenta (Machado et al., 2008a) 
1-arylethanols Cyanidioschyzon merolae (Utsukihara et al., 2008) 
Alkylcycloalkanediones; Aromatic 
heterocyclic compounds 
Caragana chamlagu, Wasabia japonica 
(Chai et al., 2003; 
Utsukihara et al., 2007b) 
 
 
The applications of biotransformation in pharmacognosy are very broad and are illustrated 
below with some of the most representative examples. First, biotransformation can generate 
novel potentially bioactive molecules that may serve as candidate drugs. For instance, 
paeonol supplied to hairy roots of Panax ginseng was converted into glycosylated 
derivatives. Paeonol glycosides have radical scavenging effects (Matsuda et al., 2001) and 
after biotransformation, two of the five detected paeonol glycosides were novel (Li et al., 
2005b). Second, biotransformation can alter the physical properties of a compound. For 
instance, the natural antioxidants genistein and quercetin that show antiallergic and anti-
inflammatory activities (Wang et al., 2006) cannot be applied as drugs because of their water-
insolubility and low absorbability after oral administration (Shimoda et al., 2008a). 
Glycosylation of flavonoids increases their water solubility (Nakajima et al., 2001), which, in 
turn, can possibly lead to a higher bioavailability of the compound. Indeed, feeding genistein 
and quercetin to cultured cells of Ipomoea batatas (sweet potato) and Marchantia 
polymorpha (liverwort) resulted in the glycosylation of these compounds and consequently 
enhanced their pharmaceutical applicability (Shimoda et al., 2008a). Third, the production of 
enantiopure compounds or molecules of one chirality is essential in the synthesis of organic 
molecules of biological interest (Rentsch, 2002). As enzymes are stereospecific biocatalysts, 
biotransformation can be applied to produce enantiopure compounds. For instance, hairy root 
cultures of Daucus carota (carrot) reduced the supplemented prochiral ketone acetophenone 
to 1-phenylethanol that consisted for more than 98% of the S-isomer (Caron et al., 2005). 
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3.3.Mutasynthesis 
A major limitation of biotransformation is its inability to generate targeted modifications on 
the applied substrates. Knowledge of metabolic pathways generates the opportunity to 
introduce particular, desired modifications on the supplied precursor molecules. This is the 
principle behind Precursor-Directed Biosynthesis (PDB), in which a compound analogous to 
the precursor is added to a secondary metabolite-producing organism. This precursor 
analogue is used by the wild-type organism in competition with the naturally occurring 
precursor, finally resulting in a mixture of the desired and the wild-type compounds (Birch, 
1963; Weist and Süssmuth, 2005; Kirschning et al., 2007; Weissman, 2007). PDB was 
originally developed for generating structural diversity in secondary metabolites of 
microorganisms (Kirschning et al., 2007). Nonetheless, it already proved to be applicable in 
plant secondary metabolism as well. Feeding of unnatural tryptamine analogues to C. roseus 
seedlings or hairy roots, led to the production of a whole range of novel alkaloids (McCoy 
and O'Connor, 2006). A major disadvantage of PDB, however, is the substrate specificity of 
the involved biosynthetic enzymes, that limits the range of unnatural precursors that can be 
applied. Furthermore, the internal competition of the analogous precursor with the naturally 
occurring endogenous precursor(s) may lead to low yields of the novel compound or to 
complex product mixtures from which the desired molecule is difficult to isolate. 
To overcome these limitations, mutational biosynthesis or mutasynthesis can be used. 
Mutasynthesis is a technique in which the analogous compound or mutasynthon is 
supplemented to a „biosynthetic block mutant‟. In this mutant, the biosynthetic pathway of 
the natural compound is blocked, so that only the analogous compound is produced 
(Rinehart, 1977; Weist and Süssmuth, 2005; Kirschning et al., 2007). In the first study 
published on mutasynthesis in plants, RNA silencing of tryptophan decarboxylase (Figure 2) 
effectively blocked the biosynthesis of tryptamine in C. roseus hairy roots. As a consequence, 
accumulation of TIAs was eliminated in these cultures. Subsequent feeding of these „mutant‟ 
hairy root cultures with an unnatural analogue of tryptamine yielded several novel TIAs. 
Importantly, the new compounds were not „contaminated‟ by the naturally present TIAs in 
the „wild-type‟ C. roseus (Runguphan et al., 2009). Another way to generate novel molecules 
via mutasynthesis is to reorient the plant biosynthetic pathways via mutated enzymes. 
Engineering enzymes via deliberate mutations can alter their substrate selectivity. For 
instance, by engineering the binding pocket of strictosidine synthase of C. roseus, mutant 
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enzymes were created that accepted strictosidine analogues that were not accepted by the 
native enzyme. Ultimately, novel, unnatural alkaloids were produced both in in vitro assays 
(Chen et al., 2006; Bernhardt et al., 2007; Loris et al., 2007) and in transgenic plant cell 
cultures (Bernhardt and O'Connor, 2009; Runguphan and O'Connor, 2009). Mutasynthesis 
has also been applied to generate novel plant polyketides. By mutation of three amino acids 
in the sequence of the pentaketide chromone synthase (PCS) from the medicinal plant Aloe 
arborescens (Krantz aloe), an enzyme was created that could condensate nine molecules of 
malonyl-CoA to form a novel nonaketide naphthopyrone (Abe, 2008). 
3.4.Combinatorial metabolism in hybrids 
Hybridization is a frequently occurring phenomenon in plants that can alter their resistance 
against biotic or abiotic stresses, facilitate introgression of plant traits, or ultimately lead to 
the formation of new plant species. Often, quantitative and qualitative variations are found in 
the secondary chemistry of hybrid plants (Orians, 2000). Hybrids may contain all of the 
secondary chemicals of both parental taxa, or may not contain certain parental chemicals, or 
may contain novel chemicals that are absent in either of the parental taxa (Orians, 2000; 
Lewinsohn and Gijzen, 2009). The latter form of hybrid metabolism is a “naturally” 
occurring form of combinatorial biochemistry in plants. 
A classical example of natural hybridization leading to novel compounds occurs in 
Helianthus (sunflower) species that produce sesquiterpene lactones (STLs) in their flowers. 
H. annuus, a species that synthesizes niveusin- and argophyllin-type STLs in its foliar 
glandular trichomes, hybridizes naturally with H. petiolaris, a species without foliar glandular 
trichomes that produces budlein-type STLs. Natural hybridization between these two species 
resulted in three hybrid-derived species in which the major STLs differ from those produced 
by either of the parental taxa (Orians, 2000). Furthermore, the F1 progeny of crosses between 
H. annuus and H. debilis contained novel STLs that were biosynthetic chimeras bearing the 
basic skeleton of one parent and the side chain of the other parent (Buschmann and Spring, 
1995). 
In an extensive literature review by Orians (2000) that underscored the potential to achieve 
combinatorial biochemistry in plants via hybridization, 32 hybrid crosses were cited that led 
to the accumulation of novel compounds (Orians, 2000). Several recent reports confirm this 
remarkable potential, a few of which are highlighted here. F1 poplar hybrids (Populus 
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deltoides cv „S9-2‟ x P. trichocarpa cv „V24‟) have been shown to accumulate an unknown 
flavanone compound that could not be detected in either of the parents. Furthermore, a 
metabolite quantitative trait locus had been identified that was postulated to control the 
accumulation level of the unknown flavanone compound (Morreel et al., 2006). Novel 
flavonoid compounds have also been detected in hybrids of Ziziphus mauritiana (jujube) 
(Bhargava et al., 2005) and Zea mays (maize) (Lee et al., 2009). In addition, three novel 
terpenoids were detected in hybrids of Artemisia tridentata (sagebrush) (Byrd et al., 1999), 
and two new odour compounds were found in Ophrys (orchid) hybrids (Vereecken et al., 
2010). 
Even crossings within different accessions, cultivars, or genotypes of a single plant species 
can result in combinatorial biochemistry, as demonstrated by a striking metabolite study of a 
collection of A. thaliana Ler/Cvi Recombinant Inbred Lines (RILs). Using untargeted liquid 
chromatography-time of flight mass spectrometry-based metabolomics, it was shown that 
more than one third of the masses detected in the RILs were not detectable in either of the 
parental accessions. This qualitative variety was attributed to the recombination of the 
parental genomes (Keurentjes et al., 2006). 
Nonetheless, in the above „classical‟ breeding cases, interspecific crossing barriers represent 
a major pitfall, that in laboratory practice can partially be overcome by somatic hybridization 
methods. In symmetric somatic hybridization, hybrids with the complete genomes of both 
parents are obtained through protoplast fusions, whereas in asymmetric somatic 
hybridizations, the donor genome is fragmented prior to protoplast fusion, yielding hybrids 
with the complete recipient genome, but a partial donor genome. An elegant example of a 
somatic hybridization experiment aimed at overcoming crossing barriers between wild and 
cultivated species of potatoes, more specifically of the wild-type, non-tuberous Solanum 
brevidens and the commonly cultivated, tuberous species, S. tuberosum (Laurila et al., 1996). 
The major glycoalkaloids normally found in the parental strains are tomatine (aglycone 
tomatidine) in S. brevidens and solanidine in S. tuberosum. The somatic hybrids, however, 
possessed large quantities of a novel glycoalkaloid, demissidine, not found in any of the 
parents, and four other unidentified compounds, along with all of the parental glycoalkaloids 
(Figure 3) (Laurila et al., 1996). In another example, the interspecific crossing barrier of 
Dendranthema morifolium (chrysanthemum) and Artemisia vulgaris (mugwort) was 
overcome via embryo rescue. The resulting intergeneric hybrids produced a small number of  
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Figure 3. Biosynthesis of a novel alkaloid, demissidine, in somatic hybrid plants of Solanum 
brevidens and Solanum tuberosum. Both parental plants produce teinemine, whereas solanidine and 
tomatidine are produced only in S. tuberosum and S. brevidens, respectively (Laurila et al., 1996; 
Oksman-Caldentey and Inzé, 2004). 
 
hybrid-specific terpenes besides the terpenes present in one or both of the parental plants 
(Deng et al., 2010). 
3.5.Activation of silent metabolism 
Recent advances in genomics indicate that the full metabolic capacity of organisms is far 
from comprehensively exploited. Bioinformatics has been used as a tool in microorganisms 
to identify a number of „orphan‟ biosynthetic pathways, i.e. pathways of which the encoded 
natural products are unknown (Gross, 2007; Chiang et al., 2011). For example, in the 
actinomycete Streptomyces coelicolor, only three antibiotics and a spore pigment had been 
described before its complete genome had been sequenced. Predictions based on the genome 
sequence revealed 18 more gene clusters potentially encoding the biosynthesis of various 
secondary metabolites (Bentley et al., 2002). Such observations illustrate that the currently 
used natural product compendia do not represent the full potential of the producing organisms 
(Cichewicz, 2010; Chiang et al., 2011). 
More than microorganisms, plant cells are capable of accumulating several thousands of 
secondary metabolites simultaneously, of which the exact biochemical role remains mostly 
unknown to date. Despite the already dazzling number of accumulating compounds, it is 
becoming clear that in plants, like in microorganisms, many biosynthetic pathways are not 
20 
 
fully active, or at least not detectably at the resolution of the present metabolite profiling 
technologies. Accordingly, many enzymes that have been annotated exist without any 
apparent endogenous substrate, pointing towards the occurrence of „occult‟ metabolic 
capabilities in plants. This phenomenon is also defined as silent metabolism (Lewinsohn and 
Gijzen, 2009) and can be „awakened‟ by either providing the appropriate substrate to the 
existing enzymes, or, alternatively, by triggering the inactive parts of the biosynthetic 
pathways. As such, ectopic onset of silent metabolism might generate unprecedented 
opportunities to obtain new enzyme-substrate combinations and serve as a tool to obtain 
novel plant-derived compounds. 
In the literature, several silent metabolism cases in plants have been described. For instance, 
only recently Arabidopsis has been found capable of producing volatile terpenes in its 
flowers (Chen et al., 2003). Before this discovery, the terpene-producing capacity of the plant 
was only suspected, based on the 32 predicted terpene synthase genes in its genome. In 
another study, scanning of the genomic regions of predicted oxidosqualene cyclases revealed 
a gene operon that was exclusively expressed in Arabidopsis roots and potentially involved in 
plant secondary metabolism. Functional analysis of the oxidosqualene cyclase gene in yeast 
showed that it catalyzed the formation of thalianol, a compound that had never been reported 
in plants before. Subsequently, the occurrence of low amounts of the triterpene thalianol was 
demonstrated in Arabidopsis roots (Field and Osbourn, 2008). Similarly, although in 
Arabidopsis no complex alkaloids have been detected yet, genome scanning revealed the 
presence of numerous homologues of enzymes involved in alkaloid biosynthesis in medicinal 
plants, including of the tropane, pyrrolidine and indole alkaloid types (Facchini et al., 2004). 
Thus, a well-studied plant such as Arabidopsis might also be capable of producing still 
undiscovered alkaloids, a hypothesis that nonetheless still needs to be substantiated (D'Auria 
and Gershenzon, 2005). More examples of silent metabolism have been recently described 
elsewhere (Lewinsohn and Gijzen, 2009). 
In a broader sense, tissue-, cell-, or even organelle-specific expression of genes in plants can 
be seen as silent metabolism as well. Activation of this alternative form of silent metabolism 
via ectopic expression can give rise to novel enzyme-substrate combinations, resulting in the 
generation of novel compounds. For instance, ectopic overexpression of the Vitis vinifera 
(grapevine) fruit-specific VvMybPA1 and VvMybPA2 MYB transcription factors activated 
protoanthocyanin biosynthesis in hairy roots. The MYB-overexpressing grapevine hairy roots 
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accumulated one specific class of protoanthocyanins, B-ring trihydroxylated units, that are 
absent in control hairy roots (Terrier et al., 2009). 
Finally, even (re)directing a metabolic pathway to a specific cellular compartment may 
activate silent metabolism and subsequent production of novel compounds. The targeting of a 
strawberry linalool/nerolidol synthase to the mitochondria in transgenic Arabidopsis, instead 
of to its natural site, the cytosol, produced small amounts of 4,8-dimethyl-1,3(E),7-nonatriene 
(E-DMNT), a new compound for Arabidopsis (Kappers et al., 2005). Hence, Arabidopsis 
contains the necessary enzymes to recognize and convert the product of the linalool/nerolidol 
synthase, (3S)-(E)-nerolidol, to E-DMNT, a signal molecule in plant defence that attracts 
enemies of herbivores (Bouwmeester et al., 1999; Kappers et al., 2005). Similarly, 
reallocating patchoulol synthase from its natural cytosolic location to the chloroplast of 
Nicotiana tabacum (tobacco), resulted in the production of high amounts of patchoulol, and 
an entire suite of novel sesquiterpenes (Wu et al., 2006). 
4. Synthetic biology - heterologous biosynthesis of plant products in 
microorganisms 
One of the major challenges in the development of plant-derived drugs is obtaining sufficient 
amounts of the compounds. In a lot of cases, the complex bioactive molecules are available at 
very low concentrations in planta. Furthermore, plant growth can be very slow, or the 
molecules are found in plant species that are rare, threatened with extinction, or that are 
recalcitrant to genetic transformation. As such, the establishment of combinatorial 
biosynthesis programs in planta may be compromised, at least in some plant species. 
As an alternative approach, sets of plant biosynthesis enzymes can be expressed in 
microorganisms, such as Escherichia coli or Saccharomyces cerevisiae (yeast), in 
combination, if necessary, with modified genes to optimize production in the microbial host. 
This approach is called synthetic biology and has become fashion thanks to the latest 
technological and strategical advances in this field (Li and Vederas, 2009; Roberts and 
Kolewe, 2010). Heterologous expression of plant enzymes in microorganisms, may generate 
unlimited opportunities for combinatorial biochemistry, provided the necessary genetic 
information is available. Genes from different plant species can be merged, thus generating 
new-to-nature enzyme combinations, that finally lead to production of novel compounds and 
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their structural variation can be increased by addition of unnatural substrates to the 
recombinant microorganisms. 
To obtain combinatorial biosynthesis it is essential to engineer the recombinant 
microorganisms to produce the desired plant compounds. To date, several classes of 
medicinal plant natural products can be produced in microorganisms. For instance, the 
simultaneous expression of phenylalanine ammonia lyase from the yeast Rhodotorula rubra, 
4-coumarate CoA ligase from the actinomycete Streptomyces coelicolor, and chalcone 
synthase from the plant Glycyrrizha echinata (licorice) in E. coli led to the production of 
plant-specific flavanones in the recombinant bacteria (Hwang et al., 2003; Kaneko et al., 
2003). Later metabolic engineering efforts in E. coli led to the fermentative production of 
several other types of plant secondary metabolites with increased amounts of the desired 
compounds including flavonoids compounds (Watts et al., 2004; Fowler and Koffas, 2009; 
Horinouchi, 2009; Du et al., 2010), terpenoids (Chemler and Koffas, 2008), and alkaloids 
(Minami et al., 2008). For instance, amorphadiene, the sesquiterpene precursor molecule of 
the powerful anti-malarial drug artemisinin, is produced in E. coli by simultaneous expression 
of the genes of the yeast mevalonate pathway and a synthetic amorphadiene synthase gene in 
the bacteria (Martin et al., 2003). As more enzymes in the artemisinin biosynthesis pathway 
were characterized, the production of up to 100 mg/L artemisinic acid was established in E. 
coli (Chang et al., 2007). Similarly, the production of the diterpene taxadiene, an intermediate 
of the biosynthesis of the anticancer drug paclitaxel was obtained in E. coli via the ectopic 
expression of genes encoding isopentenyl diphosphate isomerase from the yeast 
Schizosaccharomyces pombe, geranylgeranyl diphosphate from the bacteria Erwinia 
herbicola and taxadiene synthase from the plant Taxus brevifolia (Huang et al., 2001). 
Subsequent metabolic engineering of taxadiene producing E. coli increased production levels 
of taxadiene and taxadien-5α-ol, the next step in the biosynthesis of paclitaxel (Ajikumar et 
al., 2010; Liu and Khosla, 2010). 
Besides E. coli, S. cerevisiae cells can be used for the biosynthesis of plant natural products. 
The production of up to 100 mg/L of artemisinic acid is achieved in yeast by engineering its 
mevalonate pathway and simultaneous overexpression of amorphadiene synthase and 
CYP71AV1, a cytochrome P450 monooxygenase, from A. annua (Ro et al., 2006). 
Furthermore, the biosynthesis of various plant metabolites, such as taxol (DeJong et al., 2006; 
Engels et al., 2008), several types of flavonoids (Jiang et al., 2005; Chemler and Koffas, 
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2008; Fowler and Koffas, 2009; Horinouchi, 2009), alkaloids (Chemler and Koffas, 2008; 
Hawkins and Smolke, 2008), and saponins (Shibuya et al., 2006; Seki et al., 2008) has been 
(partially) reconstructed in yeast. 
Once a (partial) biosynthesis pathway is established in the target microbe, novel compounds 
can be produced via the combinatorial biosynthesis techniques discussed above. For instance, 
when unnatural carboxylic acids were fed to recombinant E. coli cells harboring artificial 
flavanone and stilbene biosynthesis pathways, more than 30 unnatural, novel polyketides 
were produced (Katsuyama et al., 2007). Moreover, the produced unnatural scaffolds could 
be further modified by the incorporation of downstream modification enzymes within the 
artificial biosynthetic pathways (Horinouchi, 2008, 2009; Katsuyama et al., 2010; Werner et 
al., 2010). Combinatorial biosynthesis of plant products in microorganisms can also be 
achieved by combinatorial piling up of plant biosynthetic genes in the microbes. Expressing 
genes from different plant species may lead to new-to-nature enzyme combinations, finally 
resulting in the biosynthesis of new-to-nature compounds in the recombinant microorganism. 
5. Bioactive terpenoid indole alkaloids 
To highlight the relevance of the structural variety for bioactivity, in terms of drug potential, 
two classes of plant natural products, the terpenoid indole alkaloids (TIAs) and the saponins 
will be discussed. 
Alkaloids are nitrogen-containing molecules with a low molecular weight and are mostly 
derived from the amino acids Phe, Tyr, Trp, Lys, and Arg. Approximately 20% of all plant 
species produce alkaloids. Traditionally, humans make use of the biological potency of 
alkaloids for hunting, or treatment of diseases, but also for less noble purposes, such as 
executions and warfare (De Luca and St Pierre, 2000). 
An important set of alkaloids are the TIAs, a class of structurally diverse molecules of which 
many show interesting pharmaceutical activities. TIAs are mainly found in plants belonging 
to the Apocynaceae, Icacinaceae, Loganiaceae, Nyssaceae, and Rubiaceae families and are 
derived from the common precursor molecule strictosidine, a condensation product of the 
terpenoid moiety secologanin and the tryptophan-derived indole moiety tryptamine 
(Figure 2). The structural variability of TIAs in the different TIA-producing plant species is 
due to species-specific conversions of the common strictosidine precursor molecule that are 
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either enzymatically catalyzed or occur through spontaneous chemical reactions (Memelink 
et al., 2001; O'Connor and Maresh, 2006). These species-specific decorations have profound 
effects, not only for the final complexity of the structure itself, but above all on its 
bioactivity, which sets a splendid example of the enormous resources for combinatorial 
biochemistry available within the plant kingdom, but still remains hardly explored. The 
structure and bioactivity of the most potent TIA drugs currently known are briefly described 
below. 
The predominantly investigated TIA-producing plant species is C. roseus that is capable of 
producing over 120 different TIAs in its various organs (Memelink et al., 2001; van der 
Heijden et al., 2004), some of which have therapeutic activities and are used as 
pharmaceuticals. Vinblastine and its oxidized form vincristine (Figure 4), two minor 
constituents of the complex C. roseus TIA mixture, are commercially used as anti-cancer 
drugs. They are antineoplastic drugs that bind tubulin, thereby inhibiting the assembly of 
microtubule structures, that, in turn, disrupts the assembly of the mitotic spindle and the 
kinetochore, and ultimately leads to an arrest in the metaphase of rapidly dividing cells, 
including cancer cells (Jordan et al., 1991; van der Heijden et al., 2004). Vinblastine (brand 
names, e.g. Velban
®
 and Velbe
®
) is mainly administered to treat lymphoma, but is also 
applied to treat bladder cancer, testicular cancer or Kaposi‟s sarcoma, whereas vincristine 
(brand names, e.g. Oncovin
®
 and Vincasar Pfs
®
) is used to treat lymphoma, leukaemia, and 
other types of cancer. C. roseus also accumulates the antihypertensive and antiarrhythmic 
TIA compounds ajmalicine (or raubasine; brand names, e.g. Circolene
®
, Hydrosarpan
®
, 
Isoarteril
®
 and Lamuran
®
) and serpentine (Figure 4) (van der Heijden et al., 2004; Dutta et 
al., 2005; O'Connor and Maresh, 2006). 
Another important genus of TIA producing plants is Rauwolfia, in which the most 
pharmacologically important TIAs are reserpine, ajmaline, yohimbine, and ajmalicine 
(Figure 4). Reserpine (brand name Harmonyl
®
) is administered as an antihypertensive drug to 
control high blood pressure and as an antipsychotic to treat, for instance, schizophrenia, but is 
nowadays rarely used because of its numerous side-effects and the development of drugs with 
better efficacy. Ajmaline is an antiarrhythmic drug that is, due to its short half-life, very 
useful for acute intravenous treatments of abnormal heart rhythms, such as ventricular 
tachycardia and atrial fibrillations in patients with the Wolff–Parkinson–White syndrome 
(Wellens et al., 1980). Furthermore, it is also the drug of choice to search for ST elevations in  
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Figure 4. Overview of the molecular structures of pharmacologically important TIAs derived from 
strictosidine. 
 
electrocardiograms of patients suspected of suffering from the Brugada syndrome (Miyazaki 
et al., 1996), a genetic disease causing unanticipated ventricular fibrillation, which can lead to 
cardiac arrest and death (Brugada and Brugada, 1992). Yohimbine (brand name Procomil®) 
is a psychoactive drug with stimulant and aphrodisiac effects. Yohimbine hydrochloride has 
potential clinical applications for the treatment of erectile dysfunction (Ernst and Pittler, 
1998; Drewes et al., 2003), and can also be used as a mydriatic drug to aid eye examinations 
(Phillips et al., 2000). Rauwolfia species produce yohimbine only in limited amounts, hence 
the main natural source of the molecule is the African tree Pausinystalia yohimbe (yohimbe) 
(Drewes et al., 2003). 
The Chinese „happy tree‟ Camptotheca acuminata was the first source of another important 
TIA, the antineoplastic compound camptothecin (Wall et al., 1966), which was later found in 
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a few other plant species as well (Govindachari and Viswanathan, 1972; Tafur et al., 1976; 
Gunasekera et al., 1979; Arisawa et al., 1981; Dai et al., 1999; Zhou et al., 2000; Saito et al., 
2001; Klausmeyer et al., 2007). Camptothecin (Figure 4) binds to the mammalian DNA 
topoisomerase I and, thereby, interferes with the breakage-reunion reaction of the 
topoisomerase I via the stabilization of a reaction intermediate, namely the cleavable 
complex. The S-phase specific toxicity of camptothecin is caused by the interaction between 
the stabilized topoisomerase I cleavable complexes and the moving replication forks, that 
provokes an irreversible fork arrest and ultimately highly toxic double-strand DNA breaks, 
that finally cause cell death (Hsiang et al., 1985; Hsiang et al., 1989; Liu, 1989; D‟Arpa et al., 
1990; Ryan et al., 1991; Thomas et al., 2004). Nowadays, camptothecin and its more water-
soluble derivatives topotecan and irinotecan are common anticancer agents (Thomas et al., 
2004). Topotecan hydrochloride (Hycamtin
®
) is mainly used to treat ovarian and lung cancer. 
CPT-11 or irinotecan hydrochloride (Camptosar
®
 and Campto
®
) is used to treat colon cancer, 
frequently in combination with other types of chemotherapeutical drugs. 
Other important well-known TIAs include strychnine and quinine (Figure 4). Strychnine is a 
poison produced by Strychnos nux-vomica (poison nut) that provokes muscular convulsions 
and eventually leads to death through asphyxia or sheer exhaustion and is used as a pesticide 
against small vertebrates, such as birds and rodents. Quinine is a bitter tasting TIA with 
antipyretic, antimalarial, analgesic, and anti-inflammatory activities. It is extracted from the 
bark of the Cinchona tree and was for a long time the drug-of-choice to treat malaria. The 
distinctive bitter taste of tonic water is due to the added quinine. 
To date, most advances in molecular characterization of the complex and strictly regulated 
TIA biosynthesis pathway have been made in C. roseus. The first step in the biosynthesis of 
all TIAs is the condensation of the precursor molecules tryptamine and secologanin by the 
enzyme strictosidine synthase. The indole moiety tryptamine is derived from the primary 
metabolite tryptophan via a single enzymatic step, the decarboxylation of the amino acid by 
the enzyme tryptophan decarboxylase (Figure 2). The biosynthesis of the terpenoid (iridoid) 
moiety secologanin consists of several enzymatic steps, of which only a few are 
characterized, and starts with the hydroxylation of the 2-C-methyl-D-erythritol 4-phosphate 
(MEP) pathway derived monoterpenoid geraniol (Facchini and De Luca, 2008; Murata et al., 
2008). 
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After the condensation of secologanin and tryptamine to strictosidine, the various TIA 
structures are generated via species-specific enzymatic reactions and spontaneous chemical 
modifications (Memelink et al., 2001). Because of the complexity of the pathway, most of the 
enzymes involved in the biosynthesis of the various TIA backbones are still unknown. 
Nonetheless, several subpathways, such as the six-step enzymatic conversion of tabersonine 
to vindoline in C. roseus (Loyola-Vargas et al., 2007) or the 10-step ajmaline biosynthesis in 
R. serpentina (Ruppert et al., 2005) have already been elucidated. 
6. Bioactive triterpene saponins 
Saponins compose a structurally diverse group of amphipathic glycosides, with a steroid, 
steroidal alkaloid, or triterpenoid aglycone backbone. The aglycone or sapogenin can be 
covalently linked to one (monodesmosidic) or more (di- or tridesmosidic) sugar chains via a 
glycosidic bond. Saponins are surface-active agents that, when dissolved in water, form a 
colloidal solution that foams upon shaking. Accordingly, they are used as emulsifier and 
foaming agents in the food and beverage industries. Importantly, many saponins also possess 
pharmacological properties and are, therefore, commonly used in phytotherapy and the 
cosmetic industry. 
Here, we will focus on the structure-activity relationships of only one type of saponins, the 
triterpene saponins. All terpenoids are derived by repetitive fusions of a branched five-carbon 
unit, isopentenyl diphosphate (IPP). The number of fused IPP units determines the 
classification of the terpenoids. Triterpenoids, to which also the steroids belong, contain 30 
carbon atoms. The precursor C30 unit, called squalene, is generated by the joining of two C15 
units, or farnesyl diphosphate, each of which constitutes of three IPP units (Croteau et al., 
2000) and is usually oxidized to its 2,3-epoxide, 2,3-oxidosqualene. The first committed step 
in the biosynthesis of triterpene saponins is the cyclization of 2,3-oxidosqualene. This step 
forms the branch point between the primary sterol and the secondary saponin metabolism 
(Figure 5). Predating the emergence of plants, cycloartenol synthase (CAS), involved in 
primary steroid metabolism, is the ancestor enzyme of all plant oxidosqualene cyclases 
(OSCs) involved in secondary metabolism (Figure 5) (Phillips et al., 2006). Most plants 
contain several OSCs that catalyze the formation of different triterpene skeletons. For 
instance, the genome of Arabidopsis contains up to 13 predicted OSC-encoding genes, 
producing various triterpenes of which the function in planta remains mostly unknown (Field  
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Figure 5. Biosynthesis of triterpene saponin aglycones from the common precursor 2,3-
oxidosqualene. Following cyclization of 2,3-oxidosqualene by specific oxidosqualene cyclases, the 
cyclization products are oxidized at various positions. BAS, β-amyrin synthase; CAS, cycloartenol 
synthase; DDS, dammarenediol synthase; LUS, lupeol synthase; THAS, thalianol synthase. 
 
and Osbourn, 2008). As such, nearly 100 distinct non-steroidal triterpene skeletons have been 
described in plants (Phillips et al., 2006). Usually, two distinct types of additional 
modifications of the cyclization products complete the saponin biosynthesis and dramatically 
increase the structural diversity. Firstly, cytochrome P450 mediated oxidations of the 
cyclization products give rise to different sapogenins. For instance, in the model plant 
Medicago truncatula (barrel medic), oxidation of the oleanane-type cyclization product β-
amyrin leads to at least 10 different sapogenins (Pollier et al., 2011) and in the medicinal 
plant Panax ginseng (Asian ginseng), two different saponin backbones, protopanaxadiol 
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(PPD) and protopanaxatriol (PPT) are formed by oxidation of the dammarane-type 
cyclization product dammarenediol (Lü et al., 2009) (Figure 5). Subsequently (and/or 
concomitantly), the different sapogenins can be glycosylated at different positions. The 
attached sugar chains can be linear or branched and can contain different monosaccharides, 
such as glucose, galactose, glucuronic acid, xylose, or rhamnose. Other, less common, 
modifications, such as acylations, can further increase the structural variability of the 
saponins. Even within a single plant species, an enormously rich mixture of saponins can 
occur. For example, in P. ginseng alone already over 40 ginsenosides have been reported, 
some of which have only been discovered recently (Shin et al., 2000; Dou et al., 2001; Zou et 
al., 2002; Yoshikawa et al., 2007; Tung et al., 2009; Tung et al., 2010). 
One of the most promising pharmacological activities of triterpenoid saponins is their ability 
to activate the mammalian immune system, making them candidate vaccine adjuvants (Skene 
and Sutton, 2006; Sun et al., 2009a). As candidate adjuvant, QS-21, a saponin isolated from 
the bark of Quillaja saponaria (soapbark), has been evaluated in several clinical trials (Sun et 
al., 2009a). QS-21 is far more effective than the currently accepted adjuvants for human 
vaccines, calcium and aluminium salts (Cipolla et al., 2008), but toxicity, haemolytic side 
effects and instability in the aqueous phase limit its current use in human vaccines (Liu et al., 
2002; Skene and Sutton, 2006; Yang et al., 2007; Sun et al., 2009a). Insights into the 
structure-activity relationship of saponins, in regard to their adjuvant and haemolytic effects, 
might enable to overcome some of these undesired effects. A lot of adjuvant compounds have 
an amphipathic structure. Saponins, with their lipophilic aglycone backbone and hydrophilic 
sugar chains have amphipathic properties as well. A study on the correlation between 
adjuvant activity and amphipathic structure of saponins has clearly shown an increasing 
adjuvanticity with an increasing amphipathicity of the molecules (Oda et al., 2003), whereas 
haemolytic effects are considered to be influenced by the affinity of the lipophilic aglycone to 
cholesterol in the cell membranes. The degree of affinity depends on the type of aglycone and 
side chains occurring on the aglycones (Sun et al., 2009a). 
Also the immunostimulating complex (ISCOM
®
)-based vaccines make use of the adjuvant 
properties of saponins, while overcoming their haemolytic effects (Morein et al., 1984; 
Pearse and Drane, 2005; Sun et al., 2009b). Iscoms are spherical, cage-like structures, 
typically 40 nm in diameter, that form spontaneously when saponin, cholesterol and 
phospholipid are mixed under controlled conditions. Traditionally, the ISCOM
®
-based 
30 
 
vaccines also make use of „Quil A‟ saponins, which is a crude saponin extract from the bark 
of Q. saponaria (Morein et al., 1984). However, because the Quil A extract is a 
heterogeneous mixture of dozens of closely related saponins that vary in their chemical or 
biological activities, variations in the composition of the mixture may lead to unpredictable in 
vivo effects. Hence, the current tendency is to use more purified fractions of the Quil A 
saponin extract, such as QS-21 (Sjölander et al., 1998; Pearse and Drane, 2005; Skene and 
Sutton, 2006). Several other medicinal plants contain structurally different saponins with 
adjuvant activity (Song and Hu, 2009; Sun et al., 2009a) and novel immunostimulatory 
nanoparticles could be developed by incorporation of these saponins in iscom-like 
nanostructures. Ginsomes, for instance, are nanoparticles containing saponins from the 
medicinal plant P. ginseng, and enhance the IgG responses in mice, when they are 
administered together with the antigen, instead of the antigen alone (Song et al., 2009). 
Triterpene saponins can also serve in cancer treatments. One of the most studied triterpene 
molecules in this context, is a compound isolated from the bark of Betula alba (white birch) 
trees, betulinic acid (Figure 5), which was shown to be a melanoma-specific cytotoxic agent 
able to inhibit tumour growth in vitro and in vivo, without systemic toxicity (Pisha et al., 
1995; Fulda, 2009; Laszczyk, 2009). Betulinic acid affects the mitochondrial membrane 
potential of cancer cells, resulting in the release of mitochondrial proteins, such as 
cytochrome c, in the cytosol that trigger apoptosis in the cancer cells (Fulda et al., 1998; 
Laszczyk, 2009). In contrast to other antineoplastic drugs, betulinic acid has no cytotoxic 
effects on nonmalignant cells, but the exact mechanism for the selectivity of betulinic acid 
towards malignant cells remains to be discovered (Fulda, 2009). Betulin (Figure 5), which 
differs from betulinic acid only on position 28, can also induce apoptosis in cancer cells (Pyo 
et al., 2009; Rzeski et al., 2009; Li et al., 2010), but, despite its almost identical structure and 
similar effects on cancer cells, its mode of action is different. Unlike betulinic acid, betulin 
fails to trigger the release of cytochrome c from isolated mitochondria, suggesting a different 
mechanism of triggering the intrinsic apoptotic pathway (Li et al., 2010). 
In addition to adjuvant and anti-cancer properties, a plethora of other bioactivities have been 
attributed to triterpenoid saponins (Francis et al., 2002; Sparg et al., 2004; Güçlü-Üstündağ 
and Mazza, 2007; Sun et al., 2009a; Augustin et al., 2011). For instance, ginsenosides from 
P. ginseng alone are pharmacologically significant as anti-cancer, anti-diabetic, 
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neuroprotective, cardioprotective, radioprotective, hypolipidemic, anti-amnesic and anti-
aging agents (Ji and Gong, 2007; Liang and Zhao, 2008; Ng et al., 2008; Lu et al., 2009). 
All of the pharmacologically potent triterpenes described above are naturally occurring 
compounds. Chemical modification of the triterpene scaffolds has led to the synthesis of 
semisynthetic triterpenoids with improved pharmacological properties, in comparison to the 
parent compounds. The most promising candidate drug of this sort is bardoxolone methyl, a 
chemical derivative of oleanolic acid (Figure 5). Recently, bardoxolone methyl has been 
positively evaluated in a Phase-IIB clinical trial, in which its oral administration reduced the 
stage of disease and improved measures of kidney function in patients with chronic kidney 
disease (CKD) and Type 2 diabetes (see http://www.abbott.com/global/url/pressReleases). 
Bardoxolone methyl acts by activating the transcription factor Nrf2, inducing the antioxidant 
and detoxification enzymes of the phase 2 response (Dinkova-Kostova et al., 2005; Yates et 
al., 2007). This increased cellular antioxidant content prevents activation of inflammatory 
signalling pathways, such as NF-κB and, thereby, prevents chronic “metabolic inflammation” 
that promotes Type 2 diabetes and CKD. Besides bardoxolone methyl, several other synthetic 
triterpenoids activate Nrf2. Essential features required for the activation of Nrf2 are the 
presence of Michael acceptor groups (enones) on both the A and C rings of the molecules, 
and a nitrile group at the C2 position (Yates et al., 2007). Nrf2 activation may also be useful 
for treatment of several types of cancer. Tumour-associated immune suppression is mediated 
by reactive oxygen species and contributes to tumour growth and limits the activity of cancer 
immunotherapy. Accordingly, blocking the tumour-associated immune suppression by 
treatment with bardoxolone methyl improved the immune response in tumour-bearing mice 
and cancer patients (Nagaraj et al., 2010). 
7. Outlook: Gene discovery for combinatorial biosynthesis of plant 
natural products 
Plant-derived natural products are and will undoubtedly remain very important for various 
drug discovery programs. The structural diversity of these complex molecules may be further 
enhanced with various combinatorial biosynthesis techniques, and the low production 
amounts in planta may be tackled with the heterologous expression of plant genes in 
microorganisms, such as E. coli or yeasts, or ultimately, plants themselves might be 
metabolically engineered. To exploit the full potential of plant natural products, knowledge of 
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the genes involved in the biosynthesis of the metabolites is essential, but, until now, most, if 
not all, of the biosynthesis pathways remain incompletely understood. 
Over the past five years, the commercialization of several next-generation sequencing 
techniques, such as pyrosequencing in the 454 system (Margulies et al., 2005), bridge PCR in 
the Solexa technology (Bentley, 2006), sequencing by ligation in the AB SOLiD and 
Polonator platforms (Shendure et al., 2005; Shendure and Ji, 2008), single molecule DNA 
sequencing in the HeliScope platform (Harris et al., 2008), or, more recently, the application 
of single-molecule real-time DNA sequencing in the PacBio RS system (Eid et al., 2009; 
Metzker, 2010), has revolutionized functional genomics. This tremendous progress now 
brings the whole genome or transcriptome of any plant species within reach and will 
undoubtedly greatly accelerate gene discovery for secondary metabolite pathways. 
Simultaneously, the enormous amount of data generated by such next-generation sequencing 
platforms demands for efficient strategies to identify and select the relevant biosynthetic 
genes from the pools of thousands of sequenced genes, or at least for efficient ways to exploit 
them. One way to solve this problem would be the use of elicitors, such as the phytohormone 
jasmonate. Elicitors induce the production of a compound of interest in plants or plant cell 
cultures and most often this effect is caused by the transcriptional activation of the genes 
involved in the biosynthesis of these compounds. Hence, comparison of transcriptomes at 
various stages before and after elicitor treatment will allow pinpointing the desired subsets of 
the total gene pools as candidate genes responsible for the biosynthesis of the secondary 
metabolites (Oksman-Caldentey and Inzé, 2004; Pauwels et al., 2009). Several studies have 
already demonstrated the feasibility of this approach. For instance, treatment of tobacco 
Bright Yellow 2 (BY-2) cell cultures with jasmonate induces nicotine biosynthesis in the 
cells. Genome-wide transcript profiling of the jasmonate-elicited cell cultures resulted in the 
establishment of a tobacco gene compendium (Goossens et al., 2003) from which several new 
proteins, including enzymes, regulators and transporters involved in nicotine biosynthesis 
were identified in subsequent functional screens (De Sutter et al., 2005; Häkkinen et al., 
2007; Morita et al., 2009; De Boer et al., 2011; Lackman et al., 2011). In a similar series of 
studies in the triterpene saponin-producing model legume, M. truncatula, the response of the 
metabolome and transcriptome to different elicitors was investigated (Suzuki et al., 2005). 
Analysis of unknown genes co-regulated with known triterpene saponin biosynthesis genes 
led to the identification and characterization of glucosyltransferases involved in triterpene 
saponin biosynthesis (Achnine et al., 2005; Naoumkina et al., 2010). The identification of 
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such sets of candidate genes involved in the biosynthesis of plant natural products will allow 
a high-throughput approach for combinatorial biosynthesis in plants or heterologous 
microbial systems. Alternatively, „metagenomics‟ approaches may be employed to screen for 
plant enzymes that can catalyze the synthesis of new-to-nature compounds. Indeed, capturing 
the genetic resources of complex microbial communities in metagenome libraries already 
allowed the discovery of a wealth of new enzymatic diversity, of entirely new sequence 
classes and novel functionalities (Ferrer et al., 2009). 
Hence, we can conclude that, aided by the recent technical advances in gene discovery and 
functional genomics, the large-scale implementation of different combinatorial biosynthesis 
techniques in plants will offer a bright green future for drug discovery in plant-derived 
natural products. 
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Abstract 
Saponins are an important class of plant natural products with an enormous structural variety 
and diverse bioactivities. Despite their potential, several of the steps involved in the saponin 
biosynthesis remain uncharacterized at the molecular level. Here, we used a functional 
genomics approach to identify candidate genes involved in the saponin biosynthesis of five 
different plants. After elicitation with jasmonate and targeted metabolite profiling, a genome-
wide cDNA-AFLP transcript profiling was carried out for the five plants. Taking into account 
the putative functional annotation and the expression pattern of the visualized transcript tags, 
a set of 259 candidate genes involved in hydroxylation, glycosylation and other decorations 
of the saponin backbone were identified. The generated gene list provides the basis for a 
combinatorial biosynthesis platform that targets triterpene saponins in plants. Furthermore, 
the identified transcription factors and other regulators are lead candidates for studies 
investigating the control of saponin biosynthesis in planta. 
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1. Introduction 
Saponins compose a structurally diverse group of amphipathic glycosides, with a steroid, 
steroidal alkaloid or triterpenoid aglycone backbone. The aglycone or sapogenin can be 
covalently linked to one (monodesmosidic) or more (di- or tridesmosidic) sugar chains via a 
glycosidic bond. The word saponin is derived from “sapo”, the Latin word for soap, and is 
given to this class of molecules because they are surface active agents, that, when dissolved 
in water, form a colloidal solution that foams upon shaking. Accordingly, they are used as 
emulsifier and foaming agents in the food and beverage industries. Importantly, many 
saponins also possess pharmacological properties, such as anti-inflammatory, antimicrobial, 
anticancer, or adjuvant activities, and are therefore commonly used in phytotherapy and the 
cosmetic industry (Dixon and Sumner, 2003; Sparg et al., 2004; Sun et al., 2009; Yendo et 
al., 2010; Augustin et al., 2011). 
Although triterpene saponins are an important class of plant secondary metabolites, 
knowledge of their biosynthesis remains incomplete. The precursor molecule of all triterpene 
saponins is 2,3-oxidosqualene, a precursor they share with the sterols. 2,3-oxidosqualene is 
synthesized via the isoprenoid pathway, relying on the cytosolic mevalonate pathway for the 
isopentenyl diphosphate supply (Figure 1). The first committed step in the saponin 
biosynthesis, the cyclization of 2,3-oxidosqualene, forms the branch point between the 
primary sterol metabolism and the secondary saponin metabolism. The ancestor enzyme of 
all plant oxidosqualene cyclases (OSCs) involved in secondary metabolism is cycloartenol 
synthase (CAS), involved in primary steroid metabolism (Phillips et al., 2006). Most plants 
contain several OSCs that catalyze the formation of different triterpene skeletons. For 
instance, the genome of the model plant Arabidopsis thaliana contains up to 13 predicted 
OSCs encoding genes, producing various triterpenes of which the function in planta remains 
mostly unknown (Field and Osbourn, 2008). The OSC leading to the saponin backbone has 
been characterized for several saponin producing plants, including dammarenediol-II 
synthase (DDS) in P. ginseng (Tansakul et al., 2006), and β-amyrin synthase (BAS) in M. 
truncatula (Suzuki et al., 2002) and G. glabra (Hayashi et al., 2001). Usually, two distinct 
types of additional modifications of the cyclization products complete the saponin 
biosynthesis. In a first step, cytochrome P450 mediated oxidations of the cyclization products 
give rise to different sapogenins. Thus far, only two specific cytochrome P450 enzymes have 
been characterized. The first, β-amyrin and sophoradiol 24-hydroxylase (CYP93E1) was  
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Figure 1. The triterpene saponin biosynthesis pathway in M. truncatula. HMG, 3-hydroxy-3-
methylglutaryl. 
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Figure 2. Cyclization of 2,3-oxidosqualene and characterized CytP450s in saponin biosynthesis. 
 
identified in Glycine max, and catalyzes the oxidation of position 24 of the β-amyrin 
backbone (Figure 2) (Shibuya et al., 2006). The second, β-amyrin 11-oxidase (CYP88D6) 
catalyzes the sequential two-step oxidation of β -amyrin at the C-11 position to produce 11-
oxo-β-amyrin in G. glabra (Figure 2) (Seki et al., 2008). Some more candidate genes of other 
plant species have been identified, such as Cyp51H10 from oat (Qi et al., 2006) and several 
cytochrome P450s in M. truncatula (Naoumkina et al., 2010), however, functional 
characterization of these genes at the molecular level is lacking. Hence, most of the enzymes 
catalyzing the specific oxidation reactions on the various triterpene skeletons remain 
unknown to date. 
In the second distinct step of the saponin biosynthesis, the different sapogenins are 
glycosylated on different positions. The attached sugar chains can be linear or branched and 
can contain different monosaccharides, such as glucose, galactose, glucuronic acid, xylose, or 
rhamnose. Other, less common, modifications, such as acylations or malonylations can 
further increase the structural variability of the saponins. Even within a single plant species, 
an enormously rich mixture of saponins can occur. For example, in P. ginseng alone already 
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over 40 ginsenosides have been reported (Lü et al., 2009). Similar to the oxidation reactions, 
only few of the enzymes catalyzing the various decorations have been identified. Most 
progress has been made in the model legume M. truncatula, for which three 
glucosyltransferases have been characterized to date. UGT71G1 catalyzes the glycosylation 
of medicagenic acid in vitro, however, the enzyme also catalyzes the glycosylation of certain 
isoflavones and the flavonol quercetin with higher efficiency than triterpenes, hence, it is 
probably not a saponin-specific biosynthesis enzyme (Achnine et al., 2005). UGT73K1 was 
shown to specifically catalyze the glycosylation of hederagenin and soyasapogenols B and E 
in vitro. Furthermore, it was shown to be strongly upregulated in M. truncatula cell cultures 
that showed an increased saponin accumulation after jasmonate treatment (Achnine et al., 
2005). Recently, another jasmonate responsive glucosyltransferase, UGT73F3, was shown to 
catalyze the glycosylation of hederagenin at the C28-position, and genetic loss-of-function 
studies in M. truncatula confirmed the in vivo function of this glucosyltransferase in saponin 
biosynthesis (Naoumkina et al., 2010). Furthermore, in Saponaria vaccaria, the triterpene-
specific glucosyltransferase UGT74M1 was shown to catalyze the glycosylation of the C28-
position (Meesapyodsuk et al., 2007). 
To identify candidate genes involved in the biosynthesis of secondary metabolism, a 
functional genomics approach can be applied. Elicitors, such as the phytohormone jasmonate, 
induce the production of a compound of interest in plants or plant cell cultures and most often 
this effect is caused by the transcriptional activation of the genes involved in the biosynthesis 
of these compounds. Hence, comparing transcriptomes at various stages before and after 
elicitor treatment will allow pinpointing the desired subsets of the total gene pools as 
candidate genes responsible for the biosynthesis of the secondary metabolites (Oksman-
Caldentey and Inzé, 2004; Pauwels et al., 2009). Several studies have already demonstrated 
the feasibility of this approach. For instance, treatment of tobacco Bright yellow 2 (BY-2) 
cell cultures with jasmonate induces nicotine biosynthesis in the cells. Genome-wide 
transcript profiling of the jasmonate elicited tobacco cell cultures resulted in the 
establishment of a tobacco gene compendium (Goossens et al., 2003) from which several new 
genes, encoding enzymes, regulators and transporters involved in nicotine biosynthesis were 
identified in subsequent functional screens (De Sutter et al., 2005; Häkkinen et al., 2007; 
Morita et al., 2009; De Boer et al., 2011; Lackman et al., 2011). In a similar series of studies 
in the triterpene saponin producing model legume M. truncatula, the response of the 
metabolome and transcriptome to different elicitors was investigated (Suzuki et al., 2005). 
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Analysis of unknown genes co-regulated with known triterpene saponin biosynthesis genes 
lead to the identification and characterization of the above-mentioned glucosyltransferases 
involved in triterpene saponin biosynthesis (Achnine et al., 2005; Naoumkina et al., 2010). 
Here, a functional genomics approach to identify candidate genes involved in saponin 
biosynthesis of six plants, Medicago truncatula, Glycyrrhiza glabra, Panax ginseng, 
Bupleurum falcatum, Centella asiatica, and Maesa lanceolata was applied. Targeted 
metabolite analysis revealed that treatment with methyl jasmonate (MeJA) induced the 
production of triterpene saponins in M. truncatula cell cultures, G. glabra seedlings, P. 
ginseng hairy roots, and C. asiatica leaves. Subsequent RT-PCR analysis confirmed the 
transcriptional response of several genes involved in saponin biosynthesis. Furthermore, 
hydroponically grown B. falcatum seedlings and axenic M. lanceolata shoot cultures were 
treated with methyl jasmonate, and transcriptional response to the jasmonate treatment was 
confirmed. Subsequently, genome-wide cDNA-AFLP transcript profiling of five of the plants 
allowed identifying of a set of candidate saponin biosynthesis genes. 
2. Results and Discussion 
2.1.MeJA elicitation of the six saponin producing plants 
2.1.1. MeJA elicitation stimulates saponin production in M. truncatula suspension cells 
Saponin biosynthesis in M. truncatula has been reported to be MeJA inducible in suspension-
cultured cells (Suzuki et al., 2002; Suzuki et al., 2005). Therefore, an elicitation experiment 
was set up on the same cell line and under similar conditions as described by Suzuki et al. 
(2005). As shown in Table 1, mock-treated cell cultures produced only two known saponins 
in detectable amounts: 3-Glc-28-Glc-medicagenic acid and 3-Rha-Gal-Glc-soyasapogenol B. 
Cultures that were stimulated with MeJA synthesized a more complex saponin mixture in 
which in total 13 different saponins could be detected (Table 1). This number was lower than 
that of Suzuki et al. (2005), and also fluctuated slightly between independent biological 
repeats of the experiments. Similar qualitative differences between identical elicitation 
experiments were also reported by Suzuki et al. (2005) and were attributed to the fact that 
different passages of the culture or accumulating epigenetic changes as a function of 
culturing time may to some extent affect the elicitation response. However, most importantly, 
the capacity of the M. truncatula cell culture to efficiently activate triterpene saponin 
biosynthesis following MeJA elicitation seemed to be intact. Therefore, we assumed that the  
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Table 1. Saponin profiling in elicited M. truncatula suspension cell cultures. 
Saponin EtOH MeJA 
Hex-Bayogenin   
Hex-Hex-Bayogenin   
Hex-Hex-Hex-Bayogenin  X 
Hex-Hex-Rha-Bayogenin  X 
Hex-hederagenin  X 
Pen-hederagenin   
GlcA-hederagenin  X 
Ara-Hex-hederagenin   
3-Glc-Ara-28-Glc-hederagenin   
Rha-Hex-Hex-hederagenin  X 
Rha-Hex-Hex-Hex-hederagenin   
3-Glc-medicagenic acid   
3-Glc-28-Glc-medicagenic acid X X 
3-Glc-malonyl-medicagenic acid   
3-Glc-28-Glc-malonyl-medicagenic acid  X 
3-Glc-28-Ara-Rha-Xyl-medicagenic acid  X 
3-Rha-Gal-Glc-soyasapogenol B X X 
Hex-soyasapogenol E  X 
Hex-Hex-soyasapogenol E   
Rha-Gal-GlcA-soyasapogenol E  X 
Rha-Hex-Hex-soyasapogenol E  X 
Rha-Hex-Hex-Hex-soyasapogenol E   
Hex-unknown aglycon   
Hex-Hex-unknown aglycon  X 
Presence of a particular saponin in mock (EtOH) or MeJA treated cultures, 5 days after treatment, is 
indicated by X. 
 
molecular mechanisms required in the JA-activated signalling cascade leading to the onset of 
the saponin biosynthesis pathway were largely unaffected by possible epigenetic changes. 
To address the response to the MeJA treatment on the transcript level, induction of saponin 
biosynthesis was investigated with qRT-PCR taking advantage of the knowledge of some 
genes encoding early and late steps in the pathway. As such, it was shown that BAS (Suzuki 
et al., 2002), and the glucosyltransferases UGT73K1 (Achnine et al., 2005) and UGT73F3 
(Naoumkina et al., 2010) were MeJA responsive and showed co-regulation (Figure 3). In 
contrast, the expression of UGT71G1 (Achnine et al., 2005) was not significantly responsive 
to MeJA (Figure 3). However, in contrast to the other two glucosyltransferases, UGT71G1 
also recognizes isoflavones and flavonols as substrates, and glycosylates these compounds 
with higher efficiencies than triterpenes (Achnine et al., 2005), suggesting it might not 
correspond to a saponin-specific biosynthesis gene. Together, these results suggest that the  
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Figure 3. qRT-PCR of saponin biosynthesis genes from MeJA treated M. truncatula suspension cell 
cultures. Treatments and time-points are indicated at the bottom of the graphs. 
 
cell culture was apt for a functional genomics-based gene discovery program in M. truncatula 
secondary metabolism. 
2.1.2. MeJA elicitation stimulates glycyrrhizin production in roots but not leaves of 
liquorice plants 
Although soyasaponin biosynthesis can be upregulated by MeJA in cultured cells of G. 
glabra (liquorice) (Hayashi et al., 2003), it might be more appropriate to evaluate the MeJA 
effect on saponin accumulation by functional genomics in whole plant tissues than in cultured 
cells because the latter lack the capacity to produce the economically more important saponin 
compound glycyrrhizin (Hayashi et al., 2003). Therefore, first, 7-month-old greenhouse-
grown plants were sprayed and irrigated with MeJA (100 μM) or a mock solution, and the 
content of glycyrrhizin was measured in roots and leaves 15 days after treatments. In control 
roots, in which it was expected to accumulate, glycyrrhizin was indeed detected at levels of 
0.5% dry weight. These levels are lower than those in the literature for liquorice plants (2-
8%; (Hayashi et al., 1993)) or in own measurements with pulverized liquiritiae radix 
(European Pharmacopoeia approved; 5.7%). This observation was not unexpected because 
the plants analyzed were relatively young and glycyrrhizin levels are known to substantially  
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Figure 4. RT-PCR analysis of SQS1 and BAS in MeJA treated shoot and root tissue of G. glabra 
seedlings. Treatment and time-points (in hours) are indicated on top of the gel images. 
 
increase with plant age and concordant root thickening. Most importantly, glycyrrhizin in 
roots increased by 40% after 15 days of MeJA treatment to 0.7% of root dry weight. As 
expected, in the leaves of greenhouse-grown liquorice plants glycyrrhizin was not detected, 
even not after treatment with MeJA. Elicitation on transcript level was investigated via 
Reverse Transcription (RT)-PCR analysis of squalene synthase (SQS) 1 (Hayashi et al., 1999) 
and BAS (Hayashi et al., 2001), both saponin biosynthesis genes shown to be MeJA inducible 
in cultured G. glabra cells (Hayashi et al., 2003). RT-PCR analysis, performed on leaves and 
roots of 1-month-old seedlings of liquorice, grown in liquid medium in Erlenmeyer flasks, 
and treated or not with 100 μM MeJA, showed that these genes were expressed and MeJA 
inducible in both shoots and roots tissues (Figure 4). Together these results ensured that 
whole-plant material of liquorice was apt for a functional genomics-based gene discovery 
program. 
2.1.3. MeJA elicitation stimulates ginsenoside production in 2 different P. ginseng hairy 
root lines 
Ginsenoside production has been reported to be MeJA inducible in P. ginseng hairy roots, 
both on the transcript level (Choi et al., 2005; Kim et al., 2009; Zhao et al., 2010) and the 
metabolite level (Kim et al., 2009), hence, P. ginseng hairy root cultures can be useful for 
gene discovery for saponin biosynthesis. Two different P. ginseng hairy root cultures were 
acquired, called “Cusido” and “Liu”, and were treated with 100 μM MeJA. Subsequently, the 
response of the hairy root cultures to the MeJA elicitation was verified by RT-PCR and 
saponin profiling. RT-PCR analysis showed that the transcription of both SQS (GenBank: 
AB115496) and squalene epoxidase (SQE) (GenBank: AB003516) was upregulated upon 
MeJA treatment in both hairy root cultures (Figure 5A). Saponin profiling of the hairy root 
cultures revealed that two weeks after MeJA elicitation, the saponin content in both hairy root  
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Figure 5. MeJA response of P. ginseng hairy roots. A. RT-PCR analysis of SQS and SQE in MeJA 
treated “Cusido” and “Liu” hairy root cultures. Treatment and time-points (in hours) are indicated on 
top of the gel images. B. Percentage of saponin content of ginsenosides Rb1+Rg1 and Re in “Liu” and 
“Cusido” hairy root cultures. 
 
cultures was increased and that the “Liu” culture had a higher basal saponin level than the 
“Cusido” culture (Figure 5B). Since also a large publicly available EST sequence collection 
was derived from the “Liu” cultures (Choi et al., 2005), this hairy root culture was the 
preferred model system for the genome-wide cDNA-AFLP transcript profiling. 
2.1.4. Elicitation of saponin biosynthesis in C. asiatica plants treated with MeJA. 
Also for C. asiatica, it was reported that MeJA induces saponin production (Kim et al., 
2004), hence, a jasmonate elicitation experiment was set up with two different types of C. 
asiatica plant materials: i) greenhouse grown plants grown from seeds obtained from a 
commercial source (www.SandMountainHerbs.com) and ii) callus cultures obtained from the 
lab of Prof. Rosa Cusido (Barcelona, Spain) (Figure 6A). 
Based on the available public sequence information, primer sets were developed for the BAS 
(GenBank: AY520818), SQS (GenBank: AY787628) and farnesyl pyrophosphate synthase 
(FPS) (GenBank: AY787627) genes and a RT-PCR was performed to verify their expression 
pattern in all treated tissues. RT-PCR indicated opposite and tissue-dependent gene 
expression. On the one hand FPS and SQS expression was clearly induced by MeJA in 
greenhouse grown plants but not in cell suspension cultures. On the other hand, the BAS gene  
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Figure 6. C. asiatica plant material and MeJA response. (A) C. asiatica cell cultures (left) and plants 
(right). (B) RT-PCR analysis of FPS, SQS, and BAS in MeJA treated cell cultures (left) and plants 
(right). Treatment and time-points (in hours) are indicated on top of the gel images. (C) Pilot cDNA-
AFLP analysis, showing SQS induction in MeJA treated leaves (right), but not in MeJA treated cell 
cultures (left). Treatment and time-points (in hours) are indicated on top of the gel image. 
 
was clearly upregulated in cell suspension cultures but not in greenhouse grown plants 
(Figure 6B). Identical results for the FPS and SQS gene tags were obtained when the cDNA-
AFLP pilot was performed (Figure 5C). 
Next, a new elicitation, but larger-scale, experiment was set up to allow measuring saponin 
content in elicited C. asiatica materials. In this experiment the cell suspension samples were 
harvested at 5, 7, and 9 days after elicitation, whereas the greenhouse grown plants were 
harvested 14 days after elicitation. This analysis indicated that only in greenhouse grown 
plants MeJA was capable of increasing saponin production, which means that the full  
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Figure 7. MeJA response of BAS in B. falcatum roots. A. RT-PCR analysis of SQS and BAS on 4 
pools of hydroponically grown B. falcatum plants, pool numbers are indicated on top of the gel 
images. B. Detail of a cDNA-AFLP gel, the arrow marks the gene tag corresponding to BAS. 
Treatments and time-points are indicated on top of the gel image. C. Graphical representation of the 
expression of BAS, after normalization. For normalization details, see materials and methods. 
Treatments and time-points are indicated at the bottom of the graph. 
 
genome-wide cDNA-AFLP analysis should be exclusively conducted on the latter material 
for saponin gene discovery. 
2.1.5. Upregulation of genes involved in saikosaponin production in B. falcatum roots 
after MeJA treatment 
The roots of B. falcatum are the traditional source of saikosaponins, and it was reported that 
the saponin production in B. falcatum root fragments was increased by MeJA treatment 
(Aoyagi et al., 2001). Available sequences of B. falcatum SQS and BAS (Kim et al., 2006) 
allowed performing an RT-PCR analysis on hydroponically grown B. falcatum plants, 
showing that, contrary to SQS, the expression of BAS is restricted to the roots of the plant 
(Figure 7A). The hydroponics system allowed efficient growing, elicitation and harvesting of 
the roots. Elicitation of B. falcatum plants was performed by adding MeJA to the hydroponics 
medium, at a final concentration of 50 μM. Subsequently, a pilot cDNA-AFLP experiment 
with a limited number of primer combinations was performed, which showed the response of 
the B. falcatum roots to the MeJA treatment. Notably, gene tags corresponding to SQS and 
BAS were found to be strongly MeJA responsive in B. falcatum root tissue (Figure 7B,C). 
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Together, these results suggest B. falcatum roots were apt for a functional genomics-based 
gene discovery program. 
2.1.6. MeJA elicitation of M. lanceolata axenic shoot cultures 
In Rwandan traditional medicine, aqueous extracts of M. lanceolata leaves and fruits are used 
for the treatment of various diseases, such as infectious hepatitis and bacillary dysentery, and 
it was shown that saponins isolated from the leaves were responsible for the antiviral, 
haemolytic and molluscicidal effects (Sindambiwe et al., 1996; Sindambiwe et al., 1998). 
Based on this information, a gene discovery program was initiated on M. lanceolata axenic 
shoot cultures. Since no gene sequence resources were available for M. lanceolata, the effect 
of the MeJA treatment was immediately investigated with a pilot cDNA-AFLP analysis, 
which confirmed the response of the axenic shoot cultures to the MeJA treatment on the 
transcript level. In parallel, accumulation of saponins in greenhouse-grown plants sprayed 
and irrigated with MeJA or a mock solution, and MeJA or mock-treated axenic shoot cultures 
was investigated. Contrary to M. truncatula, G. glabra, C. asiatica, and P. ginseng, no 
significantly increased saponin accumulation in the MeJA treated material could be observed. 
However, the total saponin content in the control greenhouse-grown plants was 4.9% (± 
0.8%; n = 3), which was much higher than normally observed in leaves of in nature-grown, 
older trees (Theunis et al., 2007). Furthermore, also in the axenic shoot cultures, a very high 
saponin concentration was observed. This may indicate that the investigated tissues already 
accumulate maximal amounts of saponins and that it is impossible to further increase the 
saponin content in this material. Despite this, the transcriptional response was still present, 
and thus, the gene discovery program was performed on the MeJA treated axenic shoot 
cultures. 
2.1.7. Conclusions on MeJA elicitations 
Plants or plant tissue cultures were treated with either EtOH (as a control) or MeJA, and 
samples were harvested at different time points during 48 hours. Table 2 gives an overview of 
the used plant material, the elicitation conditions and the time selected time points for each of 
the target plants. 
 
 
64 
 
Table 2. Elicitation of the target plants. 
Species Plant material (harvested) [MeJA] Time points (hours) 
M. truncatula Cell cultures 100 µM 0, 0.5, 1, 2, 4, 8, 12, 24 
G. glabra Seedling cultures (roots & shoots) 100 µM 0, 0.5, 1, 2, 4, 8, 24, 48 
M. lanceolata Axenic shoot cultures (leaves) 500 µM 0, 0.5, 1, 2, 4, 8, 24, 48 
P. ginseng Hairy roots 100 µM 0, 0.5, 1, 2, 4, 8, 24, 48 
C. asiatica Plants (leaves) and cell cultures 100 µM 0, 0.5, 1, 2, 4, 8, 24, 48, 72 
B. falcatum Plants (hydroponics) (roots & shoots) 50 µM 0, 0.5, 1, 2, 4, 8, 24, 48 
 
For all plants, elicitation was confirmed on the transcript level, via qRT-PCR, RT-PCR or a 
pilot cDNA-AFLP analysis. Furthermore, for four plants (M. truncatula, G. glabra, C. 
asiatica and P. ginseng), the elicitation was confirmed by metabolite profiling. Together, this 
allowed for the selection of tissue and time points for subsequent transcript profiling 
(Table 3). Because of sufficient gene resources from the other 5 plant species, a full C. 
asiatica cDNA-AFLP profiling was put on hold. 
 
Table 3. Selected samples for genome-wide transcript profiling via cDNA-AFLP. 
Species Plant material # Samples Time points (hours) 
M. truncatula Cell cultures 16 
EtOH: 0, 0.5, 1, 2, 4, 8, 12, 24 
MeJA: 0, 0.5, 1, 2, 4, 8, 12, 24 
G. glabra Seedlings (roots & shoots) 32 
EtOH: 0, 0.5, 1, 2, 4, 8, 24, 48 
MeJA: 0, 0.5, 1, 2, 4, 8, 24, 48 
M. lanceolata Axenic shoots (leaves) 16 
EtOH: 0, 0.5, 1, 2, 4, 8, 24, 48 
MeJA: 0, 0.5, 1, 2, 4, 8, 24, 48 
P. ginseng Hairy roots 16 
EtOH: 0, 0.5, 1, 2, 4, 8, 24, 48 
MeJA: 0, 0.5, 1, 2, 4, 8, 24, 48 
C. asiatica Plants (leaves) 18 
EtOH: 0, 0.5, 1, 2, 4, 8, 24, 48, 72 
MeJA: 0, 0.5, 1, 2, 4, 8, 24, 48, 72 
B. falcatum Plants (hydroponics): roots 13 
EtOH: 0, 1, 2, 4, 8, 24 
MeJA: 0, 0.5, 1, 2, 4, 8, 24 
 
2.2.Gene discovery for combinatorial biosynthesis by genome-wide transcript 
profiling 
2.2.1. Transcript profiling of five plants by cDNA-AFLP 
For the five target plants, a full, genome-wide transcript profiling was performed, using the 
complete set of PCRs and gel runs for a 128 BstYI+1-MseI+2 primer-combination (PC) 
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analysis. Together, a total of ≈71,000 transcript tags were visualized (Table 4). In addition to 
the in silico analysis of the gene expression patterns, visual inspection of the expression 
patterns on the gels allowed for the isolation of 4854 (6.8%) MeJA responsive transcript tags 
(Table 4). Remarkably, a much lower number of visualized tags and MeJA responsive tags 
were encountered in M. truncatula, as compared to the other plant species. The reason for this 
is unclear but it may be attributed to a high degree of ploidy or nucleotide polymorphisms in 
the seed populations acquired from a commercial source, leading to the visualization and 
apparent response of a higher number of redundant genes in the other plant species. Direct 
sequencing of the reamplified tags gave good-quality sequences for 3278 (67.5%) of the 
fragments (Table 4). To the remaining 1576 tags (32.5%), no unique sequence could be 
attributed unambiguously, indicating that they might not represent unique gene tags, hence, 
these tags were not considered for further analysis. Similar performance rates were obtained 
in previous cDNA-AFLP based transcript profiling studies (Goossens et al., 2003; Rischer et 
al., 2006; Maes et al., 2011). Blasting of the 3278 unique sequence tags, revealed that 2256 
(68.8%) displayed sequence similarity to known plant sequences (Table 4). The percentage of 
hits in M. truncatula is remarkably high, as compared to the other plant species, due to the 
extensive genome and EST information available for this plant. Also for G. glabra and P. 
ginseng, a higher number of hits as compared to M. lanceolata or B. falcatum was observed. 
The homology between the two legume species, M. truncatula and G. glabra, may account 
for the higher number of hits in G. glabra, whereas the extensive EST database of P. ginseng 
(Choi et al., 2005) may account for the higher number of hits in P. ginseng. Hence, the low 
number of hits in M. lanceolata and B. falcatum likely was due to the low similarity between 
those plants and any plant species with an extensive genome or EST sequence database. 
 
Table 4. Overview of the cDNA-AFLPs. 
Species # PCs* Tags visualized Differential tags Unique tags Hits 
M. truncatula 128 8462 282 (3,3%) 196 (69,5%) 191 (97,4 %) 
G. glabra 128 14360 1009 (7,2%) 710 (70,4%) 574 (80,8 %) 
M. lanceolata 128 13558 733 (5,4 %) 545 (74,4%) 312 (57,2 %) 
P. ginseng 128 15840 1059 (6,7 %) 699 (66,0%) 501 (72,0 %) 
B. falcatum 128 18800 1771 (9,4 %) 1128 (63,7%) 678 (60,1 %) 
Total  71020 4854 (6,8 %) 3278 (67,5%) 2256 (68,8 %) 
*
PCs: Primer Combinations  
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Figure 8. Distinct steps in the saponin biosynthesis. In a first step, the β-amyrin skeleton is oxidized on various positions to obtain the sapogenins. In a second 
distinct step, the sapogenins undergo glycosylation and binding of other groups. The predicted reactions are used to select candidate gene tags from the 
cDNA-AFLPs.  
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2.2.2. Selection of candidate genes 
The selection of genes potentially involved in the biosynthesis of triterpene saponins in the 
investigated plants was based on two different criteria. First, only genes with an annotated 
activity that may be necessary for the saponin biosynthesis were considered. It is generally 
believed that, after cyclization of 2,3-oxidosqualene, two distinct types of additional 
modifications of the cyclization products complete the saponin biosynthesis and dramatically 
increase the structural diversity. Firstly, CytP450 mediated oxidations of the cyclization 
products give rise to different sapogenins. Subsequently (and/or concomitantly), the different 
sapogenins can be glycosylated on different positions, and other, less common, 
modifications, such as acylations and malonylations can further increase the structural 
variability of the saponins. Thus, genes potentially involved in any of these distinct steps (i.e. 
cyclization of oxidosqualene, oxidation of the cyclization products, glycosylation of the 
different sapogenins, and possible additional modifications) were selected (Figure 8). 
Although it is generally believed that the oxidation of β-amyrin and dammarenediol are 
carried out by cytochrome P450 enzymes, we did not exclude that other types of oxidases can 
catalyze this step. A second criterion that was applied in the selection of the candidate genes 
was their expression pattern upon MeJA treatment. Genes that belong to the same metabolic 
pathway are often co-regulated, and as such, genes with a putative function that may be 
involved in later steps of the saponin biosynthesis and, if applicable, were co-regulated with 
the known saponin biosynthesis genes were selected as candidate genes. Additionally, for M. 
truncatula, G. glabra and M. lanceolata, a set of transcription factors with a MeJA response 
prior to or concomitant with the response of the biosynthesis genes were identified and 
selected as potential regulators of the saponin biosynthesis. 
2.2.2.1.Selection of M. truncatula genes 
Average linkage hierarchical clustering showed that upon MeJA treatment, the MeJA-
responsive genes are either transcriptionally activated (73%, clusters II-V, Figure 9) or 
transcriptionally repressed (27%, cluster I, Figure 9). The activated gene tags can be further 
divided into 3 subclusters, based on the timing of the response (Figure 9). A first cluster 
consists of genes with a response immediately after (30 minutes or less) the MeJA treatment 
(cluster II, Figure 9). This cluster is highly enriched in putative transcription factors. In a 
second cluster (cluster III, Figure 9), genes roughly respond 1 to 4 hours after MeJA  
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Figure 9. Transcriptome of jasmonate-elicited M. truncatula cells. A. General view on the average 
linkage hierarchical cluster and tree of all 196 unique M. truncatula gene tags. B. Subcluster of the M. 
truncatula transcriptome comprising tags corresponding to genes reported to be involved in saponin 
biosynthesis, or with high sequence similarity to such genes. C. Subcluster of the M. truncatula 
transcriptome comprising tags corresponding to genes encoding putative transcription factors or 
proteins involved in posttranslational protein modification and ubiquitin-mediated proteasomal 
degradation. Treatments and time points (in h) are indicated at the top. Blue and yellow boxes reflect 
transcriptional activation and repression relative to the average expression level, respectively. Gray 
boxes correspond to missing time points. 
 
treatment. In a third group (clusters IV and V, Figure 9), genes respond 4 hours or later after 
the MeJA treatment. Interestingly, in the latter group, gene tags can be found corresponding 
to SQS, SQE2 and BAS, all genes encoding enzymes catalyzing triterpene saponin 
biosynthesis. These tags displayed an almost identical expression pattern, thus suggesting a 
tight co-regulation, and reached maximum levels of expression 12 to 24 hours post elicitation 
(Figure 9). Thus, candidate saponin biosynthesis genes should be enzyme encoding genes 
with a potential function in saponin biosynthesis that cluster within this third group. The most 
promising candidate of this list is the gene corresponding to the tag Mt175. A blast search of 
the Mt175 tag in the M. truncatula EST database (http://compbio.dfci.harvard.edu/cgi-
bin/tgi/gimain.pl?gudb=medicago), revealed 100% homology to TC173919, corresponding to  
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Table 5. Overview of the selected M. truncatula cDNA-AFLP tags. 
Tag TC-code Class (putative) annotation 
MT023 TC172516 Prior steps β-amyrin synthase (Suzuki et al., 2002) 
MT141 - Prior steps geranyl diphosphate synthase 
MT173 TC173832 CytP450 9/13 hydroperoxide lyase 
MT175 TC173919 CytP450 β-amyrin and sophoradiol 24-hydroxylase 
MT004 TC183962 Ox/Red mannitol dehydrogenase 
MT019 TC174444 Ox/Red pathogenesis-related protein 
MT042 TC174665 Ox/Red aldo/keto reductase 
MT123 TC173670 Ox/Red 1-aminocyclopropanecarboxylic acid oxidase 
MT138 TC173742 Ox/Red β-glucosidase G2 (Naoumkina et al., 2007) 
MT149 TC199332 Ox/Red quinone oxidoreductase-like protein 
MT178 TC180599 Ox/Red progesterone 5-β-reductase 
MT202 TC183591 Ox/Red progesterone 5-β-reductase 
MT260 TC185299 Ox/Red alpha-dioxygenase 
MT270 TC185273 Ox/Red amine oxidase 
MT308 TC180073 Ox/Red probable mannitol dehydrogenase 
MT309 TC186395 Ox/Red 2OG-Fe(II) oxygenase 
MT038 TC178291 UGT glucosyltransferase-13 
MT127 TC179830 UGT isoflavonoid glucosyltransferase 
MT187 BG582596 UGT isoflavonoid glucosyltransferase 
- - UGT UGT71G1 (Achnine et al., 2005) 
- - UGT UGT73F3 (Naoumkina et al., 2010) 
- - UGT UGT73K1 (Achnine et al., 2005) 
MT024 TC188018 TF NAC family transcription factor 
MT061 TC173581 TF MYB family transcription factor 
MT067 TC180525 TF RING domain-containing protein, E3 Ubiquitin ligase 
MT097 TC190450 TF hypothetical protein 
MT148 TC176048 TF CCR4-NOT transcription complex protein 
MT185 TC184599 TF hypothetical protein, calmodulin binding? 
MT200 TC184840 TF hypothetical protein 
MT203 TC185509 TF LOB domain-containing protein 
MT225 TC186327 TF MYC2 transcription factor 
MT274 TC184516 TF hypothetical protein 
MT280 TC185226 TF NAC family transcription factor 
MT296 TC174418 TF JAZ domain-containing protein 
CytP450: Cytochrome P450s; Ox/Red: Oxidases and reductases; UGT: Glycosyltransferases; TF: 
Transcription factors and other regulatory proteins. 
 
CYP93E2, the M. truncatula CytP450 gene with the highest homology to the soybean 
CytP450 gene encoding the β-amyrin and sophoradiol 24-hydroxylase (Figure 2) (Shibuya et 
al., 2006). This enzyme was also identified as a candidate gene involved in triterpene saponin 
biosynthesis in another screen (Naoumkina et al., 2010). Next to Mt175, one more gene tag 
corresponding to a CytP450 enzyme showed co-regulation with the known saponin 
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biosynthesis genes, Mt173. This gene tag of 385 bp is 100% homologous to TC173832, a TC 
annotated as 9/13 hydroperoxide lyase. However, this annotation is only based on homology 
with other hydroperoxide lyases, and thus, this gene tag was selected as a candidate gene as 
well. Several other co-regulated gene tags were selected, having a predicted 
oxidase/reductase or glucosyltransferase activity. Furthermore, 12 transcription factors and 
proteins of unknown function with a jasmonate response prior to (or concurrently with) the 
saponin biosynthesis genes were selected, such as Mt067 (See Chapter 6). An overview of the 
selected candidate gene tags is given in Table 5. 
2.2.2.2.Selection of G. glabra genes 
For G. glabra, average linkage hierarchical clustering based expression analysis showed that 
for 13% and 33% of the Gg tags, the MeJA response was restricted to leaves and roots 
respectively, whereas for the remaining 54% MeJA modulated differential expression was 
observed both in roots and leaves. This observation points to a distinct JA response, 
dependent on the tissue where the signal is perceived or transmitted. Both in leaves and roots 
MeJA predominantly stimulated gene expression, which is the case for 80% of the Gg tags, 
rather than repressing gene expression. Interestingly, cDNA-AFLP tag Gg0003, which 
corresponds to the G. glabra BAS (Hayashi et al., 2001), showed a differential response in the 
roots and the leaves of the plant. In roots, the expression of BAS was induced within 1 hour 
after MeJA treatment, whereas in shoots, the gene expression was induced much later 
(starting at 24 hours). A tight co-regulated expression pattern with the BAS tag is also 
observed for the tags corresponding to genes involved in the cytosolic isoprene precursor or 
mevalonate (MVA) pathway (i.e. tags Gg0577 and Gg0869, Figure 9). Also tag Gg0161 
showed MeJA modulated expression predominantly in roots, concomitant in time with root 
induction of Gg0003 (Figure 10). Based on sequence similarity Gg0161 could be considered 
as an orthologue of the M. truncatula UGT73K1 gene (Achnine et al., 2005), encoding the 
uridine diphosphate glucosyltransferase that catalyses glycosylation of e.g. soyasapogenol B, 
an aglycone that is also encountered in liquorice. Thus, the candidate saponin biosynthesis 
genes that were eventually selected had an expression pattern that showed an early induction 
in roots, and a late induction in shoots. As such, a total of 49 candidate biosynthesis genes 
were selected. Additionally, 20 candidate transcription factors were selected. 
71 
 
 
Figure 10. Transcriptome of jasmonate-elicited G. glabra seedlings. Subcluster of the G. glabra 
transcriptome comprising tags corresponding to genes reported to be involved in terpene or 
phenylpropanoid biosynthesis, or with high sequence similarity to such genes. Treatments and time 
points (in h) are indicated at the top. Blue and yellow boxes reflect transcriptional activation and 
repression relative to the average expression level, respectively. Gray boxes correspond to missing 
time points. 
 
2.2.2.3.Gene selection for other plants 
For the three other plant species, a similar approach to select candidate biosynthesis genes 
was applied. Average linkage hierarchical clustering of the B. falcatum cDNA-AFLP tags 
showed the presence of a cluster with a late induced expression, starting at 4 hours, that 
includes gene tags corresponding to enzymes of both the MVA and MEP isoprenoid 
pathways, as well as tags corresponding to the known B. falcatum enzymes SQS and BAS 
(Kim et al., 2006). Furthermore, a gene tag with homology to the M. truncatula UGT73K1 
gene (Achnine et al., 2005) clustered within this group. Hence, gene tags that have an 
annotated function that is possibly involved in the B. falcatum saponin biosynthesis, and that 
have a late induced expression were selected as candidate genes. As such, a set of 64 
B. falcatum cDNA-AFLP tags was selected. 
Also for P. ginseng, several known saponin biosynthesis genes were shown to respond to the 
MeJA treatment. The expression of Pg0408, a gene tag corresponding to P. ginseng DDS 
(Tansakul et al., 2006) was induced within 2 hours after MeJA treatment and showed co-
regulation with cDNA-AFLP tags corresponding to FPS (Kim et al., 2010), SQS2 (GenBank: 
GQ468527) and SQE2 (Han et al., 2010). Furthermore, several genes from both the MVA 
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and MEP pathways were co-regulated with this gene set. Finally, 41 cDNA-AFLP tags with 
an expression profile similar to this gene set, and a putative function involved in ginsenoside 
biosynthesis were selected. 
Within the MeJA modulated M. lanceolata tags, we could identify gene tags corresponding to 
early terpene precursor biosynthetic pathway genes, as was also the case with the other plant 
species, and additionally also some genes potentially involved in terpene biosynthesis 
branches leading to the monoterpenes and triterpenes, pointing to a true MeJA modulated 
redirection of terpenoid biosynthesis in leaves of M. lanceolata axenic shoot cultures. Based 
on the gene expression pattern and the putative gene annotation, a set of 36 gene tags was 
selected as potentially involved in the saponin biosynthesis pathway. Additionally, 16 
putative transcription factors were selected. A gene tag corresponding to BAS was obtained 
via degenerate oligonucleotide primers based on known plant genes. 
2.2.3. Conclusions on cDNA-AFLP transcript profiling 
In conclusion, a total of 259 cDNA-AFLP tags were selected as candidate genes involved in 
saponin biosynthesis (Table 6). 
 
Table 6. Overview of the selected genes. 
 Mt Gg Ml Pg Bf 
Previous steps 2 0 2 2 2 
Oxidases/reductases 14 22 9 16 32 
CytP450s 2 12 14 7 10 
Glucosyltransferases 5 10 6 10 12 
Transferases/esterases 0 5 6 6 8 
Transcription factors 9 20 16 0 0 
Total selected 32 69 53 41 64 
 
3. Materials and Methods 
3.1.Plant cultivation and elicitation 
M. truncatula cell cultures (kindly provided by Richard A Dixon, Ardmore, USA), were 
maintained as described (Suzuki et al., 2002). For elicitation, 7 days after inoculation of 
75 mL of a 14-day-old suspension culture into 175 mL fresh medium, cells were treated with 
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100 μM MeJA (dissolved in EtOH) or an equivalent amount of EtOH as a control. Samples 
were harvested, vacuum filtrated, and frozen at -80°C. For transcript profiling, samples were 
taken 0, 0.5, 1, 2, 4, 8, 12, 24 h after elicitor or mock treatments and for metabolite profiling 
0 and 5 days after treatments. 
G. glabra seeds, obtained from a commercial source (www.SandMountainHerbs.com), were 
surface sterilized by a short ethanol treatment (70%, v/v), followed by a 7% (v/v) bleach 
treatment for 20 min. Subsequently, sterilized seeds were washed thrice with sterile water and 
allowed to germinate on wet, sterile 3 mm Whatman paper. After germination, seedlings were 
transferred to 50 mL Schenk and Hildebrandt medium in 250 mL Erlenmeyer flasks, and 
grown on a shaker under 16h/8h light/dark regime, at 22°C, and 60 rpm. Three to 4 weeks 
after germination, seedlings were treated with 100 μM MeJA or an equivalent amount of 
EtOH as a control. Samples for transcript profiling were taken 0, 0.5, 1, 2, 4, 8, 24, and 48 h 
after treatment, and for metabolite profiling 0 and 5 days after treatment. Roots and leaves 
were harvested separately, and frozen at -80°C. 
M. lanceolata axenic shoot cultures (kindly provided by Prof. Danny Geelen, Gent, Belgium) 
were maintained as described (Faizal et al., 2011). For elicitation, each pot of shoot cultures 
was sprayed with 2.0 mL deionized water, containing 0.05% (v:v) Tween-20 and 500 μM 
MeJA (10 μl 100 mM stock (dissolved in EtOH) per 2 mL water) or an equivalent amount of 
EtOH as a control. For transcript profiling, samples were taken 0, 0.5, 1, 2, 4, 8, 24, 48 h after 
elicitor or mock treatments and for metabolite profiling 0 and 5 days after treatments. For 
each sample, 3 different plants of three different pots were pooled. 
P. ginseng hairy root cultures (kindly provided by Prof. Rosa Cusido, Barcelona, Spain and 
Prof. Jang-Ryol Liu, Taejon, South-Korea) were maintained as described (Choi et al., 2005). 
Two weeks after subculturing into fresh medium, they were treated with 100 μM MeJA 
(dissolved in EtOH) or an equivalent amount of EtOH as a control. Samples were harvested 
by vacuum filtration and frozen in liquid nitrogen 0, 0.5, 1, 2, 4, 8, 24, 48 h after elicitor or 
mock treatments for transcript profiling, and 14 days after treatments for metabolite profiling. 
B. falcatum seeds, obtained from a commercial source (www.SandMountainHerbs.com), 
were sown in soil, and 2 weeks after germination, seedlings were transferred to aerated 
hydroponics medium containing 1 g/L 10-30-20 salts (Scotts, Ohio, USA), pH 6.5. Plants 
were grown at 16h/8h light/dark regime, at 21°C, and pH was monitored and daily adjusted to 
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6.5, by adding KOH to the hydroponics medium. Three weeks after the plants were 
transferred to the hydroponics medium, they were treated with 50 μM MeJA (dissolved in 
EtOH) or an equivalent amount of EtOH as a control, by adding the EtOH or MeJA solution 
to the hydroponics medium. For transcript profiling, root and leaf samples were harvested 
separately, 0, 0.5, 1, 2, 4, 8, 24, and 48 h after treatment, frozen in liquid nitrogen, and stored 
at -70°C. For each sample, 3 individual plants were pooled. 
C. asiatica callus cultures (kindly provided by Prof. Rosa Cusido, Barcelona, Spain) were 
maintained as described (Mangas et al., 2008). For elicitation, 7 days after inoculation of 
75 mL of a 14-day-old suspension culture into 175 mL fresh medium, cells were treated with 
100 μM MeJA (dissolved in EtOH) or an equivalent amount of EtOH as a control. Samples 
were harvested, vacuum filtrated, and frozen at -80°C. For transcript profiling, samples were 
taken 0, 0.5, 1, 2, 4, 8, 24, and 48 h after elicitor or mock treatments and for metabolite 
profiling 0, 5, 7, and 9 days after treatments. C. asiatica seeds, obtained from a commercial 
source (www.SandMountainHerbs.com), were sown in soil, and after germination, a single 
plant was multiplied by cutting the creeping stolons. Elicitation was performed by watering 
and spraying the plants with a 100 μM MeJA solution in water. For transcript profiling, 
samples were taken 0, 0.5, 1, 2, 4, 8, 24, 48, and 72 h after elicitor or mock treatments and for 
metabolite profiling 0 and 14 days after treatments. 
3.2.Medicago saponin profiling 
To screen M. truncatula suspension cells for the presence of known Medicago saponins 
(Huhman and Sumner, 2002; Huhman et al., 2005; Kapusta et al., 2005a; Kapusta et al., 
2005b), 0.5 g of lyophilized material was crushed in a mortar. Saponins were extracted with 
40 ml MeOH (80%, v/v) by overnight stirring. After centrifugation (45 min, 3000×g), the 
supernatant was filtered and dried under vacuum. To clean up the sample, it was dissolved in 
6 ml H2O and brought on an Chromabond
®
 SPE C18 cartridge (500 mg) (Machery-Nagel, 
Germany). The column was successively rinsed with 1 volume H2O, MeOH (10% v/v) and 
MeOH (40% v/v). Finally the saponins were eluted with 12 mL MeOH (100% v/v). This 
fraction was dried under vacuum and dissolved in 3 mL acetonitrile (ACN)/H2O (1:1). 
Saponins were identified by LC-MS and LC-MS/MS (Esquire Ion Trap 3000 plus). The 
chromatographic analysis was performed with a LiChroSpher 5 µ (250 x 4 mm; Merck, 
Germany) with a gradient (from 18 to 36% B in 55 min; from 36 to 95% B in 30 min ([A = 
0.05% HAc; B = ACN + 0.05% HAc]). The flow rate was 0.5 mL min
-1
 and the UV detector 
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was set at 210 nm. This method (based on (Kapusta et al., 2005a)) for Medicago saponin 
detection was optimized with the Soyasaponin B mixture (kindly provided by Mark A. 
Berhow, National Center for Agricultural Utilization Research Center, USA). 
3.3.G. glabra saponin profiling 
To determine the quantity of glycyrrhizin in licorice tissues, frozen samples were lyophilized 
and powdered. An HPLC method for the determination of glycyrrhizin was developed based 
on an existing method (Liquiritiae extractum fluidum normatum, German Pharmacopoeia 
(DAB)) and optimized. The extraction procedure, the extraction solvent and the extraction 
yield were investigated. For extraction, 0.5 g of plant material was sonicated in EtOH (70%; 
2 x 15 mL) for 1 h. After centrifugation (15 min, 3000×g), the supernatant was dried under 
vacuum and dissolved in 10 mL MeOH (80% v/v). Before measurement on LC-MS, this 
solution was diluted 10 fold. The chromatographic analysis was performed with a 
LiChroSpher 5 μ (250 x 4 mm; Merck, Germany) with a gradient (from 15 to 60% B in 
50 min; from 60 to 95% B in 10 min [A = 0.05% HAc; B = ACN + 0.05% HAc]). The flow 
rate was 0.8 mL min
-1
 and the UV detector was set at 254 nm. A reversed-phase HPLC-UV 
system coupled to an ESI-MS detector was used to evaluate the samples, with glycyrrhizic 
acid-NH4 salt (Serva, Germany) as external standard. The compound identity was verified 
with negative ESI-MS (Esquire Ion Trap 3000 plus, Bruker Daltonics, Germany). This 
method was fully validated according to the ICH guidelines (Text on Validation of Analytical 
Procedures,1994; Validation of Analytical procedures: Methodology,1996). The linearity of 
glycyrrhizin was investigated: graphical inspection of the residuals, the LOF test and the 
correlation 19 coefficients proved the method to be linear in the range tested (25 – 
400 μg mL-1). The t-test on the intercepts revealed that point (0,0) falls within the calibration 
curve. The precision (n=18; six replicates on 3 days; RSD between days = 4.22%) and the 
accuracy (n=9; three replicates of three levels; recovery = 87%; RSD% = 11%) are proven to 
be acceptable with the European Pharmacopoeia approved samples of liquiritiae radix that 
contained a mean content of glycyrrhizin of 5.7%. 
3.4.C. asiatica saponin profiling 
0.5 g of lyophilized material was crushed in a mortar. Saponins were extracted twice with 40 
ml MeOH (90%, v/v) for 1 hour, followed by filtration and evaporation of the MeOH under 
vacuum. To clean up the sample, it was dissolved in 15 ml MeOH and water was added till a 
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volume of 50 ml. subsequently, 5 ml of the sample was brought on an Chromabond
®
 SPE 
C18 cartridge (500 mg) (Machery-Nagel, Germany). The column was successively rinsed 
with 1 volume H2O, MeOH (10% v/v) and MeOH (40% v/v). Finally the saponins were 
eluted with 12 mL MeOH (100% v/v). This fraction was dried under vacuum and dissolved in 
3 mL acetonitrile (ACN)/H2O (1:1). Saponins were identified by LC-MS and LC-MS/MS 
(Esquire Ion Trap 3000 plus). The chromatographic analysis was performed with a 
LiChroSpher 5 µ (250 x 4 mm; Merck, Germany) with a gradient (from 20 to 36% B in 15 
min; from 36 to 70% B in 7 min ([A = 0.05% HAc; B = ACN + 0.05% HAc]). The flow rate 
was 0.5 mL min
-1
 and the UV detector was set at 214 nm. 
3.5.M. lanceolata and P. ginseng saponin profiling 
M. lanceolata saponin profiling was performed according to Theunis et al. (2007). 
The extraction and HPLC method for ginsenosides from the European Pharmacopoeia (2002) 
was used, with Rb1 and Rg1 as external standards. 
3.6.Transcript profiling 
For reverse transcription PCR (RT-PCR), cDNA was prepared with SuperScript
TM
 II Reverse 
Transcriptase (Invitrogen), and primers were designed on the available sequences using the 
Primer3 program (Rozen and Skaletsky, 2000). 
For quantitative Real Time PCR (qRT-PCR), total RNA was extracted with the RNeasy mini 
kit (Qiagen), and cDNA prepared with SuperScript
TM
 II Reverse Transcriptase (Invitrogen). 
Primers were designed with Beacon Designer version 4.0 (Premier Biosoft International, Palo 
Alto, CA, USA). qRT-PCR was carried out using a Lightcycler 480 (Roche) and SYBR 
Green QPCR Master Mix (Stratagene). For reference genes, 40S ribosomal protein S8 (40S) 
(TC160725 of the MTGI from TIGR) and translation elongation factor 1α (ELF1α) 
(TC148782 of the MTGI from TIGR) were used. Reactions were performed in triplicate, and 
relative quantification with multiple reference genes was performed with qBase (Hellemans 
et al., 2007). 
For cDNA-AFLP, after preparation of total RNA, double-stranded cDNA was prepared as 
described (Vuylsteke et al., 2007). After appropriate sample preparation, cDNA-AFLP based 
transcript profiling was performed as described, with all 128 possible BstYI+1/MseI+2 
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primer combinations (Vuylsteke et al., 2007). Gel images were analyzed with the AFLP-
QUANTARPRO software (Keygene, Wageningen, The Netherlands), allowing accurate 
quantification of band intensities. The intensity of all individual bands was determined, and 
the obtained raw expression data were corrected for lane variations (due to PCR or loading 
differences) by dividing the raw data by a correction factor. The correction factor was 
calculated by dividing the sum of the expression levels of all fragments within one lane by 
the highest sum of all lanes within a primer combination. Subsequently, the standard 
deviation (SD) and the average were calculated for each individual band. Individual gene 
expression profiles were variance normalized by subtracting the calculated average from each 
individual data point, after which the obtained value was divided by the SD. A coefficient of 
variation (CV) was obtained by dividing the SD by the calculated average. Gene tags 
displaying expression values with a CV ≥0.5 were considered as differentially expressed. 
Based on this cut-off value, together with visual inspection of cDNA-AFLP gels, 
differentially expressed gene tags were selected for further analysis. Cluster analysis, 
sequencing, and BLAST analysis were performed as described (Rischer et al., 2006). 
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Abstract 
Background 
The cDNA-Amplified Fragment Length Polymorphism (cDNA-AFLP) technique is a 
commonly used method for genome-wide expression analysis that does not require prior 
sequence knowledge. Typically with cDNA-AFLP, quantitative expression data and sequence 
information is obtained for a large number of gene tags that are differentially expressed. 
However, most of the gene tags do not correspond to full-length (FL) coding sequences, 
which is a prerequisite for subsequent functional analysis. 
Results 
A medium-throughput screening strategy, based on an approach that integrates PCR and 
colony hybridization, was developed that allows in parallel screening of a cDNA library for 
FL clones corresponding to incomplete cDNAs. The method was applied to screen for the FL 
open reading frames of a selection of 163 cDNA-AFLP tags from three different medicinal 
plants. This led to the identification of 109 (67%) FL clones. Furthermore, the protocol 
allows for the use of multiple probes in a single hybridization event, thus significantly 
increasing the throughput of the method when screening for rare transcripts. 
Conclusions 
The presented strategy offers an efficient method for the conversion of incomplete expressed 
sequence tags (ESTs), such as cDNA-AFLP tags, to FL coding sequences. 
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1. Background 
cDNA-AFLP is a widely used, robust, and reproducible tool for genome-wide expression 
analysis in any organism, without the need for prior sequence knowledge (Breyne et al., 
2003; Vuylsteke et al., 2007). The technique is derived from AFLP (Vos et al., 1995) and is 
based on the selective PCR amplification of restriction fragments from a double-stranded 
cDNA template. To this end, the double-stranded cDNA template is digested with restriction 
enzymes, followed by ligation of specific adapters to the sticky ends of the digested cDNA. 
Subsequently, a subset of the restriction fragments is amplified by PCR by using primers with 
a few selective nucleotides in addition to the sequence complementary to the adaptor and 
restriction site sequences. The amplified cDNA fragments are visualized on high-resolution 
polyacrylamide gels, on which the intensity of the fragments reflects the relative abundance 
(copy number) of the corresponding genes across the samples (Vuylsteke et al., 2006; 
Vuylsteke et al., 2007). To identify the differentially expressed genes, the corresponding 
cDNA-AFLP tags are purified from the polyacrylamide gel, reamplified, and sequenced. 
However, the resulting cDNA-AFLP tag sequences most often do not correspond to FL-
coding sequences and, thus, do not provide sufficient sequence information for functional 
characterization. 
Obtaining a FL-coding sequence of a gene of interest from a non-model species without 
genome information might often prove to be a laborious and difficult task. One of the 
commonly used methods to obtain a FL cDNA clone starting from a partial clone such as a 
cDNA-AFLP tag or any other type of EST, is the rapid amplification of cDNA ends (RACE)-
PCR strategy, in which adaptors ligated to the 3‟ and 5‟ ends of the cDNA are used to 
selectively amplify these 3‟ or 5‟ cDNA fragments by PCR through a combination of gene-
specific and adaptor-specific primers (Chenchik et al., 1996). A common problem associated 
with RACE-PCRs is the amplification of non-specific PCR products due to the presence of 
one of the primer sequences in all cDNAs (Bower and Johnston, 2010). Several methods have 
been developed to solve this problem, but most of them rely on extra enzymatic steps after 
completion of the first strand cDNA synthesis, which may introduce mistakes (Schramm et 
al., 2000). An alternative to the RACE-PCR strategy is the screening of cDNA libraries. To 
identify clones from a cDNA library that contain the gene of interest, labeled gene-specific 
DNA probes are hybridized to colonies or plaques transferred to a nylon membrane. This 
traditional manner of library screening is labour intensive, especially when screening for rare 
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transcripts (Wan et al., 2006). A more rapid approach to obtain a clone of interest from a 
cDNA library is by PCR screening of pooled clones. This approach requires arraying of 
individual clones into microtiter wells, and is therefore only practical for abundant transcripts 
(Munroe et al., 1995). Alternatively, Self-Ligation of Inverse PCR Products (SLIP) allows for 
the simultaneous screening for low abundant transcripts. In this technique, the plasmid of 
interest is amplified from a small aliquot of the cDNA library via inverse PCR, using primers 
designed in opposite orientation on the incomplete cDNA. The obtained PCR fragments are 
self-ligated, transformed into E. coli and plated. Subsequently, individual colonies are picked 
for DNA isolation and sequencing (Hoskins et al., 2005; Wan et al., 2006). However, similar 
to various RACE-PCR approaches, this PCR-based library screening strategy is susceptible to 
amplification artefacts. Hence, because of the time-consuming and labor-intensive iterative 
screening of a number of cDNA libraries or the need for directed strategies to process 
individual clones in a RACE-PCR approach, to obtain the FL cDNA clone of large numbers 
of incomplete cDNAs in parallel, may prove to be a real challenge. 
To overcome this bottleneck, we developed a medium-throughput cDNA library screening 
strategy that integrates PCR and colony hybridization. The fast and easy PCR methodology 
was combined with the robust colony hybridization technique, allowing the screening of 
approximately 100,000 cDNA clones for individual cDNA clones, in a rapid and 
straightforward manner. The screening strategy can be divided into three basic steps. First, 
100,000 cDNA colony-forming units or clones were divided in 12 pools of approximately 
8,000 cDNA clones each. The pools (inoculated from the primary transformants) were grown 
overnight in liquid medium to increase the cell mass and each culture was then split into two 
halves. In the second step, plasmid DNA was extracted of one half of each of the overnight-
grown cultures. The extracted pool plasmid DNA was used as PCR template to identify the 
pool containing the cDNA clone corresponding to the incomplete cDNA tag. In step three, 
the remaining half of the overnight-grown culture was plated out on Petri dishes for classical 
colony hybridization, using the incomplete cDNA tag as probe. The developed screening 
strategy was used to screen cDNA libraries of three medicinal plants, Maesa lanceolata (false 
assegai), Glycyrrhiza glabra (liquorice), and Panax ginseng (ginseng) and allowed to pick up 
over 100 FL clones in two screening rounds, with a success rate of 67%. 
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2. Results 
2.1.Identification of MlJAZ1 
In our research on secondary metabolism, we investigated the effect of methyl jasmonate 
(MeJA) elicitation on the transcriptome of medicinal plants by cDNA-AFLP transcript 
profiling. In one such study, the transcriptome of MeJA-elicited axenic shoot cultures of M. 
lanceolata was analyzed. A collection of MeJA-responsive gene tags was obtained, of which 
ML074 was strongly transcriptionally activated within 30 minutes after MeJA treatment 
(Figure 1A,B). The cDNA-AFLP tag was purified from the gel, reamplified as described 
(Rischer et al., 2006; Vuylsteke et al., 2007), and sequenced, revealing an EST of 449 
nucleotides that was closely homologous to the JA signaling repressor JAZ1/TIFY10A from 
Arabidopsis thaliana. To obtain the FL cDNA corresponding to the ML074 tag, a M. 
lanceolata Uncut Nanoquantity cDNA library (Invitrogen, Carlsbad, CA, USA) was screened 
with our approach. The primers for the PCR screening (forward and reverse, 5‟-
TTTATTCCCCCAGCACTCTG-3‟ and 5‟-TCGGAGCTTGCCTTACTAGC-3‟, 
respectively) (Figure 1D) were developed on the cDNA-AFLP tag with the Primer3 program 
(Rozen and Skaletsky, 2000). Subsequent screening of the pool plasmid DNA revealed that 
the clone was present in pools 1, 6, 7, 8, and 12 (Figure 1C). After colony hybridization on 
the membrane of pool 7, three candidate colonies could be observed on the resulting 
autoradiogram (Figure 1E). By means of colony PCR with the above-mentioned primers, two 
of the three candidate colonies were found to contain the clone of interest (Figure 1F). 
Sequencing of the two positive clones demonstrated that in both clones an identical FL open 
reading frame (ORF) of 819 nucleotides occurred, encoding a protein of 273 amino acids, 
hereafter referred to as MlJAZ1. The 5‟ untranslated region (UTR) present in clone 1 was 153 
nucleotides long, whereas the 5‟ UTR of clone 2 was only 36 nucleotides long. The sequence 
of clone 1 was deposited in the GenBank with accession number JF313904. Analysis of the 
obtained MlJAZ1 sequence showed that the protein contained the characteristic tify and Jas 
domains of the JAZ protein family (Figure 1D,G). The tify domain and the C-terminal Jas 
domain are characterized by the highly conserved TIF[F/Y]XG and SLX2FX2KRX2RX5PY 
amino acid sequences, respectively (Chini et al., 2007; Thines et al., 2007; Vanholme et al., 
2007; Yan et al., 2007; Staswick, 2008; Grunewald et al., 2009; Pauwels et al., 2010). 
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Figure 1. Identification of MlJAZ1. A. cDNA-AFLP gel. B. Detail of the cDNA-AFLP gel showing 
the MeJA response of the ML074 tag. C. Result of the PCR screening, showing the presence of 
ML074 in pools 1, 6, 7, 8, and 12. D. Schematic representation of MlJAZ1. E. Autoradiogram of pool 
7 after hybridization with the radioactively labeled ML074 tag; arrows mark the three candidate 
colonies. F. Colony PCR on the candidate colonies. The cDNA-AFLP tag was used as template for 
the positive control. G. Identification of the tify and Jas domains in the MlJAZ1 amino acid sequence. 
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2.2.In parallel screening for Maesa lanceolata genes 
Besides ML074, 52 other M. lanceolata cDNA-AFLP tags were selected for further analysis. 
PCR screening of the pool plasmid DNA indicated that clones corresponding to 52 of the 53 
selected tags were present in at least one of the 12 library pools (Figure 2). Furthermore, 
clones corresponding to 23 tags were present in all the pools, suggesting a high representation 
in the library. Subsequently, a first round of colony hybridizations were performed, in which 
the 52 radioactively labeled cDNA-AFLP tags were hybridized on one membrane of a pool 
for which the presence of a clone corresponding to the cDNA-AFLP tag was confirmed by 
the PCR screening. For 45 tags, at least one candidate colony was identified, but colony PCR 
revealed that for 15 tags, all identified candidate colonies were false positives. Thus, for 30 
cDNA-AFLP tags, confirmed colonies were obtained and subsequently sequenced, until a 
clone with a FL-coding sequence was identified, resulting in the identification of FL 
sequences for 19 of the 53 initially selected cDNA-AFLP tags (36%). For the remaining 33 
cDNA-AFLP tags that occurred in one or more of the pools, and for which no corresponding 
FL-coding sequence was identified, a second round of hybridizations was performed 
(Figure 2), until for every cDNA-AFLP tag a candidate colony was identified, or until all the 
pools with a hit in the PCR screen were exhausted. For all, but one, of the 33 remaining tags, 
candidate colonies were identified. Subsequent colony PCR showed that for six tags, all 
identified colonies were again false positives and, thus, colony PCR confirmed clones were 
found for 45 of the 53 initially selected cDNA-AFLP tags. Sequencing of the candidate 
colonies allowed us to identify 21 more FL clones in the second hybridization round, ending 
with a total of 40 confirmed FL clones out of the 53 initially selected cDNA-AFLP tags 
(75%); colony PCR confirmed clones corresponding to the five remaining cDNA-AFLP tags 
all contained truncated versions of the corresponding ORF. A flow-chart of the screening for 
FL clones of the M. lanceolata cDNA-AFLP tags is given in Figure 2. 
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Figure 2. Flow-chart of the screening for FL clones corresponding to the selected M. lanceolata 
cDNA-AFLP tags. For details, see text. 
 
2.3.Panax ginseng and Glycyrrhiza glabra cDNA library screening 
Besides M. lanceolata, cDNA-AFLP tags were selected from two other medicinal plants 
treated with MeJA, P. ginseng and G. glabra. For P. ginseng, a total of 41 cDNA-AFLP tags 
were selected, of which the screening PCR confirmed the presence of 38 corresponding 
clones in the approximately 100,000 screened clones of the cDNA library. For G. glabra, a 
total of 69 tags were selected and the PCR screening confirmed the presence of 59 clones. FL 
genes of G. glabra and P. ginseng were screened for as for M. lanceolata and 47 and 22 FL 
genes were obtained out of the 69 (68%) and the 42 (54%) initially selected tags, 
respectively. In conclusion, by combining the three screenings, we identified a FL clone 
corresponding to 109 cDNA-AFLP tags out of a selection of 163 tags, reaching an overall  
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Table 1. Overview of the cloning efficiency. 
Species Enzymes Transcription factors Total 
M. lanceolata 32/37 (86%) 8/16 (50%) 40/53 (75%) 
G. glabra 36/49 (73%) 11/20 (55%) 47/69 (68%) 
P. ginseng 22/41 (54%) Not selected 22/41 (54%) 
 
success rate of 67%. The overview (Table 1) illustrates that the success rate is higher for 
enzyme-encoding genes than for transcription factors, possibly because the latter are rarer 
represented in the library than the former. 
3. Discussion 
The designed “EST-to-FL conversion” strategy described here has proven efficient in the 
screening for FL clones corresponding to a large number of cDNA-AFLP tags. During the 
screening process, two hybridization rounds could be done per week, each including 12 
membranes, for which the following schedule was applied. On day 1, probes were labeled, 
and hybridizations were performed overnight. On day 2, the membranes were washed thrice 
to remove excess probe and exposed to the autoradiography films for 2 days. On day 4, the 
autoradiography films were developed and the membranes were stripped prior to a second 
round of overnight hybridizations. On day 5, the membranes were washed and exposed to the 
autoradiography films for 2 days. On day 8, the second batch of films were developed and the 
membranes stripped, and another round of hybridizations could be started. This system 
allowed us to use the membranes for up to six hybridization rounds without significant loss of 
hybridization potential. 
Furthermore, with this hybridization system, multiple probes can be utilized in a single 
hybridization event. Therefore, 50 ng of each probe was mixed, prior to labeling, in a double 
volume of the probe labeling reaction mixture and so, up to six probes on a single membrane 
could be hybridized at once. Although the hybridization throughput is highly increased and, 
thus, less handling with radiolabeled substrates is necessary, the subsequent colony PCR step 
becomes more elaborate as a consequence, because every identified candidate colony has to 
be checked with all of the primer combinations corresponding to all of the probes used in the 
hybridization. Nonetheless, despite this drawback, the use of multiple probes proved to be 
beneficial in the second round of hybridizations (Figure 2), when transcripts without positive 
colonies in the first hybridization round were screened. 
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After hybridizations, candidate colonies were confirmed by colony-PCR and subsequently 
sequenced. For instance, for the 53 selected M. lanceolata tags, a total of 167 plasmids were 
sent for sequencing. Subsequent sequence analysis showed that 73/167 (43.7%) plasmids 
corresponded to FL clones, and at least one FL clone was obtained for 40 of the 53 selected 
tags. Although the applied strategy is not specific for FL clones, it allows a medium-
throughput isolation of candidate clones. Hence, the better the quality of the screened cDNA 
library, the higher the chance of encountering a FL clone for a particular tag. To increase the 
chance of picking a FL clone from the candidate colonies, colony-PCR could be performed 
using a forward primer corresponding to the vector, at the 5‟ end of the cDNA, and a reverse 
primer corresponding to the tag or EST, and subsequently, the clone giving the largest PCR 
fragment could be sequenced. Alternatively, RACE-PCR-based approaches may have a 
higher chance of finding a FL clone for a particular tag, however, these methods are 
susceptible to amplification artefacts and are definitely more labour intensive and thus not 
applicable to obtain the FL clone of large numbers of incomplete cDNAs in parallel. Similar 
to our strategy, SLIP allows in parallel screening of a cDNA library for FL clones (Hoskins et 
al., 2005; Wan et al., 2006). Eliminating polyacrylamide gels, radioactivity and colony 
hybridization steps, the SLIP strategy allows the recovery of FL clones from plasmid cDNA 
libraries in 5 days (Wan et al., 2006). However, SLIP is basically an enzymatic method and is 
therefore sensitive to PCR artefacts, and tends to have a bias towards recovery of shorter, 
incomplete clones (Hoskins et al., 2005), disadvantages that are all omitted by colony 
hybridization strategies. 
Here, the usefulness of our “EST-to-FL conversion” strategy has been shown for one class of 
incomplete cDNAs, i.e. cDNA-AFLP tags, but, principally, it can be applied to any type of 
incomplete tag sequence. Indeed, several commonly used techniques generate often very 
large collections of incomplete cDNAs or ESTs. For instance, in the latest GenBank database 
of EST release (dbEST release 030111, http://www.ncbi.nlm.nih.gov/dbEST/index.html), a 
total of 69 million ESTs were released. Similarly to cDNA-AFLP tags, these ESTs are 
typically between 200 and 500 nucleotides long. Contigs can be generated from large 
collections of ESTs from a single organism and allow the identification of the FL ORFs of 
the genes of interest. However, for most of the organisms, the EST collection is too small to 
generate such contigs. The presented strategy might be applied to pick up the FL ORFs 
corresponding to the published ESTs. Primers designed on the released EST sequences can be 
used for the PCR screening and the resulting PCR product can be purified and labeled to use 
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it as a probe to pick up the full clone via the colony hybridization step of the presented 
strategy. 
4. Conclusions 
A screening strategy, based on an integrated PCR colony hybridization approach was 
developed that allows the simultaneous screening for FL clones corresponding to a large 
number of incomplete ESTs obtained by cDNA-AFLP transcript profiling. The designed 
method was used to screen for FL clones of an initial selection of 163 cDNA-AFLP tags, 
leading to the identification of 109 FL genes (67%) from three different medicinal plants. 
This strategy will be applicable for the conversion of any type of EST to FL clones for 
functional analysis. 
5. Methods 
5.1.Pool preparation 
As starting material, Uncut Nanoquantity cDNA libraries (custom-made by Invitrogen, 
Carlsbad, CA, USA) were used. Approximately 120,000 clones of the original library were 
transferred to a 2-mL tube and Lysogeny Broth (LB) medium containing 50 µg/mL 
kanamycin (LBKAN50) was added to a total volume of 1.5 mL. This library dilution was 
used to inoculate 12 flasks, each containing 10 mL of LBKAN50 medium with 
approximately 8,000 cDNA clones each (100 µL of the prepared library dilution per flask). 
The resulting Escherichia coli cultures were incubated for 12-16 hours at 37°C with shaking 
at 300 rpm. 
5.2.PCR screening 
For the plasmid DNA extraction, 5 mL of each 10-mL culture was used. To identify the pools 
that contained the cDNA clone corresponding to the target cDNA-AFLP tag, 50 ng of the 
pool plasmid DNA was taken as PCR template. Specific PCR primers were designed based 
on the cDNA-AFLP tag sequences with the Primer3 program (Rozen and Skaletsky, 2000). 
5.3.Pool plating 
The titer of the remaining 5 mL of each 10-mL culture was estimated by plating a serial 
dilution of the cultures on LBKAN50 plates, followed by overnight incubation at 37°C. 
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Subsequently, of each pool, approximately 10,000 cDNA clones were plated on LBKAN50 
medium containing 15 g/L agar in 24 x 24 cm Petri dishes and grown overnight at 37°C. 
Prior to colony lifting, the plates were pre-cooled at 4°C. 
5.4.Colony lifting 
The colonies grown on the 24 x 24 cm Petri dishes were lifted on Hybond-N
+
 membranes 
(GE-Healthcare, Little Chalfont, UK), according to the manufacturer‟s instructions. The 
DNA was cross-linked to the membranes by UV irradiation. 
5.5.Probe labeling 
Probes were re-amplified by PCR from the cDNA-AFLP tag (Vuylsteke et al., 2007) and 
subsequently labeled with 
32
P via a random priming reaction by incubating 25 µL of the 
following mixture at 37°C for 6 hours: 50 ng denatured probe, 1x bovine serum albumin 
(0.1 mg/mL), 5 mM MgCl2, 0.5 mM dithiothreitol (DTT), 20 mM 2-(N-
morpholino)ethanesulfonic acid (MES), 20 µM of dATP, dGTP, and dTTP each, 12.5 μCi 
deoxycytidine α-32P (500 μCi/mmol dCTP Easy Tide) (Perkin Elmer, Waltham, MA, USA), 
1 ng hexanucleotide random primer (Roche Applied Science, Brussels, Belgium), and 5 U 
Klenow Fragment of DNA Polymerase I (GE-Healthcare). The labeled probes were stored at 
-20°C until used for hybridization. 
5.6.Hybridization 
The membranes were pre-wetted for 30 min at 65°C in preheated hybridization buffer (0.4 M 
Na2HPO4, pH 7.2, 1 mM ethylenediaminetetraacetic acid (EDTA), 7% (w/v) sodium dodecyl 
sulfate (SDS)), after which the denatured radioactive probe was added. After overnight 
hybridization at 65°C, the membranes were washed thrice with preheated washing buffer 
(0.04 M Na2HPO4, pH 7.2, 1 mM EDTA, and 5% (w/v) SDS) at 65°C. Subsequently, excess 
buffer was drained off. The membranes were packed in SaranWrap and exposed to Kodak
TM
 
BioMax films (Perkin Elmer) for 2 days. The membranes can be re-used for hybridization 
after stripping by washing them thrice with preheated stripping solution (1 mM EDTA and 
0.1% (w/v) SDS) at 75°C. 
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5.7.Clone confirmation 
Candidate colonies were picked from the 24 x 24 cm Petri dishes and checked by colony PCR 
with the primers designed on the cDNA-AFLP tag. Positive clones were sequenced with the 
primers designed on the pENTR222 vector of the Uncut Nanoquantity cDNA library, 5‟-
ACGACGGCCAGTCTTAAGCTCGG-3‟ and 5‟-ACCATGTAATACGACTCACTATAGG-
3‟. 
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Abstract 
Triterpenes are one of the largest classes of plant natural products, with an enormous variety 
in structure and bioactivities. Here, triterpene saponins from hairy roots of the model legume 
Medicago truncatula were profiled with reversed-phase liquid chromatography coupled to 
negative-ion electrospray ionization Fourier transform ion cyclotron resonance mass 
spectrometry (LC ESI FT-ICR MS). Owing to the accuracy of the FT-ICR MS, reliable 
molecular formulas of the detected compounds could be predicted, which, together with the 
generated MS
n
 spectra, allowed the tentative identification of 79 different saponins, of which 
61 had not been detected previously in M. truncatula. Upon collision-induced dissociation of 
saponins that contain a uronic acid residue in the sugar chain, fragment ions resulting from 
cross-ring cleavages of the uronic acid residues were observed. The identified saponins are 
glycosides of 10 different sapogenins, of which three were not detected before in M. 
truncatula. Zanhic acid glycosides, which are prevalent in the aerial parts of M. truncatula, 
were absent in the hairy root extracts. This metabolite compendium will facilitate future 
functional genomic studies of triterpene saponin biosynthesis in M. truncatula. 
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1. Introduction 
Legumes (Fabaceae) are important agricultural crops, characterized by the presence of root 
nodules that contain symbiotic nitrogen-fixing bacteria. Fixation of atmospheric nitrogen 
allows reduced fertilizer costs and makes legumes a key player in crop rotation to replenish 
nitrogen-depleted soil. Furthermore, legumes serve as a major source of proteins and oil for 
human and animal nutrition. Leguminous crops with a significant economical value include 
oilseed crops such as soybean (Glycine max) and peanut (Arachis hypogaea), forage and soil-
conditioning crops such as alfalfa (Medicago sativa) and clover (Trifolium spp.), and pulses 
such as beans (Phaseolus spp.), peas (Pisum spp.), and lentils (Lens spp.). 
Themore than 19,400 leguminous species, distributed over 730 genera, produce a vast array 
of metabolites with diverse structures and biological activities. An important group of legume 
natural products are triterpene saponins, a class of secondary metabolites that display a wide 
range of biological activities (Dixon and Sumner, 2003). In plants they serve as allelopathic, 
antipalatability, anti-insect, or antifungal agents (Huhman and Sumner, 2002). Saponins also 
have a broad range of pharmaceutical properties, such as anti-inflammatory, antimicrobial, 
anticancer, or adjuvant activities (Sparg et al., 2004; Sun et al., 2009). Besides saponins, 
isoflavonoids, alkaloids, and nonprotein amino acids commonly occur as natural products in 
several legume species (Dixon and Sumner, 2003; Dixon and Pasinetti, 2010). 
As a model species for legume biology, barrel medic (Medicago truncatula), a close relative 
of alfalfa, is an excellent system to study secondary metabolism of legumes (Dixon and 
Sumner, 2003; Farag et al., 2009). Consequently, several studies about the metabolite 
composition of M. truncatula have been published over the past decade. Metabolite profiling 
using LC-MS-based methods revealed the presence of a complex mixture of triterpene 
saponins in various M. truncatula tissues (Huhman and Sumner, 2002; Huhman et al., 2005; 
Kapusta et al., 2005a; Kapusta et al., 2005b). In accordance with other legumes from the 
Papilionoideae subfamily, M. truncatula is rich in isoflavonoids (Farag et al., 2007; 
Schliemann et al., 2008). 
Hairy roots are generated by an infection of healthy plant tissue, not necessarily roots, with 
Agrobacterium rhizogenes. They are characterized by fast growth rates and do not require 
growth regulators for their cultivation. Furthermore, they have a high genetic stability and a 
high biosynthetic potential for a longer time than natural roots (Guillon et al., 2006a; 
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Georgiev et al., 2007). Their potential to produce compounds that are also naturally occurring 
in wild-type roots in combination with their tolerance to cultivation in large-scale bioreactors 
makes hairy roots an appealing alternative for the destructive harvesting of wild-type roots, 
especially those of endangered plant species, to obtain valuable phytochemicals (Sevón and 
Oksman-Caldentey, 2002; Guillon et al., 2006b). Hairy roots are also a valuable tool to 
investigate the secondary metabolism in M. truncatula. A prerequisite for the study of 
secondary metabolism and its application in metabolic engineering projects is the possibility 
to generate transgenic plant tissue. Although fertile transgenic M. truncatula plants can be 
obtained via Agrobacterium tumefaciens mediated transformation (Chabaud et al., 1996; 
Cook, 1999; Trieu et al., 2000; Araújo et al., 2004), the published methods are time-
consuming and lack the required throughput for simultaneous analysis of a significant 
number of genes. In contrast, A. rhizogenes-mediated transformation of M. truncatula 
seedlings allows a fast and efficient production of transgenic hairy roots (Boisson-Dernier et 
al., 2001); the generation time needed from seed to a transgenic M. truncatula hairy root 
culture, ready for profiling or other analysis, is only 3 months. 
For any metabolic engineering project targeting triterpene saponin biosynthesis, a detailed 
analysis of the saponin composition of the generated hairy roots is required. In the past 
decade, a few metabolic profiling studies on saponins in M. truncatula have been reported. In 
a first study, the presence of a large number of saponins in root extracts of M. truncatula was 
shown: based on fragmentation data under negative ionization, 27 M. truncatula saponins 
were tentatively identified (Huhman and Sumner, 2002). Optimization of the latter method 
resulted in an extended list of 31 tentatively identified saponins (Huhman et al., 2005). In a 
later study, 12 additional saponins from the aerial parts of M. truncatula were characterized 
via spectroscopic methods, and their fragmentation behavior under negative ionization 
reported (Kapusta et al., 2005a; Kapusta et al., 2005b). Nevertheless, M. truncatula was 
postulated to synthesize many more triterpene saponins than identified to date (Huhman and 
Sumner, 2002). 
For identification purposes, LC-MS-based metabolomics studies benefit from the use of 
Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS). FT-ICR MS 
provides highly accurate mass measurements, allowing a reliable prediction of the molecular 
formula of the detected ions. Here, we applied reversed-phase liquid chromatography (LC) 
coupled to negative-ion electrospray ionization (ESI) FT-ICR MS to investigate the saponin 
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composition of hairy roots of M. truncatula. As a result, 79 saponins were detected and 
tentatively identified, of which soyasaponin I and 3-Glc-28-Glc-medicagenic acid were the 
most abundant compounds. The identified saponins are glycosides of 10 different sapogenins, 
of which three had hitherto not been detected before in M. truncatula. 
2. Results and discussion 
2.1.General methodology 
For metabolite profiling of triterpene saponins, the compounds from a methanol extract of 
M. truncatula hairy roots were separated by reversed-phase LC, followed by negative-ion ESI 
FT-ICR MS. The accurate m/z measurements of the FT-ICR MS, combined with the isotope 
abundances, allowed us to predict the molecular formula of the detected saponins. The 
structural information needed for the identification of the saponins was obtained by MS
n
 
fragmentation using the linear ion trap (IT). Full FT-MS spectra were interchanged with 
dependent IT-MS
n
 scan events, existing of an MS
2
 and two MS
3
 scans. In the MS
2
 scan, the 
most abundant ion in the previous full MS scan was fragmented. The two most abundant 
daughter ions in every MS
2
 scan event were subjected to a dependent MS
3
 scan event. In 
addition, in-source fragmentation data were included in the identification process. 
2.2.Identification of saponins 
Saponins are amphipathic glycosides consisting of a lipophilic aglycone or sapogenin 
covalently linked to one (monodesmosidic) or more (di- or tridesmosidic) sugar chains via an 
ether or ester glycosidic bond. The sugar residues are mainly hexoses (e.g., glucose and 
galactose), 6-deoxyhexoses (e.g., rhamnose and fucose), pentoses (e.g., arabinose and 
xylose), and uronic acids (e.g., glucuronic acid and galacturonic acid). As reported before, 
upon collision-induced dissociation (CID) under negative ESI-MS, saponins undergo 
glycosidic cleavages, retaining the charge at the reducing terminus (i.e., the fragment that 
contains the aglycone) (Domon and Costello, 1988; Liu et al., 2004). The detected 
(grand)daughter ions in the MS
n
 spectra provide structural information about the sugar 
residues and aglycone of the fragmented saponin. 
Figure 1 illustrates the identification of a hitherto unknown saponin. As indicated in 
Figure 1A, the unknown saponin showed an [M-H]
-
 anion at m/z 945.50965. Because 
saponins consist of the elements C, H, and O, three different molecular formulas are possible  
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Figure 1. LC ESI FT-ICR MS chromatograms. (A) MS scan of peak at tR 23.19 min. (B) Zoom of the 
MS scan of panel A, showing that the quasi-molecular ion is accompanied by additional isotope ions. 
The relative intensity of the isotope ions is indicated between brackets. (C) MS
2
 fragmentation of the 
[M-H]
-
 ion at m/z 945.51 (Pen-Hex-Hex-aglycone D). 
 
within an error range of 5 ppm: C65H69O6 (δ ppm = -0.331), C40H81O24 (δ ppm = -2.830), and 
C47H77O19 (δ ppm = 3.380). To determine the correct molecular formula, the abundance of 
the isotopes was considered. In nature, stable elemental isotopes occur in a stable ratio. For 
instance, 
13
C occurs at approximately 1.11% of the most frequent carbon isotope, 
12
C. 
Similarly, 
2
H and 
17
O occur at 0.015 and 0.038% of 
1
H and 
16
O, respectively. Hence, the 
observed monoisotopic quasi-molecular ions (M0) are always accompanied by additional 
isotope ions (M+1,M+2, ...) (Figure 1B), of which the relative abundance depends on the 
elemental composition of the compound. The predicted relative abundance of the M + 1 ions 
of the three possible molecular formulas was 73.41, 46.53, and 54.05%, respectively. For the 
unknown saponin, the observed relative abundance of the M + 1 ion was 53.63% (Figure 1B), 
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indicating that the molecular formula corresponding to the [M-H]
-
 anion is C47H77O19 (δ ppm 
= 3.380). The sugar residues and the aglycone could be identified from the MS
n
 spectra. For 
this saponin, MS
2
 fragmentation led to the generation of five daughter ions, resulting from the 
loss of water (-18 Da) and/or one or more hexose (-162 Da) and/or pentose (-132 Da) 
residues. The smallest daughter ion, at m/z 489, represents the aglycone ion, [Agly-H]
-
, 
resulting from the loss of a pentose and two hexose moieties (Figure 1C). Based on this 
rationale, tens of other saponins present in the extract of M. truncatula hairy roots could 
tentatively be identified. All identified saponins and their MS
n
 data are listed in Table 1. 
2.3.Cross-ring cleavage of uronic acid residues. 
Saponins are reported to undergo only glycosidic cleavages upon CID under negative ESI 
MS (Liu et al., 2004). However, in this study, we observed a recurrent fragmentation pattern 
for saponins that contain a uronic acid residue, indicating a cross-ring cleavage of the uronic 
acid residue upon CID, as illustrated with the MS
2
 spectrum observed for 3-Rha-Gal-GlcA-
Soyasapogenol B (Figure 2A,B). The anions with the highest relative intensity, observed at 
m/z 923 and m/z 879, correlated to the neutral losses of 18 (H2O) and 62 Da (H2O + CO2), 
respectively. 
A similar pattern was observed after the loss of the rhamnose residue (m/z 795) and the ions 
observed at m/z 751 and 733 correlated to an additional loss of 44 (CO2) and 62 Da (H2O + 
CO2), respectively. Furthermore, three more characteristic peaks were observed at m/z 615, 
597, and 525, corresponding to a loss of the galactose residue, and an additional loss of 18 
(H2O), 36 (H2O + H2O), and 108 Da. The latter loss can only be explained by a cross-ring 
cleavage of the uronic acid residue. Cross-ring cleavages of glycosides are charge-remote 
fragmentations, i.e. fragmentations that are not initiated by the charge position. Because of 
the low internal energy of negative ions, cross-ring cleavages of glycosides do not readily 
occur (Liu et al., 2004). An exception are those that are linked via an ester bond as in, for 
example, feruloylated oligosaccharides (Levigne et al., 2004; Quéméner and Ralet, 2004) or 
sinapoyl glucose (Vanholme et al., 2010). Sinapoyl glucose serves as an UV protectant in 
Arabidopsis, and upon CID in the negative ionization mode, losses of 60, 90 and 120 Da are 
observed (Vanholme et al., 2010), which correspond with a 
0,4
X, 
0,3
X, and 
0,2
X cross-ring 
cleavage, respectively (see legend of Figure 2 for explanation on nomenclature). However, in 
this study, the cross-ring cleavage of the uronic acid residue should be charge-driven, because 
the carboxylic group of the uronic acid bears the negative charge. The loss of 108 Da might  
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Figure 2. Cross-ring cleavage of uronic acid residues. (A) MS
2
 fragmentation of 3-Rha-Gal-GlcA-
soyasapogenol B. (B) Structure of 3-Rha-Gal-GlcA-soyasapogenol B. (C) Nomenclature of the cross-
ring fragmentation of glucuronic acid. 
 
be due to the loss of water followed by an additional loss of a C3H6O3 fragment of 90 Da or 
by the loss of a C3H8O4 fragment involving a 
1,4
X cross-ring cleavage of the uronic acid 
residue (Figure 2C). This typical fragmentation pattern was observed in 20 compounds, and 
aided in the tentative identification of hitherto unknown saponins. By means of this 
methodology, a total of 79 saponins present in the M. truncatula hairy root extracts were 
identified (Table 1). However, MS
n
 does not provide enough information for absolute 
structural characterization of the metabolites; hence, the identifications remain tentative. 
2.4.Most abundant compounds in M. truncatula hairy roots 
In the metabolite extracts of M. truncatula hairy roots, the major peak, at a retention time (tR) 
of 33.63 min, yielded an [M-H]
-
 anion at m/z 941.51540 (C48H78O18, δ ppm = 4.101) 
(Figure 3A). In M. truncatula, two saponins have been described with the same molecular 
formula, Rha-Hex-Hex-hederagenin and soyasaponin I (3-Rha-Gal-GlcA-soyasapogenol B) 
(Huhman et al., 2005). The MS
2
 spectrum (Figure 2A and Table 1) corresponded to 
previously observed MS/MS data of soyasaponin I (Jin et al., 2007) , allowing us to conclude 
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that soyasaponin I is the most abundant saponin in the M. truncatula hairy roots extract. This 
is consistent with the previous observation that the major saponins in the roots of M. 
truncatula are soyasapogenol conjugates (Huhman et al., 2005). The second most abundant 
compound, eluting at 25.80 min, yielded an [M-H]
-
 anion at m/z 825.42987 (C42H66O16, 
δ ppm = 2.494) (Figure 3B). In the MS2 spectrum (Figure 3C), the base peak occurs at m/z 
439, a fragment ion resulting from the decarboxylation and dehydration of the medicagenic 
acid aglycone ion (Huhman and Sumner, 2002). Additional anions were observed at m/z 663, 
m/z 619, and m/z 601, correlating to the sequential loss of a hexose (162 Da), a CO2 (44 Da) 
and a H2O (18 Da) molecule from the parent ion. This fragmentation pattern corresponded to 
the previously reported MS data of 3-Glc-28-Glc-medicagenic acid and 3-Glc-Glc-
medicagenic acid (Huhman and Sumner, 2002). To annotate the detected compound, we 
scanned for other peaks containing an anion with an m/z value between 825.40 and 825.45. 
Four additional isomers were detected, but only one (tR 32.15 min) yielded a fragment ion at 
m/z 439 associated with medicagenic acid. As 3-Glc-28-Glc-medicagenic acid has been 
reported to have a lower retention time than 3-Glc-Glc-medicagenic acid (Huhman and 
Sumner, 2002), the peak at tR 25.80 min has been annotated as 3-Glc-28-Glc-medicagenic 
acid, and the peak at tR 32.15 min as 3-Glc-Glc-medicagenic acid. 
2.5.Absence of zanhic acid glycosides 
A remarkable observation was the absence of zanhic acid glycosides in the list of identified 
saponins. In previous studies, zanhic acid was shown to be one of the major aglycone 
moieties in aerial parts of M. truncatula (Kapusta et al., 2005a; Kapusta et al., 2005b), and it 
was also reported to be present in other M. truncatula plant tissues, including roots (Huhman 
et al., 2005). In a more recent study, however, zanhic acid could not be detected in M. 
truncatula roots (Confalonieri et al., 2009). Similarly, no zanhic acid-containing compounds 
were detected in the hairy roots. Hairy root cultures are known to accumulate secondary 
metabolites that are normally produced in “natural” roots of differentiated plants (Guillon et 
al., 2006a; Guillon et al., 2006b; Hu and Du, 2006). Hence, the absence of zanhic acid 
residues in hairy roots may indicate that this compound is produced only in the aerial parts of 
the plant. Consequently, the occurrence of the enzyme responsible for the 16α-hydroxylation 
of the saponin backbone (Figure 4) might be restricted to the aerial parts of the plant. This 
finding might further support a tissue-specific role for the saponins in planta. Indeed, the 
saponin mixture from the aerial parts of the plant has a protective effect against herbivores,  
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Figure 3. LC ESI FT-ICR MS chromatograms. (A) MS scan of peak at tR 33.63 min (3-Rha-Gal-
GlcA-soyasapogenol B). (B) MS scan of peak at tR 25.80 min (3-Glc-28-Glc-medicagenic acid). (C) 
MS
2
 fragmentation of 3-Glc-28-Glc-medicagenic acid. 
 
whereas that from the roots rather shows allelopathic and antimicrobial activities (Tava and 
Avato, 2006). Thus, the in vivo role of the zanhic acid glycosides might be related to 
antinutritional effects in the aerial parts of the plant. In addition to zanhic acid glycosides, 
aerial parts are particularly rich in medicagenic acid glycosides (Kapusta et al., 2005a; 
Kapusta et al., 2005b; Huhman et al., 2005). Notably, none of the major medicagenic acid 
glycosides shown to occur in the aerial parts of the plant were found in the hairy roots, further 
underscoring the unique saponin composition of roots and aerial parts. In root extracts of 
greenhouse-grown M. truncatula plants, the presence of 31 saponins, mainly soyasapogenol 
conjugates, was shown (Huhman et al., 2005). Here, we could confirm the presence of 18 of 
these 31 previously described saponins. For some of the remaining saponins of this list, we 
could detect the corresponding nominal masses, but the observed accurate masses and 
fragmentation data did not unambiguously support the proposed structures. Hence, we did not 
include them in Table 1. However, in addition to the 18 previously described saponins, 61 
other saponins were encountered in this study, all of which had not been detected before in 
M. truncatula. This result underscores the power of the applied FT-ICR MS platform in 
metabolome analysis.  
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Table 1. Observed saponins from M. truncatula hairy roots, tentative identification, and FT-ICR MS
n
 characteristics. 
Peak numbers and tentative identification 
of the observed saponins 
[M-H]- Formula (δ ppm) FT-ICR MSn: m/z (% base peak) 
1 dHex-Hex-HexA-Aglycone D 973.50386 C48H78O20 (2.560) MS
2 [973.50]: 955 (100)[M-H2O-H]
-, 929 (10)[M-CO2-H]
-, 911 (53)[M-H2O-CO2-H]
-, 827 (3)[M-dHex-
H]-, 809 (7)[M-dHex-H2O-H]
-, 783 (6)[M-dHex-CO2-H]
-, 765 (19)[M-dHex-H2O-CO2-H]
-, 665 (2)[M-
dHex-Hex-H]-, 647 (26)[M-dHex-Hex-H2O-H]
-, 629 (14)[M-dHex-Hex-H2O-H2O-H]
-, 603 (7)[M-dHex-
Hex-H2O-CO2-H]
-, 557 (13)[M-dHex-Hex-108-H]-, 489 (11)[Agly-H]- 
MS3 [973.50→955]: 911 (100)[M-H2O-CO2-H]
-, 765 (21)[M-dHex-H2O-CO2-H]
-, 679 (9), 629 (49)[M-
dHex-Hex-H2O-H2O-H]
-, 557 (55)[M-dHex-Hex-108-H]-, 489 (7)[Agly-H]- 
2 Pen-Hex-Hex-Aglycone D 945.50965 C47H78O19 (3.380) MS
2 [945.51]: 927 (3)[M-H2O-H]
-, 813 (100)[M-Pen-H]-, 795 (8)[M-Pen-H2O-H]
-, 651 (2)[M-Pen-Hex-
H]-, 489 (2)[Agly-H]- 
MS3 [945.51→813]: 651 (64)[M-Pen-Hex-H]-, 489 (100)[Agly-H]- 
3 Hex-Hex-HexA-Bayogenin 987.48370 C48H76O21 (3.106) MS
2 [987.48]: 825 (4)[M-Hex-H]-, 807 (100)[M-Hex-H2O-H]
-, 645 (10)[M-Hex-Hex-H2O-H]
-, 601 
(18)[M-Hex-Hex-H2O-CO2-H]
-, 487 (2)[Agly-H]- 
MS3 [987.48→807]: 645 (85)[M-Hex-Hex-H2O-H]
-, 601 (100)[M-Hex-Hex-H2O-CO2-H]
-, 487 
(12)[Agly-H]- 
4 Hex-dHex-Hex-Hex-Bayogenin 
dHex-Hex-Hex-Bayogenin* 
1119.56348 
957.51011* 
C54H88O24 (3.754) 
C48H78O19 (3.818) 
MS2 [1119.56]: 957 (100)[M-Hex-H]-, 811 (54)[M-Hex-dHex-H]-, 793 (9)[M-Hex-dHex-H2O-H]
-, 649 
(33)[M-Hex-dHex-Hex-H]-, 631 (13)[M-Hex-dHex-Hex-H2O-H]
-, 487 (9)[Agly-H]- 
MS3 [1119.56→957]: 811 (100)[M-Hex-dHex-H]-, 793 (6)[M-Hex-dHex-H2O-H]
-, 649 (11)[M-Hex-
dHex-Hex-H]-, 631 (3)[M-Hex-dHex-Hex-H2O-H]
-, 487 (2)[Agly-H]- 
MS3 [1119.56→811]: 649 (100)[M-Hex-dHex-Hex-H]-,631 (8)[M-Hex-dHex-Hex-H2O-H]
-, 487 
(68)[Agly-H]- 
5 Malonyl-Hex-Hex-HexA-
Bayogenin 
1073.48680 C51H78O24 (5.378) MS
2 [1073.49]: 1029 (100)[M-CO2-H]
- 
MS3 [1073.49→1029]: 867 (15)[M-CO2-Hex-H]
-, 849 (100)[M-CO2-Hex-H2O-H]
-, 807 (7)[M-malonyl-
Hex-H2O-H]
-, 789 (40)[M-malonyl-Hex-H2O-H2O-H]
-, 763 (11)[M-malonyl-Hex-H2O-CO2-H]
-, 643 
(32)[M-CO2-Hex-Hex-H2O-CO2-H]
-, 601 (45)[M-malonyl-Hex-Hex-H2O-CO2-H]
-, 583 (38)[M-malonyl-
Hex-Hex-H2O-H2O-CO2-H]
-, 565 (22), 515 (83), 487 (14)[Agly-H]- 
6 Hex-Hex-Hex-Bayogenin 973.50421 C48H78O20 (2.919) MS
2 [973.50]: 955 (10)[M-H2O-H]
-,811 (100)[M-Hex-H]-, 793 (2)[M-Hex-H2O-H]
-, 649 (20)[M-Hex-
Hex-H]-, 631 (7)[M-Hex-Hex-H2O-H]
-, 487 (8) [Agly-H]- 
MS3 [973.50→811]: 649 (100)[M-Hex-Hex-H]-, 631 (20)[M-Hex-Hex-H2O-H]
-, 487 (36) [Agly-H]- 
MS3 [973.50→649]: 487 (100) [Agly-H]- 
7 dHex-Hex-HexA-Soyasapogenol 
A 
957.50926 C48H78O19 (2.931) MS
2 [957.51]: 939 (100)[M-H2O-H]
-, 895 (49)[M-H2O-CO2-H]
-, 811 (5)[M-dHex-H]-, 767 (3)[M-dHex-
CO2-H]
-, 749 (21)[M-dHex-H2O-CO2-H]
-, 631 (25)[M-dHex-Hex-H2O-H]
-, 613 (18)[M-dHex-Hex-H2O-
H2O-H]
-, 541 (18)[M-dHex-Hex-108-H]-, 473 (11)[Agly-H]-, 453 (5) 
MS3 [957.51→939]: 895 (83)[M-H2O-CO2-H]
-, 749 (19)[M-dHex-H2O-CO2-H]
-, 613 (61)[M-dHex-Hex-
H2O-H2O-H]
-, 541 (100)[M-dHex-Hex-108-H]-, 473 (4)[Agly-H]-, 453 (2) 
8 Hex-Hex-HexA-Aglycone A 985.46884 C48H74O21 (3.914) MS
2 [985.47]: 823 (100)[M-Hex-H]-, 779 (2)[M-Hex-CO2-H]
-, 761 (2)[M-Hex-CO2-H2O-H]
-, 643 (4)[M-
Hex-Hex-H2O-H]
-, 617 (2)[M-Hex-Hex-CO2-H]
-, 599 (2)[M-Hex-Hex-CO2-H2O-H]
-, 485 (3)[Agly-H]- 
MS3 [985.47→823]: 805 (1)[M-Hex-H2O-H]
-, 779 (10)[M-Hex-CO2-H]
-, 761 (3)[M-Hex-CO2-H2O-H]
-, 
661 (2)[M-Hex-Hex-H]-, 643 (100)[M-Hex-Hex-H2O-H]
-, 617 (42)[M-Hex-Hex-CO2-H]
-, 599 (28)[M-
Hex-Hex-CO2-H2O-H]
-, 581 (3)[M-Hex-Hex-CO2-H2O-H2O-H]
-, 567 (18), 485 (65)[Agly-H]-, 467 (19) 
9 Hex-Hex-Hex-Bayogenin 973.50407 C48H78O20 (2.776) MS
2 [973.50]: 955 (10)[M-H2O-H]
-,811 (100)[M-Hex-H]-, 649 (20)[M-Hex-Hex-H]-, 631 (7)[M-Hex-
Hex-H2O-H]
-, 487 (8) [Agly-H]- 
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MS3 [973.50→811]: 649 (100)[M-Hex-Hex-H]-, 631 (42)[M-Hex-Hex-H2O-H]
-, 487 (86) [Agly-H]- 
MS3 [973.50→649]: 487 (100) [Agly-H]- 409 (1), 393 (1), 391 (1) 
10 Hex-Hex-Aglycone C 823.41585 C42H64O16 (4.481) MS
2 [823.42]: 805 (4)[M-H2O-H]
-, 661 (2)[M-Hex-H]-, 617 (3)[M-Hex-CO2-H]
-, 599 (7)[M-Hex-CO2-
H2O-H]
-, 437 (100)[Agly-CO2-H2O-H]
- 
MS3 [823.42→437]: 391 (100), 375 (6) 
11 Hex-HexA-Bayogenin 825.43079 C42H66O16 (3.610) MS
2 [825.43]: 807 (10)[M-H2O-H]
-, 781 (3)[M-CO2-H]
-, 765 (3), 763 (2)[M-H2O-CO2-H]
-, 705 (7), 663 
(100)[M-Hex-H]-, 645 (10)[M-Hex-H2O-H]
-, 619 (41)[M-Hex-CO2-H]
-, 601 (41)[M-Hex-CO2-H2O-H]
-, 
587 (6)[M-Hex-CO2-H2O-H2O-H]
-, 529 (6), 487 (34)[Agly-H]-, 
MS3 [825.43→663]: 587 (4)[M-Hex-CO2-H2O-H2O-H]
-, 487 (100)[Agly-H]-, 467 (5), 455 (6), 439 (5) 
12 Hex-Hex-HexA-Hederagenin 971.48934 C48H76O20 (3.728) MS
2 [971.49]: 851 (4), 809 (100)[M-Hex-H]-, 791 (7)[M-Hex-H2O-H]
-, 747 (3)[M-Hex-CO2-H2O-H]
-, 
629 (20)[M-Hex-Hex-H2O-H]
-, 603 (3)[M-Hex-Hex-CO2-H]
-, 585 (6)[M-Hex-Hex-CO2-H2O-H]
-, 539 
(1)[M-Hex-Hex-108-H]-, 471 (4) [Agly-H]- 
MS3 [971.49→809]: 747 (4)[M-Hex-CO2-H2O-H]
-, 647 (3)[M-Hex-Hex-H]-, 629 (100)[M-Hex-Hex-H2O-
H]-, 603 (9)[M-Hex-Hex-CO2-H]
-, 585 (15)[M-Hex-Hex-CO2-H2O-H]
-, 553 (5), 539 (4)[M-Hex-Hex-108-
H]-, 471 (15)[Agly-H]-, 469 (6), 439 (6) 
13 Hex-Hex-Hex-Medicagenic acid 987.48516 C48H76O21 (4.584) MS
2 [987.49]: 825 (100)[M-Hex-H]-, 781 (5)[M-Hex-CO2-H]
-, 711 (3), 663 (4)[M-Hex-Hex-H]-, 601 
(4)[M-Hex-Hex-CO2-H2O-H]
-, 439 (53)[Agly-CO2-H2O-H]
- 
MS3 [987.49→825]: 439 (100)[Agly-CO2-H2O-H]
- 
14 Malonyl-Hex-Hex-HexA-
Hederagenin 
1057.49199 
1013.50072* 
C51H78O23 (5.558) MS
2 [1013.50]: 971 (5)[M-malonyl-H]-, 833 (100)[M-Hex-CO2-H2O-H]
-, 791 (8)[M-malonyl-Hex-H2O-
H]-, 773 (20)[M-malonyl-Hex-H2O-H2O-H]
-, 729 (3)[M-malonyl-Hex-H2O-CO2-H]
-, 713 (3), 671 (37)[M-
Hex-Hex-CO2-H2O-H]
-, 633 (4), 627 (25)[M-Hex-Hex-CO2-CO2-H2O-H]
-, 611 (2), 601 (7), 585 (9)[M-
malonyl-Hex-Hex-CO2-H2O-H]
-, 567 (43)[M-malonyl-Hex-Hex-CO2-H2O-H2O-H]
-, 549 (6), 499 
(70)[Hex-Hex-HexA-H]-, 471 (2)[Agly-H]-, 469 (5) 
MS3 [1013.50→833]: 773 (11)[M-malonyl-Hex-H2O-H2O-H]
-, 671 (100)[M-Hex-Hex-CO2-H2O-H]
-, 633 
(11), 585 (15)[M-malonyl-Hex-Hex-CO2-H2O-H]
-, 567 (10)[M-malonyl-Hex-Hex-CO2-H2O-H2O-H]
-, 
471 (4)[Agly-H]- 
15 dHex-Hex-Hex-Hederagenin 941.51456 C48H78O18 (3.209) MS
2 [941.51]: 795 (100)[M-dHex-H]-, 777 (10)[M-dHex-H2O-H]
-, 633 (12)[M-dHex-Hex-H]-, 615 
(2)[M-dHex-Hex-H2O-H]
-, 471 (1)[Agly-H]- 
MS3 [941.51→795]: 633 (100)[M-dHex-Hex-H]-, 615 (6)[M-dHex-Hex-H2O-H]
-, 471 (25)[Agly-H]- 
MS3 [941.51→633]: 471 (100)[Agly-H]-, 405 (1), 393 (1) 
16 Malonyl-Hex-HexA-Bayogenin 911.43120 
867.44138* 
C45H68O19 (3.288) MS
2 [867.44]: 825 (2)[M-malonyl-H]-, 807 (37)[M-malonyl-H2O-H]
-, 705 (3)[M-CO2-Hex-H]
-, 645 
(100)[M-malonyl-Hex-H2O-H]
-, 601 (6)[M-malonyl-Hex-H2O-CO2-H]
- 
MS3 [867.44→645]: 469 (100)[Agly-H2O-H]
-, 423 (10), 409 (40), 391 (8), 379 (21) 
MS3 [867.44→807]: 601 (100)[M-malonyl-Hex-H2O-CO2-H]
-, 487 (2)[Agly-H]- 
17 Hex-Hex-HexA-Aglycone A 985.46931 C48H74O21 (4.391) MS
2 [985.47]: 823 (6)[M-Hex-H]-, 805 (100)[M-Hex-H2O-H]
-, 643 (10)[M-Hex-Hex-H2O-H]
-, 599 
(33)[M-Hex-Hex-H2O-CO2-H]
-, 
MS3 [985.47→805]: 685 (4), 643 (45)[M-Hex-Hex-H2O-H]
-, 599 (100)[M-Hex-Hex-H2O-CO2-H]
-, 
MS3 [985.47→599]: 527 (100), 485 (2)[Agly-H]- 
18 Hex-Hex-Bayogenin 811.45241 C42H68O15 (4.763) MS
2 [811.45]: 649 (100)[M-Hex-Hex-H]-, 631 (8)[M-Hex-Hex-H2O-H]
-, 487 (62) [Agly-H]- 
MS3 [811.45→649]: 487 (100) [Agly-H]- 
MS3 [811.45→487]: 409 (100), 403 (21), 393 (38), 391 (74) 
19 Hex-Hex-HexA-Hederagenin 971.48997 C48H76O20 (4.377) MS
2 [971.49]: 851 (3), 809 (100)[M-Hex-H]-, 603 (5)[M-Hex-Hex-CO2-H]
-, 585 (9)[M-Hex-Hex-CO2-
H2O-H]
-, 569 (9), 499 (1), 471 (10)[Agly-H]- 
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MS3 [971.49→809]: 647 (32)[M-Hex-Hex-H]-, 629 (27)[M-Hex-Hex-H2O-H]
-, 611 (10)[M-Hex-Hex-
H2O-H2O-H]
-, 603 (25)[M-Hex-Hex-CO2-H]
-, 587 (12), 585 (15)[M-Hex-Hex-CO2-H2O-H]
-, 567 (58)[M-
Hex-Hex-CO2-H2O-H2O-H]
-, 553 (14), 499 (78), 471 (100)[Agly-H]-, 469 (15), 439 (17) 
MS3 [971.49→471]: 439 (37), 405 (30), 393 (100) 
20 Malonyl-Hex-Hex-HexA-
Aglycone A 
1071.47137 
1027.48023* 
C51H76O24 (5.593) MS
2 [1071.47]: 1027 (100)[M-CO2-H]
- 
MS2 [1027.48]: 865 (14)[M-CO2-Hex-H]
-, 847 (37)[M-CO2-Hex-H2O-H]
-, 823 (10)[M-malonyl-Hex-H]-, 
805 (7)[M-malonyl-Hex-H2O-H]
-, 787 (100)[M-malonyl-Hex-H2O-H2O-H]
-, 779 (7), 761 (11), 641 
(77)[M-CO2-Hex-CO2-H2O-H]
-, 625 (9)[M-malonyl-Hex-Hex-H2O-H2O-H]
-, 581 (51)[M-malonyl-Hex-
Hex-H2O-H2O-CO2-H]
-, 513 (44), 485 (9)[Agly-H]- 
MS3 [1027.48→787]: 625 (54)[M-malonyl-Hex-Hex-H2O-H2O-H]
-, 581 (100)[M-malonyl-Hex-Hex-
H2O-H2O-CO2-H]
-, 513 (22), 485 (45)[Agly-H]- 
MS3 [1027.48→641]: 581 (100)[M-malonyl-Hex-Hex-H2O-H2O-CO2-H]
-, 569 (6), 513 (11), 485 
(38)[Agly-H]-, 439 (2) 
21 3-Glc-28-Glc-Medicagenic acid 825.42987 C42H66O16 (2.494) MS
2 [825.43]: 663 (5)[M-Glc-H]-, 619 (3)[M-Glc-CO2-H]
-, 601 (35)[M-Glc-CO2-H2O-H]
-, 439 
(100)[Agly-CO2-H2O-H]
- 
MS3 [825.43→439]: 393 (51), 391 (100), 375 (8) 
MS3 [825.43→601]: 439 (100)[Agly-CO2-H2O-H]
- 
22 Malonyl-Hex-HexA-Bayogenin 911.43371 
867.44133* 
C45H68O19 (6.041) MS
2 [867.44]: 825 (34)[M-malonyl-H]-, 807 (25)[M-malonyl-H2O-H]
-, 705 (9)[M-CO2-Hex-H]
-, 645 
(77)[M-malonyl-Hex-H2O-H]
-, 601 (100)[M-malonyl-Hex-H2O-CO2-H]
- 
MS3 [867.44→601]: 583 (3), 529 (100), 487 (7)[Agly-H]- 
23 dHex-Hex-Hex-Hederagenin 941.51536 C48H78O18 (4.058) MS
2 [941.51]: 795 (100)[M-dHex-H]-, 777 (12)[M-dHex-H2O-H]
-, 633 (13)[M-dHex-Hex-H]-, 615 
(2)[M-dHex-Hex-H2O-H]
- 
MS3 [941.51→795]: 633 (100)[M-dHex-Hex-H]-, 615 (5)[M-dHex-Hex-H2O-H]
-, 471 (20)[Agly-H]- 
MS3 [941.51→633]: 471 (100)[Agly-H]-, 393 (3) 
24 Hex-Hex-HexA-Bayogenin 987.48378 C48H76O21 (3.187) MS
2 [987.48]: 969 (3)[M-H2O-H]
-, 825 (100)[M-Hex-H]-, 645 (2)[M-Hex-Hex-H2O-H]
-, 601 (2)[M-Hex-
Hex-H2O-CO2-H]
-, 487 (3)[Agly-H]- 
MS3 [987.48→825]: 781 (4)[M-Hex-CO2-H]
-, 645 (88)[M-Hex-Hex-H2O-H]
-, 619 (24)[M-Hex-Hex-CO2-
H]-, 601 (29)[M-Hex-Hex-H2O-CO2-H]
-, 569 (23), 487 (100)[Agly-H]-, 467 (3) 
25 Hex-dHex-Hex-HexA-
Hederagenin 
1117.54979 C54H86O24 (5.515) MS
2 [1117.55]: 1099 (5)[M-H2O-H]
-, 955 (100)[M-Hex-H]-, 937 (4)[M-Hex-H2O-H]
-, 893 (4)[M-Hex-
H2O-CO2-H]
-, 791 (1)[M-Hex-dHex-H2O-H]
-, 747 (1)[M-Hex-dHex-H2O-CO2-H]
-, 629 (2)[M-Hex-dHex-
Hex-H]-, 539 (2)[M-Hex-dHex-Hex-108-H]- 
MS2 [1117.55→955]: 937 (88)[M-Hex-H2O-H]
-, 893 (67)[M-Hex-H2O-CO2-H]
-, 747 (67)[M-Hex-dHex-
H2O-CO2-H]
-, 729 (21)[M-Hex-dHex-H2O-H2O-CO2-H]
-, 629 (100)[M-Hex-dHex-Hex-H]-, 611 (15)[M-
Hex-dHex-Hex-H2O-H]
-, 585 (14)[M-Hex-dHex-Hex-CO2-H]
-, 539 (16)[M-Hex-dHex-Hex-108-H]-, 471 
(17)[Agly-H]-, 453 (31) 
26 3-Glc-malonyl-28-Glc-
Medicagenic acid 
911.43233 C45H68O19 (4.522) MS
2 [911.43]: 867 (100)[M-CO2-H]
-, 705 (3)[M-Glc-CO2-H]
- 
MS3 [911.43→867]: 705 (4)[M-Glc-CO2-H]
-, 661 (7)[M-Glc-CO2-CO2-H]
-, 601 (36)[M-Glc-malonyl-
CO2-H2O-H]
-, 439 (100)[Agly-CO2-H2O-H]
- 
27 Hex-Bayogenin 649.39774 C36H58O10 (3.108) MS
2 [649.40]: 487 (100)[Agly-H]-, 469 (15), 441 (28), 409 (36) 
28 Hex-Medicagenic acid 663.37701 C36H56O11 (3.051) MS
2 [663.38]: 645 (5)[M-H2O-H]
-, 501 (13)[Agly-H]-, 439 (100)[Agly-CO2-H2O-H]
- 
MS3 [663.38→439]: 393 (83), 391 (100) 
29 Hex-HexA-Aglycone A 823.41492 C42H64O16 (3.352) MS
2 [823.41]: 661 (100)[M-Hex-H]-, 617 (33)[M-Hex-CO2-H]
-, 599 (52)[M-Hex-H2O-CO2-H]
-, 485 
(15)[Agly-H]- 
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MS3 [823.41→661]: 585 (5), 485 (100)[Agly-H]-, 467 (34) 
MS3 [823.41→599]: 527 (100), 485 (3)[Agly-H]-, 467 (2) 
30 Malonyl-Hex-Hex-Medicagenic 
acid 
911.43152 
867.44123* 
C45H68O19 (3.638) MS
2 [867.44]: 825 (33)[M-malonyl-H]-, 807 (16)[M-malonyl-H2O-H]
-, 705 (12)[M-Hex-CO2-H]
-, 663 
(10)[M-malonyl-Hex-H]-, 645 (63)[M-malonyl-Hex-H2O-H]
-, 601 (100)[M-malonyl-Hex-H2O-CO2-H]
-, 
487 (9), 439 (82)[Agly-CO2-H2O-H]
- 
31 dHex-Hex-HexA-Hederagenin 955.49433 C48H76O19 (3.690) MS
2 [955.49]: 937 (100)[M-H2O-H]
-, 911 (7)[M-CO2-H]
-, 893 (35)[M-H2O-CO2-H]
-, 809 (8)[M-dHex-
H]-, 747 (24)[M-dHex-H2O-CO2-H]
-, 629 (28)[M-dHex-Hex-H2O-H]
-, 611 (11)[M-dHex-Hex-H2O-H2O-
H]-, 539 (22)[M-dHex-Hex-108-H]-, 471 (4)[Agly-H]- 
MS3 [955.49→937]: 893 (100)[M-H2O-CO2-H]
-, 859 (6), 747 (20)[M-dHex-H2O-CO2-H]
-, 611 (66)[M-
dHex-Hex-H2O-H2O-H]
-, 539 (74)[M-dHex-Hex-108-H]-, 471 (13)[Agly-H]-, 451 (4), 441 (9) 
MS3 [955.49→893]: 747 (100)[M-dHex-H2O-CO2-H]
-, 729 (2), 585 (3), 567 (5), 471 (12)[Agly-H]- 
32 Hex-dHex-Hex-HexA-
Soyasapogenol E 
1101.55386 C54H86O23 (4.673) MS
2 [1101.55]: 1083 (8)[M-H2O-H]
-, 939 (100)[M-Hex-H]-, 921 (6)[M-Hex-H2O-H]
-, 877 (4)[M-Hex-
H2O-CO2-H]
-, 731 (1)[M-Hex-dHex-H2O-CO2-H]
-, 613 (2)[M-Hex-dHex-Hex-H2O-H]
-, 523 (3) 
MS3 [1101.55→939]: 921 (100)[M-Hex-H2O-H]
-, 877 (36)[M-Hex-H2O-CO2-H]
-, 793 (5), 731 (43)[M-
Hex-dHex-H2O-CO2-H]
-, 713 (12)[M-Hex-dHex-H2O-H2O-CO2-H]
-, 613 (47)[M-Hex-dHex-Hex-H2O-
H]-, 595 (26)[M-Hex-dHex-Hex-H2O-H2O-H]
-, 523 (58)[M-Hex-dHex-Hex-108-H]-, 455 (7)[Agly-H]-, 
453 (4) 
MS3 [1101.55→1083]: 921 (100)[M-Hex-H2O-H]
-, 877 (43)[M-Hex-H2O-CO2-H]
-, 757 (22), 523 (50)[M-
Hex-dHex-Hex-108-H]- 
33 Hex-Hex-HexA-Hederagenin 971.48921 C48H76O20 (3.594) MS
2 [971.49]: 809 (100)[M-Hex-H]-, 791 (1)[M-Hex-H2O-H]
-, 765 (1)[M-Hex-CO2-H]
-, 629 (2)[M-Hex-
Hex-H2O-H]
-, 603 (1)[M-Hex-Hex-CO2-H]
-, 585 (1)[M-Hex-Hex-CO2-H2O-H]
-, 539 (1), 471 (1)[Agly-
H]- 
MS3 [971.49→809]: 765 (6)[M-Hex-CO2-H]
-, 747 (6)[M-Hex-CO2-H2O-H]
-, 647 (1)[M-Hex-Hex-H]-, 
629 (100)[M-Hex-Hex-H2O-H]
-, 611 (2)[M-Hex-Hex-H2O-H2O-H]
-, 603 (27)[M-Hex-Hex-CO2-H]
-, 585 
(24)[M-Hex-Hex-CO2-H2O-H]
-, 567 (5)[M-Hex-Hex-CO2-H2O-H2O-H]
-, 553 (17), 539 (9)[M-Hex-Hex-
108-H]-, 471 (100)[Agly-H]-, 453 (17) 
34 dHex-Hex-Hex-HexA-
Soyasapogenol B 
1103.57097 C54H88O23 (5.987) MS
2 [1103.57]: 1085 (100)[M-H2O-H]
-, 1041 (60)[M-H2O-CO2-H]
-, 957 (9)[M-dHex-H]-, 913 (7)[M-
dHex-CO2-H]
-, 895 (33)[M-dHex-H2O-CO2-H]
-, 795 (2)[M-dHex-Hex-H]-, 777 (31)[M-dHex-Hex-H2O-
H]-, 759 (16)[M-dHex-Hex-H2O-H2O-H]
-, 620 (2), 571 (1), 457 (1)[Agly-H]- 
MS3 [1103.57→1085]: 1067 (18)[M-H2O-H2O-H]
-, 1041 (100)[M-H2O-CO2-H]
-, 895 (19)[M-dHex-H2O-
CO2-H]
-, 759 (54)[M-dHex-Hex-H2O-H2O-H]
-, 619 (11) 
35 Malonyl-Hex-malonyl-Hex-
Bayogenin 
983.45391 C48H72O21 (4.654) (MS): 983 (21)[M-H]
-, 895 (21)[M-CO2-CO2-H]
-, 734 (11)[M-CO2-CO2-Hex-H]
-, 691 (100)[M-malonyl-
Hex-CO2-H]
-, 649 (18)[M-malonyl-Hex-malonyl-H]-, 631 (62)[M-malonyl-Hex-malonyl-H2O-H]
-, 487 
(39)[Agly-H]- 
36 Malonyl-Hex-malonyl-Hex-
Medicagenic acid 
997.4345 C48H70O22 (5.918) MS
2 [997.43]: 953 (51)[M-CO2-H]
-, 909 (100)[M-CO2-CO2-H]
-, 733 (6), 705 (24)[M-malonyl-Hex-CO2-
H]-, 691 (26) 
MS3 [997.43→909]: 891 (4)[M-CO2-CO2-H2O-H]
-, 865 (6)[M-CO2-CO2-CO2-H]
-, 849 (3)[M-CO2-CO2-
malonyl-H2O-H]
-, 703 (4)[M-CO2-CO2-CO2-Hex-H]
-, 661 (6)[M-CO2-CO2-malonyl-Hex-H]
-, 643 
(15)[M-CO2-CO2-malonyl-Hex-H2O-H]
-, 439 (100)[Agly-CO2-H2O-H]
- 
37 dHex-Hex-HexA-Soyasapogenol 
A 
957.51003 C48H78O19 (3.735) MS
2 [957.51]: 939 (100)[M-H2O-H]
-, 895 (50)[M-H2O-CO2-H]
-, 811 (8)[M-dHex-H]-, 767 (3)[M-dHex-
CO2-H]
-, 749 (29)[M-dHex-H2O-CO2-H]
-, 649 (1)[M-dHex-Hex-H]-, 631 (29)[M-dHex-Hex-H2O-H]
-, 
613 (15)[M-dHex-Hex-H2O-H2O-H]
-, 541 (23)[M-dHex-Hex-108-H]-, 473 (8)[Agly-H]- 
MS3 [957.51→939]: 895 (100)[M-H2O-CO2-H]
-, 749 (14)[M-dHex-H2O-CO2-H]
-, 613 (61)[M-dHex-
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Hex-H2O-H2O-H]
-, 541 (62)[M-dHex-Hex-108-H]- 
MS3 [957.51→895]: 749 (100)[M-dHex-H2O-CO2-H]
-, 587 (5)[M-dHex-Hex-H2O-CO2-H]
-, 473 
(13)[Agly-H]- 
38 Malonyl-Hex-HexA-Hederagenin 895.43802 
851.44613* 
C45H68O18 (5.283) 
C44H68O16 (3.136) 
MS2 [851.45]: 809 (29)[M-malonyl-H]-, 791 (27)[M-malonyl-H2O-H]
-, 689 (82)[M-Hex-CO2-H]
-, 629 
(84)[M-malonyl-Hex-H2O-H]
-, 585 (100)[M-malonyl-Hex-CO2-H2O-H]
-, 471 (4)[Agly-H]- 
MS3 [851.45→585]: 513 (100), 471 (13)[Agly-H]- 
MS3 [851.45→629]: 629 (100)[M-malonyl-H2O-H]
-, 513 (54), 471 (78)[Agly-H]-, 453 (45), 405 (64), 393 
(74), 387 (22) 
39 dHex-Hex-HexA-Hederagenin 955.49392 C48H76O19 (3.261) MS
2 [955.49]: 937 (100)[M-H2O-H]
-, 911 (34)[M-CO2-H]
-, 893 (68)[M-H2O-CO2-H]
-, 809 (30)[M-dHex-
H]-, 747 (20)[M-dHex-H2O-CO2-H]
-, 689 (8), 629 (48)[M-dHex-Hex-H2O-H]
-, 611 (8)[M-dHex-Hex-
H2O-H2O-H]
-, 539 (14)[M- dHex-Hex-108-H]-, 471 (17)[Agly-H]- 
40 Hex-HexA-malonyl-Aglycone A 909.41850 
865.42579* 
C45H66O19 (6.539) 
C44H66O17 (3.543) 
MS2 [865.43]: 823 (3)[M-malonyl-H]-, 821 (4)[M-CO2-CO2-H]
-, 805 (28)[M-malonyl-H2O-H]
-, 761 
(4)[M-malonyl-CO2-H2O-H]
-, 703 (8)[M-CO2-Hex-H]
-, 643 (100)[M-malonyl-Hex-H2O-H]
-, 599 (35)[M-
malonyl-Hex-CO2-H2O-H]
-, 485 (1)[Agly-H]- 
MS3 [865.43→643]: 509 (100), 485 (64)[Agly-H]-, 467 (41), 421 (41) 
41 Hex-Hederagenin 633.40242 C36H58O9 (2.547) MS
2 [633.40]: 615 (33)[M-H2O-H]
-, 513 (15), 471 (100)[Agly-H]-, 453 (24), 405 (24), 393 (39) 
42 Hex-Hex-HexA-Soyasapogenol E 955.49420 C48H76O19 (3.554) MS
2 [955.49]: 937 (2)[M-H2O-H]
-, 835 (2), 793(100)[M-Hex-H]-, 775 (2)[M-Hex-H2O-H]
-, 731 (2)[M-
Hex-H2O-CO2-H]
-, 613 (4)[M-Hex-Hex-H2O-H]
-, 523 (5)[M-Hex-Hex-108-H]- 
MS3 [955.49→793]: 749 (3)[M-Hex-CO2-H]
-, 731 (29)[M-Hex-H2O-CO2-H]
-, 631 (2)[M-Hex-Hex-H]-, 
613 (100)[M-Hex-Hex-H2O-H]
-, 595 (8)[M-Hex-Hex-H2O-H2O-H]
-, 587 (5)[M-Hex-Hex-CO2-H]
-, 569 
(8)[M-Hex-Hex-H2O-CO2-H]
-, 551 (6)[M-Hex-Hex-H2O-H2O-CO2-H]
-, 537 (5), 523 (54)[M-Hex-Hex-
108-H]-, 455 (14)[Agly-H]-, 453 (6) 
43 Malonyl-Hex-malonyl-Hex-
Hederagenin 
967.45877 
879.47798* 
C48H72O20 (4.498) MS
2 [879,47]: 861 (2)[M-CO2-CO2-H2O-H]
-, 819 (6)[M-malonyl-CO2-H2O-H]
-, 777 (5)[M-malonyl-
malonyl-H2O-H]
-, 717 (27)[M-Hex-CO2-CO2-H]
-, 675 (100)[M-Hex-malonyl-CO2-H]
-, 657 (3)[M-Hex-
malonyl-CO2-H2O-H]
-, 615 (72)[M-Hex-malonyl-malonyl-H2O-H]
- 
MS3 [879.47→675]: 657 (3)[M-Hex-malonyl-CO2-H2O-H]
-, 633 (20)[M-Hex-malonyl-malonyl-H]-, 615 
(100)[M-Hex-malonyl-malonyl-H2O-H]
-, 513 (6)[M-Hex-malonyl-Hex-CO2-H]
-, 485 (5), 471 (2)[Agly-
H]-, 453 (2), 425 (6), 393 (2) 
MS3 [879.47→615]: 585 (26), 543 (6), 499 (6), 495 (8), 471 (23)[Agly-H]-, 453 (9), 405 (16), 393 (100), 
373 (7) 
44 Hex-Pen-Hederagenin 765.44543 C71H66O13 (3.088) MS
2 [765.45]: 603 (100)[M-Hex-H]-, 585 (7)[M-Hex-H2O-H]
-, 471 (6)[Agly-H]- 
MS3 [765.45→603]: 471 (100)[Agly-H]-, 423 (14) 
45 dHex-Hex-Hex-Soyasapogenol E 925.51905 C48H78O17 (2.620) MS
2 [925.52]: 779 (100)[M-dHex-H]-, 761 (13)[M-dHex-H2O-H]
-, 617 (7)[M-dHex-Hex-H]-, 599 (1)[M-
dHex-Hex-H2O-H]
-, 455 (1)[Agly-H]- 
MS3 [925.52→779]: 617 (100)[M-dHex-Hex-H]-, 599 (4)[M-dHex-Hex-H2O-H]
-, 455 (9)[Agly-H]- 
46 dHex-Hex-HexA-Hederagenin 955.49417 C48H76O19 (3.523) MS
2 [955.49]: 937 (100)[M-H2O-H]
-, 911 (7)[M-CO2-H]
-, 893 (50)[M-H2O-CO2-H]
-, 809 (15)[M-dHex-
H]-, 767 (8), 747 (8)[M-dHex-H2O-CO2-H]
-, 629 (23)[M-dHex-Hex-H2O-H]
-, 611 (28)[M-dHex-Hex-
H2O-H2O-H]
-, 539 (36)[M- dHex-Hex-108-H]-, 471 (11)[Agly-H]- 
47 Malonyl-Hex-Hex-HexA-
Soyasapogenol E 
1041.49582 
997.50288* 
C51H78O22 (4.438) MS
2 [997.50]: 835 (3)[M-Hex-CO2-H]
-, 817 (51)[M-Hex-H2O-CO2-H]
-, 775 (12)[M-Hex-H2O-malonyl-
H]-, 757 (4)[M-Hex-H2O-malonyl-H2O-H]
-, 679 (3), 655 (100)[M-Hex-Hex-H2O-CO2-H]
-, 611 (5)[M-
Hex-Hex-H2O-CO2-CO2-H]
-, 595 (2)[M-Hex-Hex-H2O-malonyl-H2O-H]
-, 551 (3)[M-Hex-Hex-H2O-CO2-
malonyl-H2O-H]
- 
MS3 [997.50→655]: 595 (4)[M-Hex-Hex-H2O-malonyl-H2O-H]
-,551 (20)[M-Hex-Hex-H2O-CO2-
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malonyl-H2O-H]
-,539 (100), 509 (65), 455 (15)[Agly-H]- 
48 dHex-Hex-Hex-Aglycone A 955.49454 C48H76O19 (3.910) MS
2 [955.49]: 809 (100)[M-dHex-H]-, 791 (8)[M-dHex-H2O-H]
-, 647 (5)[M-dHex-Hex-H]- 
MS3 [955.49→809]: 647 (100)[M-dHex-Hex-H]-, 485 (5)[Agly-H]- 
49 dHex-Hex-HexA-Bayogenin 971.48812 C48H76O20 (2.473) MS
2 [971.49]: 953 (66)[M-H2O-H]
-, 927 (15)[M-CO2-H]
-, 909 (100)[M-H2O-CO2-H]
-, 825 (4)[M-dHex-
H]-, 763 (6)[M-dHex-H2O-CO2-H]
-, 663 (3)[M-dHex-Hex-H]-, 645 (47)[M-dHex-Hex-H2O-H]
-, 627 
(5)[M-dHex-Hex-H2O-H2O-H]
-, 601 (5)[M-dHex-Hex-H2O-H2O-CO2-H]
-, 555 (15)[M-dHex-Hex-108-
H]-, 527 (5), 487 (5)[Agly-H]-, 483 (3), 469 (6) 
MS3 [971.49→909]: 837 (7), 763 (100)[M-dHex-H2O-CO2-H]
-, 745 (3)[M-dHex-H2O-H2O-CO2-H]
-, 601 
(24)[M-dHex-Hex-H2O-H2O-CO2-H]
-, 583 (2), 573 (10), 487 (6)[Agly-H]-, 485 (1), 459 (4), 439 (3) 
MS3 [971.49→953]: 909 (100)[M-H2O-CO2-H]
-, 627 (11)[M-dHex-Hex-H2O-H2O-H]
-, 555 (40)[M-
dHex-Hex-108-H]-, 527 (2), 487 (2)[Agly-H]-, 469 (6), 441 (1) 
50 dHex-Hex-HexA-Hederagenin 955.49245 C48H76O19 (1.723) MS
2 [955.49]: 937 (100)[M-H2O-H]
-, 893 (35)[M-H2O-CO2-H]
-, 747 (30)[M-dHex-H2O-CO2-H]
-, 629 
(41)[M-dHex-Hex-H2O-H]
-, 611 (22)[M-dHex-Hex-H2O-H2O-H]
-, 539 (21)[M-dHex-Hex-108-H]-, 471 
(18)[Agly-H]-, 451 (4), 307 (4) 
51 dHex-Hex-Hex-Bayogenin 957.50866 C48H78O19 (2.304) MS
2 [957.50]: 939(2)[M-H2O-H]
-, 811 (100)[M-dHex-H]-, 793 (6)[M-dHex-H2O-H]
-, 649 (12)[M-dHex-
Hex-H]-, 631 (2)[M-dHex-Hex-H2O-H]
-, 487 (2)[Agly-H]- 
MS3 [957.50→811]: 649 (100)[M-dHex-Hex-H]-, 631 (12)[M-dHex-Hex-H2O-H]
-, 487 (56)[Agly-H]- 
52 Hex-HexA-Bayogenin 825.43024 C42H66O16 (3.162) MS
2 [825.43]: 645 (100)[M-Hex-H2O-H]
-, 619 (28)[M-Hex-CO2-H]
-, 601 (20)[M-Hex-H2O-CO2-H]
-, 569 
(11), 487 (78)[Agly-H]-, 455 (8) 
MS3 [825.43→645]: 557 (11), 487 (11)[Agly-H]-, 469 (47), 439 (100) 
MS3 [825.43→487]: 467 (67), 455 (72), 437 (15), 409 (100), 393 (10), 391 (15) 
53 Malonyl-dHex-Hex-HexA-
Soyasapogenol B (Pisumsaponin 
I) 
1027.51636 C51H80O21 (4.308) MS
2 [1027.52]: 983 (100)[M-CO2-H]
- 
MS3 [1027.52→983]: 965 (100)[M-CO2-H2O-H]
-, 921 (54)[M-CO2-CO2-H2O-H]
-, 837 (10)[M-CO2-
dHex-H]-, 793 (10)[M-CO2-dHex-CO2-H2O-H]
-, 775 (23)[M-CO2-dHex-CO2-H2O-H2O-H]
-, 675 (3)[M-
CO2-dHex-Hex-H]
-, 657 (24)[M-CO2-dHex-Hex-H2O-H]
-, 639 (20)[M-CO2-dHex-Hex-H2O-H2O-H]
-, 613 
(1)[M-CO2-dHex-Hex-H2O-CO2-H]
-, 567 (21)[M-CO2-dHex-Hex-108-H]
-, 499 (7)[M-CO2-dHex-Hex-
HexA-H]- 
54 Hex-HexA-Soyasapogenol E 793.43923 C42H66O14 (1.575) MS
2 [793.44]: 673 (8), 631 (100)[M-Hex-H]-, 613 (13)[M-Hex-H2O-H]
-, 569 (8)[M-Hex-H2O-CO2-H]
- 
MS3 [793.44→631]: 613 (4)[M-Hex-H2O-H]
-, 555 (3), 497 (2), 455 (100)[Agly-H]- 
55 Malonyl-dHex-Hex-Medicagenic 
acid 
895.43821 
851.44654* 
C45H68O18 (5.496) 
C44H68O16 (3.617) 
MS2 [851.45]: 809 (49)[M-malonyl-H]-, 791 (8)[M-malonyl-H2O-H]
-, 689 (37)[M-Hex-CO2-H]
-, 629 
(48)[M-malonyl-Hex-H2O-H]
-, 585 (100)[M-malonyl-Hex-H2O-CO2-H]
-, 439 (9)[Agly-CO2-H2O-H]
- 
56 Hex-Hex-Bayogenin 811.45028 C42H68O15 (2.138) MS
2 [811.45]: 649 (100)[M-Hex-H]-, 631 (8)[M-Hex-H2O-H]
-, 487 (58)[Agly-H]- 
MS3 [811.45→649]: 487 (100)[Agly-H]-, 439 (1) 
57 dHex-Hex-Hex-Aglycone A 955.49230 C48H76O19 (1.566) MS
2 [955.49]: 937 (3)[M-H2O-H]
-, 809 (100)[M-dHex-H]-, 791 (6)[M-dHex-H2O-H]
-, 647 (15)[M-dHex-
Hex-H]-, 629 (6)[M-dHex-Hex-H2O-H]
-, 485 (8)[Agly-H]- 
MS3 [955.49→809]: 647 (100)[M-dHex-Hex-H]-, 629 (26)[M-dHex-Hex-H2O-H]
-, 485 (92)[Agly-H]- 
58 Hex-Hex-Bayogenin 811.45207 C42H68O15 (4.344) MS
2 [811.45]: 649 (100)[M-Hex-H]-, 631 (31)[M-Hex-H2O-H]
-, 487 (98)[Agly-H]- 
MS3 [811.45→649]: 487 (100)[Agly-H]-, 439 (1) 
59 Hex-HexA-Bayogenin 825.43143 C42H66O16 (4.386) MS
2 [825.43]: 645 (100)[M-Hex-H2O-H]
-, 601 (17)[M-Hex-H2O-CO2-H]
-, 487 (6)[Agly-H]-, 439 (1) 
MS3 [825.43→645]: 487 (100)[Agly-H]-, 467 (2), 455 (5), 439 (9) 
MS3 [825.43→601]: 529 (100), 487 (8)[Agly-H]- 
60 3-Glc-Glc-Medicagenic acid 825.43148 C42H66O16 (4.446) MS
2 [825.43]: 663 (1)[M-Glc-H]-, 601 (1)[M-Glc-H2O-CO2-H]
-, 439 (100)[Agly-CO2-H2O-H]
- 
MS3 [825.43→439]: 393 (61), 391 (100), 375 (25) 
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61 dHex-Hex-Hex-Hederagenin 941.51621 C48H78O18 (4.961) MS
2 [941.51]: 795 (100)[M-dHex-H]-, 777 (10)[M-dHex-H2O-H]
-, 633 (13)[M-dHex-Hex-H]-, 615 
(2)[M-dHex-Hex-H2O-H]
-, 471 (1)[Agly-H]- 
MS3 [941.51→795]: 633 (100)[M-dHex-Hex-H]-, 615 (5)[M-dHex-Hex-H2O-H]
-, 471 (24)[Agly-H]- 
MS3 [941.51→633]: 471 (100)[Agly-H]- 
62 Malonyl-Hex-Hex-Bayogenin 897.45213 
853.46093* 
C45H70O18 (3.556) 
C44H70O16 (2.132) 
MS2 [853.46]: 811 (100)[M-malonyl-H]-, 793 (85)[M-malonyl-H2O-H]
-, 691 (6)[M-CO2-Hex-H]
-, 673 
(2)[M-CO2-H2O-Hex-H]
-, 649 (3)[M-malonyl-Hex-H]-, 631 (6)[M-malonyl-Hex-H2O-H]
-, 613 (2)[M-
malonyl-Hex-CO2-H]
-, 487 (10)[Agly-H]- 
MS3 [853.46→811]: 649 (100)[M-malonyl-Hex-H]-, 631 (33)[M-malonyl-Hex-H2O-H]
-, 487 (40)[Agly-
H]- 
MS3 [853.46→793]: 715 (2), 691 (6), 649 (8)[M-malonyl-Hex-H]-, 631 (51)[M-malonyl-Hex-H2O-H]
-, 
613 (8)[M-malonyl-Hex-CO2-H]
-, 595 (4)[M-malonyl-Hex-H2O-CO2-H]
-, 583 (2), 515 (1), 487 
(100)[Agly-H]-, 469 (4), 439 (10) 
63 Hex-HexA-Hederagenin 809.43693 C42H66O15 (4.985) MS
2 [809.44]: 747 (5)[M-H2O-CO2-H]
-, 647 (2)[M-Hex-H]-, 629 (100)[M-Hex-H2O-H]
-, 603 (11)[M-
Hex-CO2-H]
-, 585 (14)[M-Hex-H2O-CO2-H]
-, 567 (2)[M-Hex-H2O-H2O-CO2-H]
-, 553 (5), 539 (2)[M-
Hex-108-H]-, 471 (15)[Agly-H]-, 469 (6), 453 (1), 451 (1), 439 (8), 423 (2) 
64 Hex-HexA-Aglycone A 823.41390 C42H66O16 (2.113) MS
2 [823.41]: 779 (12)[M-CO2-H]
-, 761 (5)[M-H2O-CO2-H]
-, 643 (100)[M-Hex-H2O-H]
-, 617 (40)[M-
Hex-CO2-H]
-, 599 (34)[M-Hex-H2O-CO2-H]
-, 581 (4)[M-Hex-H2O-H2O-CO2-H]
-, 567 (12), 485 
(72)[Agly-H]-, 467 (21) 
65 Pen-Hex-Hex-Aglycone B 925.48149 C47H74O18 (1.352) MS
2 [925.48]: 907 (25)[M-H2O-H]
-, 793 (100)[M-Pen-H]-, 775 (12)[M-Pen-H2O-H]
-, 631 (54)[M-Pen-
Hex-H]-, 613 (7)[M-Pen-Hex-H2O-H]
-, 469 (5)[Agly-H]- 
MS3 [925.48→793]: 775 (9)[M-Pen-H2O-H]
-, 631 (100)[M-Pen-Hex-H]-, 613 (10)[M-Pen-Hex-H2O-H]
-, 
469 (9)[Agly-H]- 
MS3 [925.48→631]: 613 (29)[M-Pen-Hex-H2O-H]
-, 469 (100)[Agly-H]-, 451 (3) 
66 Hex-Hex-Aglycone A 809.43647 C42H66O15 (4.417) MS
2 [809.44]: 647 (99)[M-Hex-H]-, 629 (27)[M-Hex-H2O-H]
-, 485 (100)[Agly-H]- 
MS3 [809.44→485]: 467 (100), 455 (21), 439 (11), 423 (40), 421 (61), 403 (48), 391 (11), 363 (10), 347 
(18) 
MS3 [809.44→647]: 485 (100)[Agly-H]- 
67 Hex-Medicagenic acid 663.37661 C36H56O11 (2.448) MS
2 [663.38]: 487 (6)[Agly-H2O-H]
-, 439 (100)[Agly-CO2-H2O-H]
- 
MS3 [663.38→439]: 393 (61), 391 (100), 375 (11) 
68 dHex-Hex-HexA-Soyasapogenol 
E 
939.49979 C48H76O18 (4.152) MS
2 [939.50]: 921 (100)[M-H2O-H]
-, 877 (24)[M-H2O-CO2-H]
-, 793 (11)[M-dHex-H]-, 749 (5)[M-dHex-
CO2-H]
-, 731 (18)[M-dHex-H2O-CO2-H]
-, 613 (14)[M-dHex-Hex-H2O-H]
-, 595 (17)[M-dHex-Hex-2H2O-
H]-, 523 (11)[M-dHex-Hex-108-H]-, 465 (24), 455 (8)[Agly-H]- 
MS3 [939.50→921]: 877 (100)[M-H2O-CO2-H]
-, 731 (44)[M-dHex-H2O-CO2-H]
-, 595 (35)[M-dHex-
Hex-2H2O-H]
-, 523 (14)[M-dHex-Hex-108-H]-, 465 (45) 
69 dHex-Hex-HexA-Hederagenin 955.49569 C48H76O19 (5.114) MS
2 [955.49]: 937 (100)[M-H2O-H]
-, 893 (63)[M-H2O-CO2-H]
-, 809 (14)[M-dHex-H]-, 765 (23)[M-
dHex-CO2-H]
-, 747 (19)[M-dHex-H2O-CO2-H]
-, 629 (18)[M-dHex-Hex-H2O-H]
-, 611 (19)[M-dHex-Hex-
2H2O-H]
-, 539 (21) )[M-dHex-Hex-108-H]-, 471 (8)[Agly-H]-, 469 (3) 
70 Hex-Bayogenin 649.39741 C36H58O10 (2.599) MS
2 [649.39]: 487 (100)[Agly-H]-, 409 (3), 391 (2) 
MS3 [649.39→487]: 467 (29), 455 (14), 421 (35), 409 (100), 403 (17), 393 (34), 391 (52), 379 (17) 
71 Hex-HexA-Hederagenin 809.43534 C42H66O15 (3.021) MS
2 [809.44]: 629 (100)[M-Hex-H2O-H]
-, 585 (11)[M-Hex-H2O-CO2-H]
-, 471 (2)[Agly-H]- 
MS3 [809.44→629]: 499 (12), 471 (100)[Agly-H]-, 469 (11), 439 (12) 
MS3 [809.44→585]: 513 (100), 499 (2), 471 (5)[Agly-H]- 
72 Malonyl-Hex-Medicagenic acid 749.37838 C39H58O14 (4.003) MS
2 [749.38]: 705 (100)[M-CO2-H]
- 
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705.38773* C38H58O12 (3.089) MS
2 [705.39]: 439 (100)[Agly-CO2-H2O-H]
- 
MS3 [705.39→439]: 393 (70), 391 (100), 375 (9) 
73 Pen-Hex-HexA-Soyasapogenol B 927.49925 C47H76O18 (3.624) MS
2 [927.50]: 909 (100)[M-H2O-H]
-, 865 (14)[M-CO2-H2O-H]
-, 795 (50)[M-Pen-H]-, 733 (34)[M-Pen-
CO2-H2O-H]
-, 633 (3)[M-Pen-Hex-H]-, 615 (44)[M-Pen-Hex-H2O-H]
-, 597 (65)[M-Pen-Hex-H2O-H2O-
H]-, 571 (4)[M-Pen-Hex-CO2-H2O-H]
-, 525 (72)[M-Pen-Hex-108-H]-, 457 (15)[Agly-H]- 
74 Hex-HexA-Aglycone A 823.41450 C42H66O16 (2.842) MS
2 [823.41]: 643 (100)[M-Hex-H2O-H]
-, 599 (50)[M-Hex-H2O-CO2-H]
-, 485 (4)[Agly-H]-, 467 (4) 
MS3 [823.41→643]: 599 (26)[M-Hex-H2O-CO2-H]
-, 515 (13), 487 (12), 485 (87)[Agly-H]-, 469 (12), 467 
(100) 
MS3 [823.41→599]: 581 (1), 527 (100), 485 (4)[Agly-H]-, 439 (2) 
75 Malonyl-Hex-Bayogenin 735.39924 
691.40869* 
C39H60O13 (4.003) 
C38H60O11 (3.477) 
MS2 [691.41]: 649 (10)[M-malonyl-H]-, 631 (100)[M-malonyl-H2O-H]
-, 487 (2)[Agly-H]- 
MS3 [691.41→631]: 601 (100), 487 (10)[Agly-H]-, 469 (20), 421 (6), 409 (18), 393 (10), 391 (10) 
MS3 [691.41→649]: 487 (100)[Agly-H]-, 439 (1) 
76 Malonyl-Hex-HexA-Hederagenin 895.43874 
851.44633* 
C45H68O18 (6.088) 
C44H68O16 (3.371) 
MS2 [851.45]: 809 (1)[M-malonyl-H]-, 791 (2)[M-malonyl-H2O-H]
-, 671 (39)[M-Hex-C2H2O-H2O-H]
-, 
627 (14)[M-Hex-malonyl-H2O-H]
-, 611 (11)[M-Hex-malonyl-CO2-H]
-, 585 (9), 567 (13), 499 (100), 471 
(4)[Agly-H]- 
77 3-Rha-Gal-GlcA-Soyasapogenol 
B 
941.51540 C48H78O18 (4.101) MS
2 [941.52]: 923 (100)[M-H2O-H]
-, 879 (43)[M-H2O-CO2-H]
-, 795 (8)[M-Rha-H]-, 751 (5)[M-Rha-
CO2-H]
-, 733 (24)[M-Rha-H2O-CO2-H]
-, 633 (2)[M-Rha-Gal-H]-, 615 (28)[M-Rha-Gal-H2O-H]
-, 597 
(17)[M-Rha-Gal-2H2O-H]
-, 525 (25)[M-Rha-Gal-108-H]-, 457 (8)[Agly-H]- 
MS3 [941.52→923]: 879 (100)[M-H2O-CO2-H]
-, 733 (19)[M-Rha-H2O-CO2-H]
-, 597 (54)[M-Rha-Gal-
2H2O-H]
-, 525 (70)[M-Rha-Gal-108-H]-, 457 (4)[Agly-H]- 
MS3 [941.52→879]: 733 (100) [M-Rha-H2O-CO2-H]
-, 457 (7)[Agly-H]- 
78 Rha-Gal-GlcA-Soyasapogenol E 939.49939 C48H76O18 (3.726) MS
2 [939.50]: 921 (100)[M-H2O-H]
-, 877 (42)[M-H2O-CO2-H]
-, 793 (8)[M-Rha-H]-, 749 (1)[M-Rha-
CO2-H]
-, 731 (41)[M-Rha-H2O-CO2-H]
-, 613 (47)[M-Rha-Gal-H2O-H]
-, 595 (29)[M-Rha-Gal-2H2O-H]
-, 
523 (64)[M-Rha-Gal-108-H]-, 455 (5)[Agly-H]- 
MS3 [939.50→921]: 877 (78)[M-H2O-CO2-H]
-, 731 (26)[M-Rha-H2O-CO2-H]
-, 595 (36)[M-Rha-Gal-
2H2O-H]
-, 523 (100)[M-Rha-Gal-108-H]-, 455 (6)[Agly-H]- 
MS3 [939.50→523]: 455 (91)[Agly-H]-, 453 (100), 439 (13) 
79 HexA-Hederagenin 647.38199 C36H56O10 (3.726) MS
2 [647.38]: 629 (5), 587 (7), 571 (18), 527 (4), 499 (3), 471 (100)[Agly-H]-, 439 (7) 
MS3 [647.38→471]: 439 (18), 405 (43), 393 (100) 
* Ion resulting from in source fragmentation. 
HexA, uronic acid, such as glucuronic acid or galacturonic acid; Hex, hexose, such as glucose or galactose; dHex, 6-deoxyhexose, such as rhamnose or 
fucose; Pen, pentose, such as arabinose or xylose; GlcA, glucuronic acid; Glc, glucose; Gal, galactose; Rha, rhamnose 
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2.6.Ten different aglycones 
One prerequisite we applied to include the detected compounds in the list of tentatively 
identified saponins was the occurrence of an aglycone ion in the MS
n
 fragmentation data. As 
such, we could show that the 79 identified saponins present in the extract of M. truncatula 
hairy roots were glycosides of 10 different aglycones. The structures of the aglycones are 
given in Figure 4 and the observed aglycone ions, their predicted molecular formulas and 
tentative identifications are listed in Table 2. For five of the aglycones, i.e., hederagenin, 
bayogenin, medicagenic acid, and soyasapogenols B and E (Figure 4), saponins containing 
the aglycone have been described before (Huhman and Sumner, 2002; Kapusta et al., 2005a; 
Kapusta et al., 2005b; Huhman et al., 2005). A sixth aglycone yielded an [Agly-H]
-
 ion at m/z 
473 (Figure 5A). Although this aglycone was only detected as a (grand)daughter ion with 
nominal m/z values, its molecular formula could be predicted by the accurate prediction of 
the molecular formula of the parent ion and the observed loss of sugar residues. With this 
method, the molecular formula was predicted to be C30H50O4, which corresponds to the 
molecular formula of soyasapogenol A. No saponins of M. truncatula that contain 
soyasapogenol A as the aglycone had been described, but the compound had been shown to 
occur in M. truncatula as a sapogenin (Confalonieri et al., 2009). Hence, the two saponins 
containing this aglycone were tentatively identified as soyasapogenol A glycosides. 
 
Table 2. Observed aglycones in M. truncatula. 
m/z [Observed ion] Molecular Formula Tentative identification 
455 [Agly-H]- C30H48O3 Soyasapogenol E 
457 [Agly-H]- C30H50O3 Soyasapogenol B 
469 [Agly-H]- C30H46O4 Aglycone B (3β-hydroxy-23-oxo-olean-12-en-28-oic acid) 
471 [Agly-H]- C30H48O4 Hederagenin 
473 [Agly-H]- C30H50O4 Soyasapogenol A 
485 [Agly-H]- C30H46O5 Aglycone A (2β,3β-dihydroxy-23-oxo-olean-12-en-28-oic acid) 
487 [Agly-H]- C30H48O5 Bayogenin 
489 [Agly-H]- C30H50O5 Aglycone D 
437 [Agly-CO2-H2O-H]
- C30H44O6 Aglycone C 
439 [Agly-CO2-H2O-H]
- C30H46O6 Medicagenic acid 
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Figure 4. Theoretical biosynthetic pathway of sapogenins in M. truncatula and m/z values of the 
observed aglycones in the hairy roots extract. 
 
Furthermore, four other, unknown, aglycones were observed. Aglycone A was shown to 
occur in 10 of the tentatively identified saponins. It had an observed [Agly-H]
-
 ion at m/z 485 
(Figure 5C), and its molecular formula was calculated to be C30H46O5. An aglycone with this 
mass had been previously observed in M. truncatula, but its structure was not elucidated 
(Huhman and Sumner, 2002; Huhman et al., 2005; Naoumkina et al., 2010). Only one 
sapogenin with this molecular formula is known to occur in the genus Medicago, namely 
2β,3β-dihydroxy-23-oxo-olean-12-en-28-oic acid. This aglycone contains C-23 formyl group, 
which is thought to be the biosynthetic intermediate in the enzymatic oxidation of the C-23 
hydroxy group of bayogenin, eventually leading to the carboxylation of medicagenic acid 
(Figure 4) (Tava et al., 2010). Thus, compounds containing aglycone A as the sapogenin 
could be 2β,3β-dihydroxy-23-oxo-olean-12-en-28-oic acid glycosides. Another identified 
saponin yielded an aglycone anion at m/z 469 (Figure 5D) and a predicted molecular formula 
of C30H46O4 (aglycone B). Similar to aglycone A, this compound may contain a C-23 formyl 
group and may be the result of an enzymatic oxidation of hederagenin, leading to 3β-
hydroxy-23-oxo-olean-12-en-28-oic acid (Figure 4). 
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Figure 5. LC ESI FT-ICR MS chromatograms leading to the detection of the various aglycones. (A) 
MS
2
 fragmentation of dHex-Hex-HexA-soyasapogenol A. (B) MS
2
 fragmentation of dHex-Hex-Hex-
bayogenin. (C) MS
2
 fragmentation of dHex-Hex-Hex-aglycone A. (D) MS
2
 fragmentation of Pen-
Hex-Hex-aglycone B. 
 
Aglycone C, a third unknown aglycone encountered in one of the saponins of M. truncatula 
hairy roots, yielded a first product ion at m/z 437. Similar to medicagenic acid, this ion is the 
result of the decarboxylation and dehydration of aglycone C, which has a calculated 
molecular formula of C30H44O6. Decarboxylation and dehydration of aglycones are observed 
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only in medicagenic acid (Huhman and Sumner, 2002) and zanhic acid (Kapusta et al., 
2005b) and, thus, could be related to the presence of a C-23 carboxylic group. Consequently, 
we assume that aglycone C contains a C-23 carboxylic group. Two saponins contain an 
aglycone (aglycone D) yielding an anion at m/z 489 (Figure 1C) and a calculated molecular 
formula of C30H50O5. No aglycones with this molecular formula have been described in 
Medicago to date, but, assuming a β-amyrin-derived triterpene skeleton, the molecular 
formula points toward an aglycone containing five hydroxy groups. Thus, we postulate that 
aglycone D could be an oxidation product of soyasapogenol A. However, since we cannot 
postulate a structure based on these assumptions, we did not include the aglycones C and D in 
Figure 4. 
3. Experimental section 
3.1.Generation and cultivation of transgenic M. truncatula hairy roots 
A. rhizogenes-mediated transformation of M. truncatula (ecotype Jemalong J5) hairy roots 
was carried out as reported (Boisson-Dernier et al., 2001) with the following modifications. 
After scarification by treatment with sulfuric acid for 5 min, seeds were surface sterilized 
with 12% NaOCl during 2 min and washed with sterile H2O. Subsequently, seeds were 
treated with 1 μM 6-benzylaminopurine for 3 h and thereafter allowed to germinate on wet, 
sterile 3 mm Whatman paper at room temperature in the dark. After 2 days of germination, 
the seedlings were wounded by cutting approximately 2 mm from the root tip of the radicle. 
The wounded seedlings were infected with A. rhizogenes and placed on slanted agar plates 
containing Murashige and Skoog (MS) medium (pH 5.8) supplemented with vitamins 
(Duchefa). The plates were sealed with micropore tape and placed vertically. Cocultivation 
was allowed for 10 days under a 16 h/8 h light/dark regime at 22°C. After 10 days, the plants 
were transferred to new plates, containing 100 mg/L cefotaxime to prevent A. rhizogenes 
growth, and incubated under identical conditions. After 10 days, hairy roots were excised 
from the plants and transferred to liquid MS medium (pH 5.8) supplemented with vitamins, 
1% (w/v) sucrose, and 100 mg/L cefotaxime to eliminate A. rhizogenes contamination. The 
hairy roots were grown for 7 days in the dark at 24°C and shaking at 300 rpm. Subsequently, 
the roots were transferred to horizontal Petri dishes containing solid MS medium (pH 5.8) 
supplemented with 1% (w/v) sucrose and 100 mg/L cefotaxime and grown in the dark at 
24°C. After 3 weeks, young hairy root tissue was subcultured to solid medium without 
antibiotics. For maintenance, the axenic hairy roots cultures were subcultured every 3 weeks 
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onto fresh plates. Hairy roots for metabolic profiling were grown for 21 days in liquid MS 
medium (pH 5.8) supplemented with vitamins and 1% (w/v) sucrose. 
3.2.Metabolite extractions 
M. truncatula hairy roots, grown for 21 days in liquid medium, were harvested and rinsed 
with purified H2O under vacuum filtration. Subsequently, the roots were frozen and ground in 
liquid N2. Of the ground material, 400 mg was extracted with 1 mL of MeOH at room 
temperature for 10 min, followed by centrifugation for 10 min at 20800g. Under vacuum, 
500 μL of the supernatant was evaporated to dryness, and the residue was dissolved in 600 μL 
of H2O/cyclohexane (2:1, v/v). Samples were centrifuged (10 min at 20800g), and 200 μL of 
the aqueous phase was retained for analysis. 
3.3.LC ESI FT-ICR MS 
For reversed-phase LC, an Acquity UPLC BEH C18 column (150 x 2.1 mm, 1.7 µm; Waters, 
Milford, MA) was serially coupled to an Acquity UPLC BEH C18 column (100 x 2.1 mm, 
1.7 µm) and mounted on an ultra-high-performance LC system consisting of a Accela pump 
(Thermo Electron Corporation, Waltham, MA, USA) and Accela autosampler (Thermo 
Electron Corporation). The Accela LC system was hyphenated to a LTQ FT Ultra (Thermo 
Electron Corporation) via an electrospray ionization source. The following gradient was run 
using water:MeCN (99:1, v:v) acidified with 0.1% (v:v) HOAc (solvent A) and MeCN:water 
(99:1, v:v) acidified with 0.1% (v:v) HOAc (solvent B): time 0 min, 5% B; 30 min, 55% B; 
35 min, 100% B. The loop size, flow, and column temperature were 25 µL, 300 µL/min and 
80°C, respectively. Full loop injection was applied. Negative ionization was obtained with 
the following parameter values: capillary temperature 150°C, sheath gas 25 (arbitrary units), 
aux. gas 3 (arbitrary units), and spray voltage 4.5 kV. Full FT-MS spectra between m/z 120–
1400 were recorded at a resolution of 100,000. For identification, full MS spectra were 
interchanged with a dependent MS
2
 scan event in which the most abundant ion in the 
previous full MS scan was fragmented, and two dependent MS
3
 scan events in which the two 
most abundant daughter ions were fragmented. The collision energy was set at 35%. 
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Abstract 
Plants are a rich source of natural products that feed various drug discovery programs. 
However, there is an ever increasing demand for novel compounds, due to, amongst others, 
the growing drug tolerance and resistance in microorganisms and newly emerging diseases. 
In microorganisms, combinatorial biosynthesis is a widely used tool to increase structural 
variation in several classes of (microbial) natural products. Because of the more complex 
genetic make-up of plants and the lack of tools to manipulate them, combinatorial 
biosynthesis in plants is still in its infancy. The recent technical advances in gene discovery 
and functional genomics have brought plants within the scope of combinatorial biosynthesis. 
Here, we demonstrate the establishment of a combinatorial biosynthesis platform in plants, 
with the metabolite class of the triterpene saponins as the target. By ectopic expression of 
candidate saponin biosynthesis genes of several medicinal plants in M. truncatula hairy roots, 
transgenic lines were generated, some of which accumulated a set of novel compounds. 
Structural elucidation of the novel compounds revealed that new saponin aglycones were 
obtained for oleanane- and dammarane-type saponins were obtained. 
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1. Introduction 
Plants are an enormously rich source of natural products that are used in a variety of 
therapeutics and in various drug discovery programs (Li and Vederas, 2009). Due to 
problems such as growing drug tolerance and resistance in microorganisms and newly 
emerging diseases, the demand for a continuous supply of novel molecules with novel or 
superior pharmaceutical activities is ever increasing. Screening of medicinal plant extracts 
may lead to the discovery of novel compounds, however, these methods are often time 
consuming and expensive (Littleton et al., 2005). Hence, despite the potential of plants in 
terms of novel compounds, the pharmaceutical industry has shifted focus to the high 
throughput screening of combinatorial chemistry libraries. This shift may have been 
premature, since the output in terms of new drugs is far below the initial expectations 
(Ortholand and Ganesan, 2004). 
An alternative approach to generate new molecules is combinatorial biosynthesis, that can be 
defined as an approach in which gene products from different organisms are combined to 
produce new bioactive compounds. In microorganisms, various combinatorial biosynthesis 
techniques have been successfully applied to increase structural variation in several classes of 
microbial natural products, such as polyketides and indolocarbazoles (Floss, 2006; Sánchez et 
al., 2006; Lam, 2007; Menzella and Reeves, 2007; Zhou et al., 2008; Salas and Méndez, 
2009). Until recently, due to their more complex genetic makeup and the lack of tools to 
manipulate them, plants remained out of scope of combinatorial biosynthesis. However, with 
the recent technical advances in gene discovery and functional genomics, the large-scale 
implementation of different combinatorial biosynthesis techniques in plants may become 
feasible. Indeed, some pioneering studies have already shown the feasibility of this approach. 
For instance, RNA silencing of tryptophan decarboxylase in Catharanthus roseus hairy roots 
effectively blocked the biosynthesis of tryptamine in the transgenic roots. As a consequence, 
accumulation of terpenoid indole alkaloids (TIAs), a class of pharmacologically important 
secondary metabolites for which tryptamine is used as a building block, was eliminated in 
these cultures. Subsequent feeding of these „mutant‟ hairy root cultures with an unnatural 
analog of tryptamine yielded several novel TIAs. Importantly, the new compounds were not 
„contaminated‟ by the TIAs naturally present in „wild-type‟ C. roseus (Runguphan et al., 
2009). Furthermore, by introducing prokaryotic halogenases that chlorinate the indole ring of 
tryptophan into C. roseus hairy roots, chlorinated tryptophan was produced in planta, and 
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used by the downstream TIA biosynthesis enzymes to produce halogenated alkaloids in 
planta (Runguphan et al., 2010). The latter pioneering study can be considered as the first 
example of combinatorial biosynthesis in plants and underscores its huge potential. 
Here, we successfully demonstrate the establishment of a combinatorial biosynthesis platform 
in plants, with the secondary metabolite class of the triterpene saponins as the target. To this 
end, candidate saponin biosynthesis genes of different medicinal plants were expressed in 
hairy roots of the saponin-producing model legume Medicago truncatula. Several of the 
introduced enzymes proved to be functional and generated substrates in the transgenic hairy 
roots that are normally not present in M. truncatula. Furthermore, these substrates were 
incorporated by downstream biosynthesis enzymes, and ultimately led to the accumulation of 
novel compounds in the transgenic M. truncatula hairy roots. Structural elucidation of the 
novel compounds revealed that new aglycones were obtained for oleanane-type saponins and 
that new, dammarane-type saponins, a class of pharmacologically important saponins 
naturally restricted to the genus Panax, were produced in the M. truncatula hairy roots. And 
although the target of the study was triterpene saponins, we also detected novel, non-saponin 
compounds in one of the overexpression lines, indicating that the applied method is 
applicable to generate structural variation in other classes of plant natural products as well. 
2. Results 
2.1.Heterologous expression of 52 candidate genes in M. truncatula hairy roots 
From the genome-wide cDNA-AFLP transcript profiling of MeJA treated plants or plant cell 
cultures, a list of 259 MeJA responsive gene tags were selected as candidate genes involved 
in saponin biosynthesis or its regulation (see chapter 2). Subsequently, the FL-ORFs of these 
candidate genes were cloned (M. truncatula) or screened for in a cDNA-library (M. 
lanceolata, P. ginseng, G. glabra, and B. falcatum), leading to a set of 140 FL genes 
consisting of candidate genes involved in saponin biosynthesis or its regulation (see 
chapter 3). To obtain proof of concept of combinatorial biosynthesis of triterpene saponins in 
plants, a subset of this list, 52 genes, were selected to be transformed into M. truncatula hairy 
roots. This list consisted solely of candidate biosynthesis genes from P. ginseng (20), M. 
lanceolata (24), and B. falcatum (8). CaMV 35S-mediated overexpression constructs of the 
FL-ORFs of the candidate genes were transformed into M. truncatula hairy roots, and for 
each construct, hairy roots of a minimum of 5 independent transformation events were  
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Figure 1. RT-PCR screening of M. truncatula hairy roots for the presence of the transgene in 
PG0221, PG0119, PG0317, and PG0821 overexpression lines. The expected fragment size is 
indicated between brackets. As positive (+) and negative (-) controls, the cDNA-AFLP fragment and 
water were used, respectively. T1-T6, transgenic lines; C1-C6, control lines; L, DNA ladder 
(SmartLadder, Eurogentec), the size of the fragments of the ladder are indicated on the right. 
 
obtained. Subsequently, the obtained hairy roots were screened for the presence of the 
transgene by RT-PCR (Figure 1). As such, for all of the 52 genes, at least three independent 
hairy root lines expressing the transgene were obtained. 
2.2.Metabolite profiling reveals the presence of dammarane-type triterpene saponins 
in transgenic hairy roots expressing dammarenediol synthase of P. ginseng 
Since all saponins of M. truncatula possess an oleanane-type triterpene backbone derived 
from β-amyrin (Tava et al., 2010), overexpression of the gene encoding dammarenediol-II 
synthase (PgDDS) of P. ginseng (Tansakul et al., 2006), may lead to the production of 
dammarenediol-II in the M. truncatula hairy roots. Subsequently, this compound may be 
incorporated in the natural M. truncatula saponin biosynthesis, and as such lead to a new 
class of aglycones in M. truncatula (Figure 2). Furthermore, oxidation of the triterpene 
backbone in P. ginseng and M. truncatula occurs on different positions of the backbone, and 
thus, compounds new to both parental species may be produced in the transgenic lines. 
In our genome-wide transcript transcript profiling, a gene tag corresponding to PgDDS 
(PG0408) was encountered (see chapter 2). Subsequent cloning of the FL-ORF of the gene 
(see chapter 3) allowed for ectopic expression of PgDDS in M. truncatula hairy roots. After 
confirmation of overexpression with RT-PCR (Figure 2B), five biological repeats of three 
independent transgenic and control lines were profiled with liquid chromatography 
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Figure 2. Overexpression of PgDDS in M. truncatula hairy roots. A. Presence of PgDDS could lead 
to a new class of aglycones in M. truncatula hairy roots. B. RT-PCR screening of M. truncatula hairy 
roots for the presence of the transgene in PG0408 overexpression lines. The lines indicated with an 
arrow were selected for further analysis. T1-T6, transgenic lines; C1-C6, control lines; L, DNA 
ladder. C. Biosynthesis of protopanaxatriol in P. ginseng. 
 
electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry (LC-
ESI-FT-ICRMS) to compare the saponin composition of overexpression roots with that of 
control roots. Comparative analysis of the root extracts of control and PG0408 
overexpression roots yielded a total of 19,778 m/z peaks. Notably, 280 discrete peaks 
between PG0408 overexpression roots and control roots were observed, corresponding to 39 
discretely present compounds. These compounds were present in all of the PG0408 
overexpression lines, whereas they were absent in all of the control lines. To (tentatively) 
identify the new compounds, the accurate m/z measurements of the FT-ICR MS were 
combined with the isotope abundances to predict the molecular formula of the detected 
compounds. The structural information needed for the identification of the saponins was 
obtained by MS
n
 fragmentation using the linear ion trap (IT). Full FT-MS spectra were 
interchanged with dependent IT-MS
n
 scan events, existing of a MS
2
 and two MS
3
 scans. In 
the MS
2
 scan, the most abundant ion in the previous full MS scan was fragmented. The two  
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Figure 3. LC ESI FT-ICR MS chromatograms. (A) MS scan of peak at tR 25.70 min. (B) MS
2
 
fragmentation of the [M-H]
-
 ion at m/z 1077.59 (C) MS
3
 fragmentation of the most abundant MS
2
 
daughter ion of the [M-H]
-
 ion at m/z 1077.59. 
 
most abundant daughter ions in every MS
2
 scan event were subjected to a MS
3
 scan event. As 
such, for some of the most abundant new compounds, the aglycone backbone could be 
determined. For instance, the new compound at retention time (tR) 25.70 yields a [M-H]
-
 
anion at m/z 1077.58977 (Figure 3A). Because saponins consist of the elements C, H, and O, 
four different molecular formulas are possible within an error range of 5 ppm: C71H81O9 
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(δ ppm = 1.079), C46H93O27 (δ ppm = -1.114), C53H89O22 (δ ppm = 4.336), and C64H85O14 
(δ ppm = -4.371). To determine the correct molecular formula, the abundance of the isotopes 
was considered. The predicted relative abundance of the M+1 ions of the four possible 
molecular formulas were 80.37%, 53.48%, 61.00%, and 72.85%, respectively. For the 
unknown saponin, the observed relative abundance of the M+1 ion was 60.74%, indicating 
that the molecular formula corresponding to the [M-H]
-
 anion is C53H89O22 (δ ppm = 4.336). 
The sugar residues and the aglycone could be identified from the MS
n
 spectra. For this 
saponin, MS
2
 fragmentation led to the generation of 2 major daughter ions, the first, at m/z 
945, resulting from the loss of a pentose (-132 Da) residue and a second, at m/z 783 from the 
loss of the pentose and an extra hexose (-162 Da) residue (Figure 3B). MS
3
 fragmentation of 
the most abundant MS
2
 daughter ion ([M-Pen-H]
-
) led to the generation of 5 daughter ions, 
the smallest of which, at m/z 459, represents the aglycone ion, [Agly-H]
-
, resulting from the 
loss of a pentose and three hexose moieties (Figure 3C). Although this aglycone was only 
detected as a granddaughter ion with nominal m/z values, its molecular formula could be 
predicted by the accurate prediction of the molecular formula of the parent ion and the 
observed loss of sugar residues. With this method, the molecular formula of the aglycone was 
predicted to be C30H52O3. In M. truncatula, no aglycones with this molecular formula have 
been described before, however, in P. ginseng a dammarane-type triterpene sapogenin with 
the same molecular formula, protopanaxadiol, had been described (Kim et al., 2009; Lü et al., 
2009). This aglycone has three hydroxyl groups, two of which are generated by PgDDS, and 
a third by an unknown P. ginseng enzyme (Figure 2) (Yue et al., 2008). In M. truncatula, 
 
Table 1. Tentatively annotated new compounds in hairy roots overexpressing PG0408. 
Cpd # [M-H]
-
 Formula (δ ppm) Aglycone Decoration 
4 1077.58977 C53H89O22 (4.336) 
C30H52O3 
hydroxydammarenediol 
Pen-Hex-Hex-Hex- 
7 809.47104 C43H70O14 (2.174) 
C30H52O2 
dammarenediol 
Malonyl-Hex-Hex- 
12 929.55140 C48H82O17 (3.739) 
C30H52O3 
hydroxydammarenediol 
dHex-Hex-Hex- 
15 885.48794 C45H74O17 (2.955) 
C30H52O4 
dihydroxydammarenediol 
Malonyl-Hex-Hex- 
16 929.51545 C47H78O18 (4.208) 
C30H50O4 
carboxydammarenediol 
Pen-Hex-Hex- 
34 933.54564 C47H82O18 (3.001) 
C30H54O4 
25-hydroxyprotopanaxadiol 
Pen-Hex-Hex- 
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Figure 4. Chromatogram of a P. ginseng extract analyzed with the M. truncatula method. Several of 
the ginsenosides described in the literature are annotated in the chromatogram. 
 
however, oxidation at the same position of the oleanane-type triterpene sapogenins is not 
occurring. Hence, the new aglycone may be dammarenediol-II, with an extra hydroxyl group. 
Analogously, for several of the other new compounds present in the metabolite extract of 
PG0408 overexpression lines, the aglycone could be determined via a similar analysis. All of 
them could be tentatively annotated as dammarane-type aglycones (Table 1). 
In a strict sense, for combinatorial biosynthesis the produced compounds should be truly 
novel and not just ginsenosides that are also naturally produced in wild-type P. ginseng roots. 
Hence, also a P. ginseng sample was extracted and analyzed with the M. truncatula profiling 
method, and several of the major compounds of the extract were identified based on their 
similar masses and fragmentation pattern of P. ginseng saponins described in the literature 
(Figure 4). Comparison of the retention time, masses and the fragmentation patterns of 
dammarenediol derived compounds in the M. truncatula PG408 line, with the ones in the P. 
ginseng extract revealed that the compounds that are occurring in the transgenic M. 
truncatula hairy roots are not present in either the M. truncatula control roots nor the P. 
ginseng sample. Compound 15, for instance, has a predicted molecular formula of C45H74O17, 
which is similar to the one of malonyl-Rg1 (Ma et al., 2005). Furthermore, their 
fragmentation pattern indicates that both Rg1 and compound 15 consist of an aglycone with a 
similar mass, on which 2 hexose moieties and a malonyl group are bound (Figure 5). 
However, the retention times of both compounds are significantly different: malonyl-Rg1 
elutes at 20.52 minutes (Figure 4), whereas compound 15 elutes at 29.55 minutes. Since 
separation of the compounds was achieved using reversed phase liquid chromatography, the  
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Figure 5. Comparison of the ginsenoside malonyl-Rg1 (left) and compound 15 (right). (A) MS
2
 
fragmentation of the [M-CO2-H]
-
 ion at m/z 842.50. (B) MS
3
 fragmentation of the MS
2
 daughter ion at 
m/z 799. 
 
different elution times indicate a different hydrophobicity of the molecules, and thus different 
molecules. In conclusion, compound 15 is new to both species, and thus proof of concept of 
combinatorial biosynthesis in plants has been established. 
2.3.New saponins in M. truncatula hairy roots overexpressing a B. falcatum CytP450 
(BF0567). 
Based on the putative annotation of the genes or the presence of a phenotype in the hairy 
roots, four other lines were prioritized for metabolite profiling as performed for the PG0408 
overexpression lines. The results of the analysis of these 4 lines are summarized in Table 2. 
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Table 2. Top-candidate genes analyzed in a pilot LC ESI FT-ICR MS screening. 
Gene Annotation # peaks # new compounds 
ML041 CytP450 18500 0 
ML158 Glucosyltransferase 18825 0 
PG0555 CytP450 19293 0 
BF0567 CytP450 18689 19 
 
In the BF0567 overexpression lines, the presence of 19 new, mostly low abundant 
compounds was confirmed. For 7 compounds of this list, essential MS
n
 information for the 
tentative identification of the compounds was generated (Table 3). This revealed that all new 
compounds were triterpene saponins, most of them having an aglycone brutoformula 
corresponding to known Medicago aglycones. However, BF0567 is a gene from B. falcatum, 
a plant that produces a set of saikogenins as aglycones of its saponins. These aglycones have 
the same brutoformula as the sapogenins from M. truncatula, and thus, distinguishing 
between the two types of aglycones based on brutoformula alone is impossible. However, the 
fragmentation pattern of the new saponins of the BF0567 overexpression lines, and the 
 
Table 3. Tentatively identified new saponins in BF0567 overexpression lines. 
Cpd Name [M-H]- Formula (δ ppm) FT-ICR MSn: m/z (% base peak) 
1 Hex-Hex-Hex-
Aglycone 
1003.47939 C48H76O22 (3.830) MS
2 [1003.48]: 841 (100)[M-Hex-H]-, 797 (17)[M-Hex-CO2-H]
-, 455 
(76) [Agly-CO2-H2O-H]
- 
2 Hex-dHex-Hex-
HexA-Aglycone 
1133.54373 C54H86O25 (4.578) MS
2 [1133.54]: 971 (100)[M-Hex-H]- 
MS3 [1133.54→971]: 953 (70)[M-Hex-H2O-H]
-, 927 (10)[M-Hex-
CO2-H]
-, 909 (100)[M-Hex-H2O-CO2-H]
-, 763 (17)[M-Hex-dHex-
CO2-H2O-H]
-, 645 (78)[M-Hex-dHex-Hex-H2O-H]
-, 627 (18)[M-Hex-
dHex-Hex-2H2O-H]
-, 555 (13)[M-Hex-dHex-Hex-108-H]-, 469 
(15)[Agly-H2O-H]
- 
3 Hex-HexA-
Aglycone 
825.42998 C42H66O16 (2.630) MS
2 [825.43]: 705 (16), 663 (100)[M-Hex-H]-, 645 (3)[M-Hex-H2O-
H]-, 601 (9)[M-Hex-H2O-CO2-H]
-, 487 (3)[Agly-H]- 
MS3 [925.43→663]: 645 (3)[M-Hex-H2O-H]
-, 617 (11)[M-Hex-46-H]-
, 601 (100)[M-Hex-H2O-CO2-H]
-, 587 (6), 487 (49)[Agly-H]-, 393 (10) 
4 Hex-dHex-Hex-
HexA-Aglycone 
1117.54977 C54H86O24 (5.497) MS
2 [1117.55]: 955 (100)[M-Hex-H]-, 937 (3)[M-Hex-H2O-H]
- 
MS3 [1117.55→955]: 937 (100)[M-Hex-H2O-H]
-, 893 (87)[M-Hex-
H2O-CO2-H]
-, 809 (6)[M-Hex-dHex-H]-, 747 (12)[M-Hex-dHex-CO2-
H2O-H]
-, 629 (81)[M-Hex-dHex-Hex-H2O-H]
-, 611 (34)[M-Hex-
dHex-Hex-2H2O-H]
-, 567 (5)[M-Hex-dHex-Hex-2H2O-CO2-H]
-, 555 
(71)[M-Hex-dHex-Hex-108-H]-, 471 (5)[Agly-H]-, 409 (4), 407 (3) 
5 dHex-Hex-Hex-
Aglycone 
957.50948 C48H78O19 (3.161) MS
2 [957.51]: 811 (100)[M-dHex-H]-, 793 (9)[M-dHex-H2O-H]
-, 649 
(12)[M-dHex-Hex-H]-, 631 (3)[M-dHex-Hex-H2O-H]
-, 487 (1)[Agly-
H]- 
MS3 [957.51→811]: 749 (3)[M-dHex-H2O-CO2-H]
-, 649 (100)[M-
dHex-Hex-H]-, 587 (7)[M-dHex-Hex-H2O-CO2-H]
-, 487 (16)[Agly-H]- 
MS3 [957.51→649]: 631 (4)[M-dHex-Hex-H2O-H]
-, 603 (100)[M-
dHex-Hex-HCOOH-H]-, 587 (10)[M-dHex-Hex-H2O-CO2-H]
-, 571 
(8), 487 (86)[Agly-H]-, 425 (32)[Agly-H2O-CO2-H]
- 
6 Hex-Aglycone 649.39731 C36H58O10 (2.447) MS
2 [649.40]: 631 (14)[M-H2O-H]
-, 603 (100)[M-HCOOH-H]-, 587 
(12)[M-H2O-CO2-H]
-, 487 (32)[Agly-H]-, 425 (26)[Agly-H2O-CO2-H]
- 
7 Hex-??? 781.43869 C41H66O14 (0.909) MS
2 [781.44]: 763 (15)[M-H2O-H]
-, 737 (23)[M-CO2-H]
-, 619 
(100)[M-Hex-H]-, 557 (14)[M-Hex-H2O-CO2-H]
- 
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Figure 6. Comparison of the fragmentation behavior of dHex-Hex-Hex-Bayogenin (left) and dHex-
Hex-Hex-New Aglycone (right). A. MS
2
 fragmentation of the [M-H]
-
 ion at m/z 957.51. B. MS
3
 
fragmentation of MS
2
 daughter ion at m/z 811. C. MS
3
 fragmentation of MS
2
 daughter ion at m/z 649. 
The different fragment ions are indicated in red. 
 
corresponding M. truncatula saponins are significantly different. This is illustrated with the 
fragmentation pattern of the new compound with an [M-H]
-
 ion at m/z 957.50948, leading to 
an aglycone with the [Agly-H]
-
 anion at m/z 487. In M. truncatula control roots, a similar 
compound could be detected, dHex-Hex-Hex-bayogenin, either as an in-source fragment ion 
of compound 4 or as compound 51 (see chapter 4). In Figure 6, the fragmentation pattern of 
dHex-Hex-Hex-bayogenin is compared with that of the new compound, showing that, 
although they have the same sugar moieties, there are clear differences in the MS
3
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fragmentation. Notably, when the daughter ion at m/z 649 is fragmented, as in case of the 
new compound, the most abundant granddaughter ion is not the aglycone ion, as is the case 
for Hex-bayogenin, but an ion corresponding with a loss of 46 Da, which may be the result of 
the loss of formic acid during the fragmentation process. Furthermore, another high abundant 
peak, at m/z 425 was observed, corresponding to a loss of 62 Da from the aglycone ion. 
Similar to medicagenic acid (see chapter 4), this may be due to the loss of CO2 and H2O from 
the aglycone ion, hence, the aglycone should be hydroxylated at position 3, and carboxylated 
at position 24. This would indicate that 2 more hydroxyl groups are present on this aglycone, 
however their exact positions remain unknown. Hence, carboxylation at position 28 is 
impossible, and thus, hydroxylation, followed by formation of an ether bridge remains an 
option. In conclusion, several new saponins were detected in the BF0567 overexpression 
lines, and although they have aglycones with similar masses as the M. truncatula sapogenins, 
they show a different fragmentation pattern, and therefore may represent novel aglycones. 
2.4.Overexpression of a M. lanceolata CytP450 leads to accumulation of new, 
unknown compounds 
In a second selection, based on bioactivity screens with extracts of the transgenic hairy roots 
(Moses et al., unpublished results), several more lines were screened. Within this set, in the 
lines that overexpress a M. lanceolata CytP450, ML385, accumulation of very high amounts 
of a few new compounds was observed (Figure 7). 
 
 
Figure 7. Comparison of the chromatogram of a control line (red) and a ML385 overexpression line 
(black). Several new peaks (indicated with blue arrow) can be observed in the raw chromatogram. 
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Figure 8. Tentative identification of the compound corresponding to the peak at tR 14.21. (A) MS 
scan of peak at tR 14.21 min. (B) MS
2
 fragmentation of the [M-malonyl-H]
-
 ion at m/z 249.13 that 
could correspond to pentyl hexose (green). 
 
The retention time of the new compounds is much shorter than the retention time of saponins. 
Furthermore, also the generated MS
n
 data indicated that the new compounds were not 
saponins. Tentative identification of the compounds revealed that at least some of them are 
most likely glycosides. For instance, the new compound eluting at tR 14.21 (Figure 7) has a 
[M-H]
-
 anion at m/z 335.13570 (Figure 8A). Due to in source fragmentation, additional ions 
were observed at m/z 291.14551 and m/z 249.13476, correlating to the loss of 44 and 86 Da 
from the molecular species, respectively. These ions are identified as the loss of a CO2 and a 
malonyl group, respectively. This indicates that the new compound is malonylated, which is 
reported to occur in glycosides of M. truncatula saponins and flavonoids as well (Huhman 
and Sumner, 2002). The molecular formulas corresponding to the [M-H]
-
 anion and the [M-
malonyl-H]
-
 anion are C14H24O9 (δ ppm = 2.818), and C11H22O6 (δ ppm = 1.599), 
respectively, confirming the loss of a malonyl group (C3H2O3). MS
2
 fragmentation of the [M-
malonyl-H]
-
 ion at m/z 249.13 led to the generation of 1 major daughter ion at m/z 161, 
resulting from the loss of 88 Da from the parent ion. Furthermore, several less abundant 
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daughter ions were present, most of which were characteristic for the fragmentation of a 
glycoside residue (Figure 8B). Hence, the daughter ion at m/z 161 results from a hexose 
residue (C6H10O5), whereas the neutral loss of 88 Da corresponds to the loss of pentanol 
(C5H12O). Thus, the compound at m/z 249.13 could be pentyl hexose, and as such the parental 
compound at m/z 335 could be malonylated pentyl hexose. Similarly, structural elucidation of 
the other new compounds was attempted (Table 4), showing that some of the other 
compounds are also possible glycosides. 
 
Table 4. Tentative identification of the new compounds in the ML385 overexpression lines. 
tR [M-H]
-
 Formula (δ ppm) Tentative annotation 
11.86 381.17720 C16H30O10 (1.521) pentose + pentyl + hexose 
14.21 355.13570 C14H24O9 (2.818) malonyl + pentyl + hexose 
14.55 467.17822 C19H32O13 (2.581) malonyl + pentose + pentyl + hexose 
14.83 369.12011 C17H22O9 (2.722) cinnamate + acetyl + hexose 
14.97 501.16258 C22H30O13 (2.426) malonyl + ??? 
17.15 573.22059 C26H38O14 (2.985) vanillic acid + ??? 
17.97 763.27025 C33H48O20 (4.760) malonyl + hexose + hydroxyphenylacetic acid + ??? 
18.11 763.27023 C33H48O20 (4.734) malonyl + hexose + hydroxyphenylacetic acid + ??? 
19.43 501.19884 C23H34O12 (2.176) ??? 
19.69 529.19380 C24H34O13 (2.146) Phthalic acid + ??? 
 
3. Discussion 
3.1.Proof of concept: novel dammarane-type saponins in M. truncatula 
The aim of this study was to obtain proof of concept of combinatorial biosynthesis in plants, 
with the secondary metabolite class of the triterpene saponins as a target. To this end, 
candidate saponin biosynthesis genes of different medicinal plants were expressed in hairy 
roots of the saponin-producing model legume M. truncatula, thereby creating the possibility 
of new enzyme-substrate combinations in M. truncatula. The products thereof may be used 
by the downstream saponin biosynthesis genes and ultimately lead to novel saponins in the 
M. truncatula hairy roots. Proof of concept of combinatorial biosynthesis was first obtained 
by the overexpression of dammarenediol-II synthase of P. ginseng (Tansakul et al., 2006), 
which led to the accumulation of 39 new compounds in the transgenic M. truncatula hairy  
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Figure 9. Structures of protopanaxatriol and medicagenic acid. 
 
roots. Structural elucidation of some of these compounds showed that they were saponins 
with dammarane-type aglycones, a new type of aglycones for M. truncatula. Furthermore, 
comparison with a P. ginseng extract showed that these saponins are not only new to M. 
truncatula, but are also new to P. ginseng. Although for some of the compounds isomers with 
a similar fragmentation pattern could be found in both P. ginseng and M. truncatula, the 
retention times of the isomers were significantly different, indicating a different 
hydrophobicity of the molecules that may be due to a different position of hydroxylation on 
the dammarane backbone. In P. ginseng, hydroxylation of dammarenediol occurs 
preferentially on positions 6 and 12 (Figure 9). In M. truncatula, however, oxidation of the β-
amyrin backbone never occurs on these positions as illustrated with the most oxidized 
sapogenin in M. truncatula hairy roots, medicagenic acid (Figure 9). Hence, the 
dammarenediol molecule produced by the dammarenediol synthase in the M. truncatula hairy 
roots is most probably hydroxylated on a different position. 
3.2.Novel oxidations on the oleanane skeleton 
Next to the PG0408 lines, new compounds have also been detected in M. truncatula hairy 
roots transformed with the BF0567 gene that encodes a CytP450 enzyme from B. falcatum. In 
saponin biosynthesis, CytP450 enzymes are involved in the oxidation of the cyclization 
products of 2,3-oxidosqualene on various positions, leading to the different sapogenins. Since 
the new aglycones were encountered in the M. truncatula hairy roots overexpressing BF0567, 
it can be expected that the corresponding enzyme acts on the oleanane backbone on a position 
that is normally not attacked by M. truncatula CytP450 enzymes. Comparison of the 
sapogenins of M. truncatula and B. falcatum may address the function of the enzyme. Firstly, 
unlike the M. truncatula sapogenins (Chapter 4), the three most abundant sapogenins of B. 
falcatum contain a C13-O-CH2-C17 ether linkage (Figure 10A) (Ashour and Wink, 2011). 
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Figure 10. Structures of all saikogenins described in the literature (Ashour and Wink, 2011). (A) 
Saikogenins with a C13-O-CH2-C17 ether bridge. (B) All other described saikogenins. 
 
This oxygen bridge may be formed by a dehydration reaction between a C13-OH group and a 
C17-CH2OH group (Vincken et al., 2007). The hydroxyl group at the C13-position is never 
encountered in a free form, and its formation also requires isomerisation of the C12-C13 
double bond towards unsaturation at position C11-C12. Thus, by hydroxylation at the C13-
position and formation of the ether linkage as a consequence, isomerisation of the double 
bond may occur in parallel. Since the molecular formula of the saikogenins with an ether 
bridge is the same as some of the predicted molecular formulas of the detected new 
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aglycones, the formation of a 13,28 ether bridge by BF0567 is a valid hypothesis for the 
detected new aglycones. 
A second difference between the B. falcatum saikogenins and M. truncatula sapogenins is the 
occurrence of a hydroxyl group at the C16-position in all saikogenins of B. falcatum 
(Figure 10). Although present in zanhic acid, a main sapogenin of M. truncatula leaf tissue 
(Kapusta et al., 2005a; Kapusta et al., 2005b), this modification does not occur in M. 
truncatula hairy roots (see chapter 4), and would thus be a possible activity of BF0567. If so, 
zanhic acid conjugates are expected to be detectable in the BF0567 expressing hairy roots. 
Indeed, fragmentation of compound 1 (Table 3) leads to the detection of a possible zanhic 
acid derived fragment ion at m/z 455, resulting from the decarboxylation and dehydration of 
the aglycone ion. Furthermore, also some of the other observed aglycone masses could be 
explained by this type of modification. Hence, also oxidation at the C16-position remains a 
possible explanation. To confirm this type of activity, the saponin profile of the BF0567 
expressing roots could be compared with that of a M. truncatula leaf sample. 
Another difference between the M. truncatula sapogenins and the B. falcatum saikogenins is 
the oxidation at the C11-position. Like the oxidation at the C16-position, this could also be a 
possible mode of action of the BF0567 gene. For instance, the fragmentation of compound 1 
(Table 4) leads to a fragment ion at m/z 455, resulting from the decarboxylation and 
dehydration of the aglycone ion. Although a zanhic acid aglycone is a possible explanation 
for this, it cannot be excluded that the observed aglycone is derived from medicagenic acid 
(Figure 9) that is oxidized at the C11-position instead of the C16-position as in zanhic acid. 
In conclusion, the overexpression of the BF0567 CytP450 enzyme in M. truncatula hairy 
roots, led to the accumulation of saponins with new aglycones, thr exact structure of which 
cannot be elucidated yet with the applied methodology. 
3.3.Combinatorial biosynthesis of non-saponin compounds 
In M. truncatula hairy root lines overexpressing the ML385 gene, the accumulation of high 
amounts of novel, likely non-saponin compounds was observed. An extract of M. lanceolata 
was screened for these compounds, and indicated that similar compounds were not 
encountered in wild-type M. lanceolata plants, confirming the specificity of the detected 
molecules in M. truncatula, and thus confirming combinatorial biosynthesis. Structural 
elucidation revealed these compounds were not saponins, but glycosides of small molecules  
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Figure 11. Conversion of amino acids (AA) to the corresponding acetaldoximes by enzymes of the 
CYP79 clan. 
 
such as vanillic acid, phthalic acid, cinnamic acid, hydroxyphenylacetic acid or pentanol 
(Table 4), however, their exact structure remains unknown. Hence, despite the focus on 
putative saponin biosynthesis genes, at least one of the selected genes seems to be involved in 
another biosynthesis pathway. A blast search of the FL-ORF of ML385 revealed the enzyme 
belongs to the CYP79 clan. Several enzymes of this clan have been characterized on the 
molecular level, showing they are all involved in N-hydroxylation of amino acids (Andersen 
et al., 2000; Bak et al., 2000; Hull et al., 2000; Mikkelsen et al., 2000; Nielsen and Møller, 
2000; Wittstock and Halkier, 2000). Via a multi-step reaction, the characterized enzymes 
converse the amino acids to the corresponding acetaldoximes (Figure 11), which are 
subsequently used as input for the biosynthesis of amino acid-derived secondary metabolites. 
The closest (characterized) homolog of ML385 is the Sorghum bicolor CYP79A1 (tyrosine 
N-monooxygenase) that catalyzes the first step in the biosynthesis of dhurrin, a cyanogenic 
glucoside. Ectopic expression of this enzyme in Arabidopsis and tobacco (Nicotiana 
tabacum) plants led to the accumulation of several p-hydroxyphenylacetaldoxime-derived 
glycosides in the transgenic plants (Bak et al., 2000). Similar here, we detected the 
accumulation of a set of glycosides in the M. truncatula hairy roots. Hence, the M. lanceolata 
CYP79, ML385, may act by converting tyrosine or other amino acids to the corresponding 
acetaldoximes. Subsequently, enzymes present in the M. truncatula hairy roots may convert 
these molecules to yield the detected glucosides. 
3.4.Conclusions 
Heterologous expression of candidate saponin biosynthesis genes in hairy roots of M. 
truncatula led to the accumulation of a set of compounds in some of the transgenic lines. 
These compounds were shown to be novel to both M. truncatula and the plant of which the 
expressed gene was derived. Hence, proof of concept of combinatorial biosynthesis in plants 
was established. The targets of this study were compounds belonging to the secondary 
metabolite class of the triterpene saponins. Novel saponin aglycones were obtained for 
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oleanane-type saponins and the pharmacologically more important dammarane-type 
saponins. Furthermore, we also detected novel, non-saponin compounds in one of the 
overexpression constructs, showing that the applied method is applicable to generate 
structural variation in other classes of plant natural products as well. 
4. Materials and Methods 
4.1.Generation of DNA constructs 
For stable overexpression, the identified FL-clones entry clones were Gateway recombined 
into the pK7WG2D binary vector (Karimi et al., 2002), and the resulting clones were 
transformed into A. rhizogenes by electroporation. 
4.2.Generation of M. truncatula hairy roots 
M. truncatula hairy roots were generated as described (Pollier et al., 2011). 
4.3.Transcriptional analysis of M. truncatula hairy roots 
For Reverse Transcription PCR (RT-PCR), total RNA was extracted with TRI Reagent
®
 
(Ambion), and cDNA prepared with SuperScript
TM
 II Reverse Transcriptase (Invitrogen). 
Specific PCR primers were designed based on the cDNA-AFLP tag sequences with the 
Primer3 program (Rozen and Skaletsky, 2000). 
4.4.Metabolite profiling of M. truncatula hairy roots 
Metabolite profiling of M. truncatula hairy roots was performed as described (Pollier et al., 
2011). 
4.5.Identification of new peaks 
Per transgene construct, 5 five biological repeats of three independent transgenic lines were 
analyzed. The resulting chromatograms were grouped per construct and each group was 
integrated and aligned versus the control group with the XCMS package (Smith et al., 2006) 
in R version 2.6.1. The following parameter values were applied: xcmsSet(fwhm=8, 
max=300, snthresh=5, mzdiff=0.5), group(bw=8, max=300), retcor(method=loess, 
family=symmetric). A second grouping was done with the same parameter values. In this 
analysis, discretely present m/z peaks correspond to novel or disappeared compounds in the 
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transgenic lines. Due to in-source fragmentation, multiple m/z peaks for each compound were 
often observed. For identification, full MS spectra were interchanged with a dependent MS
2
 
scan event in which the most abundant ion in the previous full MS scan was fragmented, and 
two dependent MS
3
 scan events of the two most abundant daughter ions. The collision energy 
was set at 35%. Elucidation of the MS
n
 spectra was based on (Pollier et al., 2011). 
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Abstract 
Triterpene saponins are compounds that possess many biological activities and have a 
widespread occurrence in the plant kingdom. They share a common biogenic origin with the 
ubiquitous sterols. Both compounds are derived from the precursor oxidosqualene that relies 
on the mevalonate pathway for isopentenyl diphosphate supply. Saponin accumulation in 
plant cells is stimulated in the defense responses that are triggered by phytohormones, such as 
jasmonates, but the underlying molecular mechanisms remain unknown. To screen for 
candidate regulators of saponin biosynthesis, we used genome-wide transcript profiling of the 
jasmonate-response of the model legume Medicago truncatula. A jasmonate-inducible gene 
encoding a RING membrane-anchor E3 ubiquitin ligase, MAKIBISHI1 (MKB1), was 
identified. MKB1 targeted the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), the 
enzyme catalyzing the rate-limiting step in the mevalonate pathway, for ubiquitin-mediated 
proteasomal degradation, thereby controlling saponin biosynthesis. The MKB1-mediated 
control apparatus from M. truncatula is equivalent to the endoplasmatic reticulum-associated 
degradation system that regulates HMGR stability and sterol synthesis in yeast and 
mammalian cells. Our findings demonstrate that the general mechanistic principle for the 
control of triterpene biosynthesis is conserved across eukaryotes, despite the divergent 
molecular structures of both the effectors and targets involved. 
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1. Introduction 
The more than 19,000 species of legumes, distributed over 730 genera, display an 
overwhelming variety in type and number of natural products they can produce. Most 
renowned are the isoflavones. In contrast to the omnipresent flavonoids, the occurrence of 
these molecules is more restricted in the plant kingdom, in particular to the Papilionoideae 
subfamily of the Leguminosae, in which they function as phytoalexins or induce nodulation 
through symbiotic N2-fixing bacteria (Dixon and Sumner, 2003). Another substantial group 
of secondary metabolites in legumes is formed by the triterpene saponins that serve, in 
planta, as allelopathic or anti-insect agents, but also display a wide range of biological 
activities. Many leguminous genera can produce triterpene saponins, including Acacia, 
Glycyrrhiza, Lathyrus, Lupinus, Medicago, Trifolium, and Vigna, with different 
pharmaceutical properties, such as antiinflammatory, antimicrobial, anticancer, or adjuvant 
activities (Dixon and Sumner, 2003; Sparg et al., 2004; Sun et al., 2009; Yendo et al., 2010; 
Augustin et al., 2011). 
Leguminous natural products can be synthesized constitutively or inducibly, depending on 
species, developmental stage, or environmental conditions of biotic or abiotic nature. In 
particular, the phytohormone jasmonate (JA) and its derivatives, collectively called 
jasmonates (JAs), are powerful elicitors of secondary metabolite synthesis in a multitude of 
leguminous plants and have been demonstrated to induce leguminous natural products of a 
wide structural variety, including the isoflavones and triterpene saponins (Suzuki et al., 2002, 
2005; Zhao et al., 2005; Pauwels et al., 2009; Yendo et al., 2010). The central module of the 
JA signaling cascade has been discovered in Arabidopsis (Arabidopsis thaliana) and found to 
be conserved across the plant kingdom (Pauwels et al., 2009; Fonseca et al., 2009a; Browse, 
2009). In Arabidopsis, the F-box protein CORONATINE INSENSITIVE (COI1) fulfils a key 
role in JA signaling. COI1 participates in the SKP/CULLIN/F-BOX-COI1 (SCF
COI1
) E3 
ubiquitin ligase complex that perceives bioactive JAs such as jasmonoyl-isoleucine (JA-Ile). 
In the presence of JA-Ile, COI1 interacts with the JA ZIM-domain (JAZ) repressor proteins 
that are subsequently marked for degradation by the 26S proteasome (Chini et al., 2007; 
Thines et al., 2007; Fonseca et al., 2009b; Sheard et al., 2010). This event releases the bHLH-
type transcriptional activators, such as MYC2, MYC3, and MYC4, thereby activating the first 
wave of JA-induced gene expression (Pauwels et al., 2009; Fernández-Calvo et al., 2011). In 
the absence of JA-Ile, the JAZ proteins bind the MYC factors and recruit a co-repressor 
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complex that blocks MYC activity and, hence, the JA response (Chini et al., 2007; Thines et 
al., 2007; Pauwels et al., 2010; Fernández-Calvo et al., 2011). In leguminous plants the 
efforts to understand JA signal transduction have remained rather limited. A soybean 
(Glycine max) COI1 gene that shares significant homology with that of Arabidopsis, has been 
identified and can restore the defective JA responses, including plant defense and fertility, of 
the Arabidopsis coi1-1 mutant (Wang et al., 2005), supporting the existence of a general JA 
pathway with signal components that are functionally conserved across the plant kingdom. 
Nevertheless, the action radius of JAs in different plant species also exhibits species-specific 
molecular fine-tuning, activating species-specific secondary metabolic pathways, for instance 
(Pauwels et al., 2009). To date, only a few other JA signaling factors or regulators of 
secondary metabolism from legumes have been identified. Comprehensive genome-wide 
transcriptome analyses of JA-responsive gene expression in M. truncatula cell suspension 
cultures have identified enzymes that catalyze triterpene saponin biosynthesis and a few 
elicitor-induced transcription factors involved in the regulation of the biosynthesis of 
phenolics (Suzuki et al., 2002, 2005; Achnine et al., 2005; Naoumkina et al., 2007, 2008, 
2010). However, until now the molecular components of the signaling cascade(s) that steer 
triterpene saponin biosynthesis remain unknown. 
Triterpene saponins share a common biogenic origin with sterols, molecules that are 
ubiquitous in eukaryotic cells. Both classes of metabolites are derived from oxidosqualene, 
the last common intermediate in triterpene saponin and sterol biosynthesis (Figure 1, 
Chapter 2). As such, it is generally accepted that triterpene saponin biosynthesis depends on 
the cytosolic pathway that involves mevalonate (MVA) as a key intermediate for isopentenyl 
diphosphate supply (Chappell, 2002). Saponin and sterol biosynthetic pathways have more 
points in common than mere precursors. The two pathways diverge after 2,3-oxidosqualene, 
which can be cyclized either by cycloartenol synthase (CAS) to yield cycloartenol, the sterol 
precursor, or by β-amyrin synthase (BAS) to yield β-amyrin, the precursor of many classes of 
triterpene saponins (Figure 1, Chapter 2). CAS and BAS share extensive sequence homology, 
suggesting an evolutionary recruitment of (at least some) triterpene saponin biosynthesis 
genes from sterol metabolism genes (Phillips et al., 2006). 
In yeast and mammalian cells, the sterol content is continuously adjusted by the regulation of 
the levels of key synthetic enzymes, in particular of 3-hydroxy-3-methylglutaryl-CoA 
reductase (HMGR), by means of sterol-regulated ubiquitin-mediated protein degradation. 
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When cultured yeast or mammalian cells are grown in sterol-rich medium, the HMGR levels 
drop whereas in sterol-starved cells they increase. The constitutively active endoplasmatic 
reticulum (ER)-associated degradation (ERAD) quality control system directs the feedback 
regulated destruction of the HMGR enzyme, both in yeast and mammals (Hampton, 2002a 
and 2002b; Debose-Boyd, 2008; Hirsch et al., 2009; Jo and Debose-Boyd, 2010). The ERAD 
molecular machinery that recognizes and targets HMGR for destruction has first been 
characterized in yeast (Saccharomyces cerevisiae) and involves the RING E3-ligase HMGR 
DEGRADATION 1 (Hrd1) (Hampton, 2002a and 2002b). Later, two human proteins with 
homology to Hrd1 were identified, called HRD1 and gp78, that ubiquitinate and target 
HMGR for degradation, implying that the role of the ERAD system in sterol metabolism is 
broadly conserved (Hirsch et al., 2009). Both yeast and humans have other, distinct, E3-
ligases, such as RING-FINGER PROTEIN WITH MEMBRANE ANCHOR 1 (RMA1) in 
humans that participate in ERAD but not in the regulation of HMGR stability (Hirsch et al., 
2009). 
Here, we monitored over time the methyl jasmonate (MeJA)-modulated transcriptome of M. 
truncatula cells and identified MAKIBISHI 1 (MKB1), a membrane-anchored RING E3-
ligase homologous to RMA1. MKB1 operates in an ERAD-like manner to regulate the 
degradation of the HMGR enzymes and, thereby, steers the flux to the triterpene biosynthetic 
pathway in M. truncatula. 
2. Results 
2.1.Expression of regulatory genes is upregulated in elicited M. truncatula cells 
prior to the onset of secondary metabolism 
In suspension-cultured cells of M. truncatula MeJA-inducible triterpene saponin biosynthesis 
has been reported (Suzuki et al., 2002; 2005; Naoumkina et al., 2007). A MeJA elicitation 
experiment was set up on the same cell line and under similar conditions as described by 
Suzuki et al. (2005), but, we covered an extensive time course sample and performed 
transcript profiling by means of cDNA-AFLP analysis. The expression of a total of 8,462 
transcript tags was visualized and 282 MeJA-responsive tags, hereafter designated Mt tags, 
were identified (see chapter 2). Approximately 9% of the identified MeJA-responsive tags 
corresponded to genes potentially involved in transcriptional regulation of gene expression, 
including 14 transcription factors, and approximately 8% corresponded to signal transducing 
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proteins, including 5 protein kinases. 10% of the Mt tags was presumably involved in the 
regulation of protein synthesis and fate, including 10 proteins involved in the ubiquitin (Ub)-
mediated targeting of proteins for proteasomal degradation (Figure 9C, chapter 2). From 
these three categories, the putative transcription factors, protein kinases, RING- and F-box-
proteins were selected for further analysis. Fifteen of the selected tags had maximal 
transcriptional upregulation within 30 min to 2 h after elicitation, thus prior or concurrent to 
the onset of the genes involved in triterpene saponin and phenylpropanoid biosynthesis 
(Figure 9C, chapter 2). For all the 15 early induced gene tags, a full-matching EST was 
encountered in the DFCI Medicago Gene Index 
(http://compbio.dfci.harvard.edu/cgibin/tgi/gimain.pl?gudb=medicago), hence verification of 
the expression pattern could be achieved by consulting the Medicago truncatula Gene 
Expression Atlas (MtGEA; Benedito et al., 2008; He et al., 2009; 
http://bioinfo.noble.org/gene-atlas/), in which also data of MeJA-treated cell cultures are 
included (measured at 2 h and 24 h; Naoumkina et al., 2007). As such, for 12 of the cDNA-
AFLP gene tags, the early MeJA response was confirmed. 
2.2.A reverse genetics screen for novel genes involved in the regulation of legume 
saponin biosynthesis reveals the MAKIBISHI phenotype 
To assess the function of the candidate regulatory genes, a reverse genetics screen was 
launched in which gain- and loss-of-function of the candidate genes was pursued by 
constitutive CaMV 35S-mediated overexpression of the full-length open reading frame (FL-
ORF) or of a hairpin RNA-mediated interference (hpRNAi) construct, respectively, in M. 
truncatula hairy roots. When transgenic hairy roots were transferred to liquid medium for 
upscaling, one particular hpRNAi construct, corresponding to the gene tag Mt067, caused a 
striking phenotype in transgenic lines. In its most pronounced form, silencing of the Mt067 
gene, encoding a RING E3 Ub ligase, caused „dissociation‟ of the hairy roots in „caltrop-like‟ 
structures (Figure 1; Figure 2). Accordingly, the Mt067 gene was renamed MAKIBISHI1 
(MKB1), referring to the Japanese term for caltrop. No such caltrop phenotypes were 
observed in Mt067/MKB1 overexpression (MKB1
OE
) lines or hairy root lines transformed 
with control constructs (Figure 1; Figure 2). 
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Figure 1. The MAKIBISHI phenotype. (A) Light microscopy analysis of roots of control (WT), 
MKB1
OE
, and MKB1
KD
 lines grown on solid medium. (B) Light microscopy analysis of roots of 
control (WT) and MKB1
KD
 lines grown in liquid medium. (C) Longitudinal optical sections obtained 
by confocal microscopy of roots of WT, MKB1
OE
, and MKB1
KD
 lines grown in liquid medium. (D) 
SEM analysis of WT and MKB1
KD
 root lines grown in liquid medium. (E) TEM analysis of cross 
sections from roots from WT and MKB1
KD
 lines grown in liquid medium. Arrows indicate 
wavy/thickened appearance of cell margins in MKB1
KD
 roots. 
 
Microscopic analysis of the MAKIBISHI phenotype in the MKB1 knock-down (MKB1
KD
) 
lines revealed severe root growth and epidermal deficiencies as visualized by confocal 
microscopy on roots grown in liquid medium and taking advantage of the constitutive GFP 
expression provided by the T-DNA insert from the pK7GWIWG2D(II) expression vector 
used to generate the hpRNAi (Karimi et al., 2002). Although the MKB1
KD
 roots formed a 
root tip that was still quite similar to that of control roots, the root elongation zone was 
clearly aberrant and displayed marked loosening of the outer cell layers (Figure 1C). 
Interestingly, the MKB1
KD
 root phenotype strongly resembled the stunted root morphology 
and epidermal defects of the oat (Avena sativa) mutants sad3 and sad4, that lack the glycosyl 
transferase activity needed to fully glycosylate the triterpene saponin avenacin A-1. 
Accumulation of incompletely glycosylated avenacin A-1 in oat roots disrupts membrane 
trafficking and provokes degeneration of the epidermis, with consequential effects on root 
hair formation and root growth (Mylona et al, 2008). The growth and epidermal defects of  
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Figure 2. Expression of MKB1 and its homologues in M. truncatula hairy roots. CTR, control lines; 
OE, MKB1
OE
 lines; KD, MKB1
KD
 lines. 
 
MKB1
KD
 roots were further illustrated by scanning electron microscopy (SEM; Figure 1D) 
and transmission electron microscopy (TEM; Figure 1E). SEM analysis pointed towards a 
discontinuous epidermis and a resultant direct contact of cortical and other inner cells with 
the medium (Figure 1D). TEM analysis revealed that cell margins in MKB1
KD
 roots had a 
wavy appearance (Figure 1E). 
2.3.RNAi-mediated silencing of MAKIBISHI1 causes increased accumulation of 
monoglycosylated triterpene saponins 
Considering the resemblance of MKB1
KD
 roots with oat roots deficient in saponin 
biosynthesis and the co-regulation of the MKB1 and saponin biosynthesis genes in M. 
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truncatula, we performed metabolite profiling by liquid chromatography electrospray 
ionization Fourier transform ion cyclotron resonance mass spectrometry (LC-ESI-FT-
ICRMS) to compare saponin accumulation in MKB1
KD
 and MKB1
OE
 roots with that of 
control roots (Figure 3; Supplementary Table S1, p216). Comparative analysis of the root 
extracts of control and MKB1
OE
 roots yielded a total of 19,584 m/z peaks, but notably, 
without significant differences between the two lines. Comparative analysis of control and 
MKB1
KD
 roots yielded 20,637 m/z peaks that were distributed over 269 peak groups (see 
Methods), indicating that at least 269 distinct compounds had been profiled. In addition to 
discretely present peaks (141 and 292 m/z peaks in MKB1
KD
 and control samples, 
respectively), a Student‟s t-test with Welch correction (α=10-5) pinpointed 15 significantly 
up- and 343 down-regulated m/z peaks in MKB1
KD
 roots, respectively. Whenever a peak 
group contained at least two discretely present or significantly changed peaks (26 up- and 89 
down-regulated peak groups in MKB1
KD
 when compared to the control), they were further 
structurally elucidated (Supplementary Table S1, p216). Of the 26 up-regulated peak groups, 
six corresponded to phenolics and eight to saponins, whereas 24 and 12 of the 89 down-
regulated peak groups corresponded to phenolics and saponins, respectively (Supplementary 
Table S1, p216). The remainder of the peak groups could not be annotated. Triglycosylated 
saponins were more represented among the down-regulated peaks, whereas half of all 
saponins that were up-regulated were monoglycosylated saponins, such as Hex-medicagenic 
acid, Hex-bayogenin, and Hex-hederagenin (Figure 3; Table 1). 
Remarkably, the LC-ESI-FT-ICR-MS analysis of the growth medium of MKB1
KD
 roots 
revealed the presence of tens of compounds, whereas in the chromatograms of the growth 
medium from control or MKB1
OE
 roots metabolites were totally absent (Figure 3D), 
indicating release or leakage of compounds from the MKB1
KD
 roots. This release might 
(partially) account for the high number of down-regulated peaks in the MKB1
KD
 roots. 
However, some of the compounds that were up-regulated in the MKB1
KD
 roots occurred also 
in the medium, such as the monoglycosylated saponins Hex-medicagenic acid, Hex-
bayogenin, and Hex-hederagenin (Figure 3). Collectively, these findings suggest that 
silencing of MKB1 primarily causes deficient, ectopic, or de novo biosynthesis of triterpene 
saponins, leading to the overaccumulation and release of incompletely glycosylated saponins. 
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Figure 3. Saponin profiling of MKB1
OE
 and MKB1
KD
 roots. (A) Detail of the full MS scan of a 
control line (green) and a MKB1
KD
 line (red). (B) Average Total Ion Current (TIC) of the main 
masses corresponding to the peaks at retention time 26.25 (unknown compound) and 26.71 (Hex-
medicagenic acid). (C) Average Total Ion Current (TIC) of the main masses corresponding to Hex-
bayogenin (left) and Hex-hederagenin (right). (D) Detail of the full MS scan of the medium from a 
control line (green) and a MKB1
KD
 line (red). The peak at tR 27.95 represents Hex-medicagenic acid. 
 
2.4.Accumulation of monoglycosylated triterpene saponins triggers the 
MAKIBISHI phenotype 
By crossing with an oat mutant blocked in the first committed step in the avenacin pathway, 
the presence of incompletely glycosylated avenacin A-1 was shown to be the cause rather 
than the consequence of the membrane trafficking, epidermal, and root defects in the sad3 
and sad4 oat mutants (Mylona et al., 2008). To evaluate whether this was also the case in the 
M. truncatula transgenic roots we tried to phenocopy the MKB1
KD
 phenotype in the absence 
of suitable mutant M. truncatula backgrounds. Therefore, aliquots of the culture medium of 
MKB1
KD
 roots that also contained the incompletely glycosylated saponins were applied to 
control root cultures. Assessment of the subsequent root growth demonstrated that the 
MKB1
KD
 root culture medium could cause epidermal loosening of control roots (Figure 4A). 
The strength of the phenotype varied depending on the concentration and the age of the 
MKB1
KD
 root culture from which the medium was collected. The epidermal defects were 
never obtained by supplementing the culture medium with similar or higher doses of medium 
from control roots that is devoid of saponins (Figure 4A). The phenocopy was still observable 
when an MKB1
KD
 root culture aliquot was applied that had passed through a protein filter  
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Figure 4. Phenocopy of the MKB1
KD
 phenotype. (A) Light microscopy analysis of control hairy roots 
incubated for 1 week in medium supplemented with medium from control (WT; left) or MKB1
KD
 
(right) root lines. (B) Light microscopy analysis of control hairy roots incubated for 1 week in 
medium supplemented with medium from control (WT; left) or MKB1
KD
 (right) root lines that was 
passed through a protein filter with a cut-off of 5 kDa. (C) Light microscopy analysis of control hairy 
roots incubated for 1 day in medium supplemented with purified 3-O-Glc-medicagenic acid (GMA), 
medicagenic acid (MA) or an equivalent amount of the solvent (EtOH). 
 
before application, implying that small molecule(s), such as incompletely glycosylated 
saponins might cause the MAKIBISHI phenotype (Figure 4B). No phenocopy was observed 
after treatment with individual hormones (e.g., gibberellins, cytokinins, JAs, auxins, or anti-
auxins) or with commercially available compounds, such as the flavonoid quercetin or the 
fully glycosylated soyasaponin I, the most abundant compound in control hairy roots and 
abundantly present in the medium of MKB1
KD
 roots. However, a transient phenocopy was 
obtained after addition of purified 3-O-Glc-medicagenic acid (Oleszek et al., 1990) to the 
growth medium of control root cultures, but not of purified medicagenic acid (Supplemental 
Figure 2C). Collectively, these findings suggest that the ectopic biosynthesis of one or more 
monoglycosylated saponins accounts, at least partially, for the root and epidermis defects in 
the MKB1
KD
 roots. 
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Figure 5. Sequence and structural comparison of eukaryote RMA and HMGR proteins. (A) Kyte & 
Doolittle hydropathy plot of MKB1 with window size 7. The red bar indicates the membrane anchor. 
(B) Kyte & Doolittle hydropathy plot of Arabidopsis Rma2 (At4g27470) with window size 7. The red 
bar indicates the membrane anchor. (C) Kyte & Doolittle hydropathy plot of M. truncatula HMGR1 
with window size 7. The two red bars indicate the hydrophobic transmembrane domains. (D) Kyte & 
Doolittle hydropathy plot of S. cerevisiae Hmg1p with window size 15. The seven red bars indicate 
the hydrophobic transmembrane domains. (E) Comparison of the amino acid sequence of MKB1 with 
the Arabidopsis Rma 1 (At4g03510), Rma2 (At4g28270), and Rma3 (At4g27470), the hot pepper 
Rma1H1, the C. elegans RNF5, and the human RNF5/Rma1 proteins. Conserved amino acids that are 
identical in the 7 proteins are indicated with an asterisk. The solid lines indicate the N-terminal RING 
Finger Domain and the C-terminal Membrane Anchor, respectively. 
 
2.5.MAKIBISHI1 encodes a RING Membrane-Anchor E3 Ubiquitin Ligase 
Homolog 
MKB1 encodes a protein of 250 amino acids, with a calculated mass of 27.97 kDa and a 
predicted pI of 7.61. The MKB1 protein contains a single N-terminal C3HC4-type RING 
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domain (Kosarev et al., 2002) and hydropathy analysis (Kyte and Doolittle, 1982) revealed 
the presence of a short hydrophobic domain, a putative membrane anchor, at the C-terminus 
of the protein (Figure 5; Figure 6A). BLAST searches and phylogenetic analysis showed that 
MKB1 is closely related to the Arabidopsis RMA proteins, with RMA2 (At4g27470) being 
the closest homolog (49% identity at the amino acid level). Arabidopsis RMA proteins also 
correspond to membrane-anchored RING E3 Ub ligases (Matsuda et al., 2001; Lee et al., 
2009) and are conserved in higher eukaryotes, but absent in yeast (Matsuda et al., 2001). 
Sequence analysis showed that MKB1 shares 24% and 22% homology with human RMA1 
and nematode RNF5 RMA-type RING E3 Ub ligases, respectively (Figure 5; Figure 6B). 
Screening of the sequences present in the DFCI Medicago Gene Index 
(http://compbio.dfci.harvard.edu/tgi/cgi-bin/tgi/gimain.pl?gudb=medicago) indicated that M. 
truncatula encodes at least five other RMA-type proteins that are closely related to MKB1 
(Figure 6B). qRT-PCR analysis of these homologues revealed silencing in the MKB
KD
 lines 
is specific for MKB1 (Figure 2). 
 
 
Figure 6. Phylogenetic analysis of MKB1 and other membrane anchored RING E3 Ub ligases. (A) 
Schematic representation of the MKB1 protein and its domain structure. (B) Phylogenetic tree of 
membrane anchored RING E3 Ub ligases. The percentage of replicate trees that clustered together in 
the bootstrap test is shown next to the branches. 
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Figure 7. MKB1 is an ER-localized protein with auto-ubiquitination activity. (A) In vitro auto-
ubiquitination assay of MKB1. The bacterially expressed GST-MKB1 constructs were incubated with 
ATP in the presence or absence of his-tagged Ub, E1 (rabbit UBE1), and E2 (human UbcH5a). 
Samples were resolved by 8% SDS-PAGE, followed by protein immunoblot analysis using anti-GST 
(top) or anti-His (bottom) antibodies. (B) Subcellular localization of MKB1 in bombarded onion cells. 
The pictures show the GFP signal and the GFP-bright light merged image (left and right, respectively) 
of GFP-MKB1 and GFP-MKB1ΔC (top and bottom, respectively). 
 
2.6.MAKIBISHI1 localizes to the ER and possesses E3 Ub ligase activity in vitro 
Arabidopsis and mammalian RMA proteins localize to the ER and possess E3 Ub ligase 
activity in vitro (Matsuda et al., 2001; Lee et al., 2009). To verify the ubiquitination activity 
of MKB1, a truncated version of the MKB1 protein, lacking the membrane anchor domain 
(MKB1ΔC) was fused to the glutathione S-transferase (GST) tag, produced and purified from 
Escherichia coli cells. The recombinant protein was incubated with His-tagged Ub, ATP, and 
E1 (rabbit UBE1), and E2 (human Ubc5Ha) enzymes and subjected to immunoblot analysis 
with anti-GST and anti-His antibodies. GST-MKB1 E3 Ub ligase activity was demonstrated 
by the high molecular mass smear ladders, in which discrete bands corresponding to 
ubiquitinated GST-MKB1ΔC could be observed. No such signal was obtained when E1, E2, 
or Ub were omitted from the reaction mixture (Figure 7A). Next, a double amino-acid-
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mutated version of the GST-MKB1ΔC fusion protein was created in which the amino acid 
residues Cys
37
 and Cys
40
, essential within the RING domain (Kosarev et al., 2002), were 
substituted by Ser residues (Figure 6A). As expected, the corresponding recombinant protein 
(GST-MKB1ΔCmut) did not exhibit ubiquitination activity anymore (Figure 7A), thus 
indicating that MKB1 represents a bona fide E3 Ub ligase. 
To verify the presumed ER localization of MKB1, we generated GFP-tagged versions of both 
the FL MKB1 and the truncated MKB1ΔC. The fusion proteins were produced in bombarded 
onion (Allium cepa) cells that were analyzed by confocal microscopy. The GFP-MKB1 
protein was visible in a network pattern, reminiscent of ER-targeted proteins (Lee et al., 
2009). This pattern was lost and replaced by a cytosolic distribution pattern when the GFP-
MKB1ΔC protein was produced in onion cells (Figure 7B). Thus, like its homologs in other 
organisms, MKB1 corresponds to an active RMA-type ER-localized E3 Ub RING ligase. 
2.7.MAKIBISHI1 targets HMGR for degradation 
Arabidopsis RMA1 protein has recently been shown to regulate aquaporin levels by 
ubiquitination and subsequent proteasomal degradation (Lee et al., 2009). Similarly, human 
RMA proteins are involved in the ERAD quality control system that ensures that only 
properly folded proteins are released to their appropriate destinations (Hirsch et al., 2009). 
Furthermore, humans and yeasts have other ER-localized RING E3 Ub ligases, i.e., the HRD-
type, that play a crucial role in the control of sterol synthesis through the regulation of 
HMGR levels (Hampton, 2002a and 2002b; DeBose-Boyd, 2008; Hirsch et al., 2009; Jo and 
Debose-Boyd, 2010). To our knowledge, a role for RMA proteins in the latter process has not 
been reported yet. Nonetheless, despite the apparent lack of sequence similarity between the 
two types of RING ligases and the different membrane topology of the HMGR enzymes from 
plants, yeasts and mammals (Figure 8; Figure 9A), we reasoned that the M. truncatula MKB1 
homolog of the RMA proteins might target the HMGR, just like the HRD proteins. Two 
observations indirectly supported this hypothesis: (i) MKB1
KD
 roots accumulated 
incompletely glycosylated saponins, pointing to a defect in the saponin biosynthetic pathway 
or the transport chain and (ii) mining of the gene expression data in the MtGEA revealed an 
extraordinarily high expression correlation between MKB1 and M. truncatula HMGR1 
(Figure 8) but not between HMGR1 and the putative M. truncatula homolog of yeast HRD1 
(Figure 8). 
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Figure 8. Co-expression of M. truncatula MKB1 and HMGR1. Screenshot of the co-expression 
analysis of M. truncatula MKB1 (green), HMGR1 (red) and HRD1 (black) with the MtGEA software. 
 
To experimentally support this hypothesis we first checked whether MKB1 could target yeast 
HMGR and thereby complement a yeast strain devoid of functional HRD1. Complementation 
was carried out in a yeast hrd1-1 strain and scored by determining the ability of transformed 
strains to grow on lovastatin containing medium. Strikingly, the lovastatin tolerance of the 
hrd1-1 strain was returned to wildtype levels after transformation with MKB1 but not with the 
ligase-dead MKB1mut version, demonstrating that the E3 ligase activity of MKB1 is required 
to overcome HRD1 deficiency (Figure 9B). To verify that the hrd1-1 complementation 
resulted from the re-established HMGR degradation, we carried out cycloheximide (CHX) 
chase assays and monitored the levels of the 6myc-tagged Hmg2p protein in the transformed 
yeast strains. In the wildtype HRD1 yeast background, the tagged Hmg2p was nearly absent 
after a 4 h CHX chase, whereas in the hrd1-1 strain, it could still be detected. Basal Hmg2p 
levels were also significantly higher in the hrd1-1 strain (Figure 9C). In agreement with the 
lovastatin growth complementation assay, expression of FL wildtype MKB1, but not the 
ligase-dead MKB1mut, restored the Hmg2p levels to those of the HRD1 strain, both before 
and after CHX chase (Figure 9C). Together, these results indicate that, despite the extensive 
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sequence divergence, MKB1 can functionally complement the yeast HRD1 and, thereby, 
target the yeast HMGR for Ub-mediated degradation. 
To experimentally support this hypothesis we first checked whether MKB1 could target yeast 
HMGR and thereby complement a yeast strain devoid of functional HRD1. Complementation 
was carried out in a yeast hrd1-1 strain and scored by determining the ability of transformed 
strains to grow on lovastatin containing medium. Strikingly, the lovastatin tolerance of the 
hrd1-1 strain was returned to wildtype levels after transformation with MKB1 but not with the 
ligase-dead MKB1mut version, demonstrating that the E3 ligase activity of MKB1 is required 
to overcome HRD1 deficiency (Figure 9B). To verify that the hrd1-1 complementation 
resulted from the re-established HMGR degradation, we carried out cycloheximide (CHX) 
chase assays and monitored the levels of the 6myc-tagged Hmg2p protein in the transformed 
yeast strains. In the wildtype HRD1 yeast background, the tagged Hmg2p was nearly absent 
after a 4 h CHX chase, whereas in the hrd1-1 strain, it could still be detected. Basal Hmg2p 
levels were also significantly higher in the hrd1-1 strain (Figure 9C). In agreement with the 
lovastatin growth complementation assay, expression of FL wildtype MKB1, but not the 
ligase-dead MKB1mut, restored the Hmg2p levels to those of the HRD1 strain, both before 
and after CHX chase (Figure 9C). Together, these results indicate that, despite the extensive 
sequence divergence, MKB1 can functionally complement the yeast HRD1 and, thereby, 
target the yeast HMGR for Ub-mediated degradation. 
To assess whether MKB1 also targets plant HMGR proteins, we produced a firefly luciferase 
(fLUC)-tagged version of the M. truncatula HMGR1 protein in tobacco (Nicotiana tabacum) 
protoplasts combined or not with MKB1. This analysis showed that cotransfection with 
MKB1 decreased the HMGR1-fLUC signal almost by 2-fold, whereas it did not reduce the 
activity of free fLUC (Figure 9D), indicating that MKB1 could target M. truncatula HMGR 
proteins for Ub-mediated degradation. 
2.8.Altered MKB1 expression alters expression of triterpene saponin but not of 
sterol biosynthesis genes 
Having established the role of MKB1 in the regulation of HMGR levels and, hence, in the 
control of the flux toward the triterpene saponins, we assessed whether loss- or gain-of-
function of MKB1 in the transgenic MKB1
KD
 and MKB1
OE
 lines, respectively, altered the 
steady-state levels of the gene transcripts corresponding to enzymes involved in the triterpene  
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Figure 9. MKB1 targets HMGR. (A) Schematic overview of the topology of HMGR enzymes and 
ERAD E3 Ub ligases from yeast, M. truncatula and human. (B) Complementation of the yeast hrd1-1 
mutant. HRD1 (H) or hrd1-1 (h) Yeast cells were transformed with MKB1 (M) or MKB1mut (m), 
spotted in 10- or 100-fold dilutions on SD medium lacking URA supplemented (SD-U+LOV) or not 
(SD-U) with lovastatin and grown for 2 days at 30ºC. The destination vector pAG426GPD was used 
as a control (-). (C) Degradation of yeast Hmg2p. Immunoblot analysis for 6myc-tagged Hmg2p 
protein in HRD1 or hrd1-1 yeast cells transformed with MKB1 or MKB1mut, 0 h and 4 h after CHX 
treatment. The destination vector pAG426GPD was used as a control (-). (D) Degradation of M. 
truncatula HMGR1-fLUC in tobacco protoplasts. Left and right panels indicate the absolute fLUC 
values obtained with each construct in each transfection (numbers in the Y-axis) and the percentage 
stability relative to the fLUC value measured in the absence of MKB1 (set at 100%), respectively. 
Error bars indicate the standard error (n=24). Statistical significance was determined by Student‟s t-
test (** P<0.01). 
 
and other (secondary) metabolic pathways. First, the steady-state levels of the gene 
corresponding to the MKB1 target, HMGR, for which five isoforms are present in the M. 
truncatula genome (Kevei et al., 2007), were measured. Although some fluctuations –but 
generally less than 1.5-fold- were observed, expression of none of the five HMGR genes, nor 
of the SQS, SQE1, and SQE2 genes, was markedly altered in the MKB1
KD
 lines (Figure 10), 
170 
 
indicating that expression of the genes encoding the enzymes catalyzing triterpene synthesis 
up to the oxidosqualene precursor was not affected by silencing of the MKB1 gene. Similarly, 
steady-state levels of the putative M. truncatula homologs of genes corresponding to sterol 
biosynthesis enzymes from Arabidopsis, such as cycloartenol synthase (CAS), sterol-C24-
methyltransferase (C24MT and CVP1), obtusifoliol 14α-demethylase (CYP51G1), sterol C-
14 reductase (FACKEL), sterol C-8,7 isomerase (HYDRA1), and CYP710A15 (Schrick et 
al., 2004; Morikawa et al., 2006) were not altered either, indicating that alteration in the 
expression of MKB1 did not affect the transcriptional regulation of sterol biosynthesis 
(Figure 11). 
In contrast, the expression of almost all of the hitherto known triterpene saponin biosynthetic 
genes was strongly downregulated in the MKB1
KD
 lines, pointing to a possible specific 
feedback mechanism caused by the ectopic accumulation of incompletely glycosylated 
saponins. BAS and UGT73F3 transcript levels were reduced 2- to 4-fold, whereas expression 
of UGT73K1 was reduced 5- to 10-fold (Figure 10). Also, the expression of the Mt175-
CYP93E2 gene, which is the M. truncatula gene with the highest homology to the soybean 
CytP450 gene encoding the β-amyrin and sophoradiol 24-hydroxylase (Shibuya et al., 2006), 
was reduced 5- to 50-fold in the MKB1
KD
 lines (Figure 10). The only presumed saponin 
biosynthesis gene of which the expression was not affected by silencing of MKB1, was 
UGT71G1 (Figure 10). However, in contrast to the other two glycosyltransferases, UGT71G1 
also recognized isoflavones and flavonols as substrates and glycosylated these compounds 
with higher efficiencies than triterpenes (Achnine et al., 2005), suggesting it might not 
correspond to a saponin-specific biosynthesis gene. The expression of any of the tested 
metabolic pathway genes did not differ in MKB1
OE
 lines (Figure 10; Figure 11), which is in 
accordance with the lack of any observable (metabolic) phenotype in the MKB1
OE
 lines. 
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Figure 10. qRT-PCR analysis of saponin biosynthetic genes in MKB1
KD
 and MKB1
OE
 lines. CTR, 
control lines; OE, MKB1
OE
 lines; KD, MKB1
KD
 lines. 
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Figure 11. qRT-PCR analysis of sterol biosynthetic genes in MKB1
KD
 and MKB1
OE
 lines. A 
schematic overview of the sterol biosynthesis pathway and the qRT-PCR patterns are shown left and 
right, respectively. CTR, control lines; OE, MKB1
OE
 lines; KD, MKB1
KD
 lines. 
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3. Discussion 
3.1.Importance of the MVA pathway in legume triterpene saponin biosynthesis 
In this study, a cDNA-AFLP-based transcriptome analysis of a time series covering the early 
response of M. truncatula cells to MeJA elicitation was carried out, with the aim to unravel 
the signaling cascades that steer triterpene saponin biosynthesis. These plant natural products 
share a common biogenic origin with the ubiquitous sterols since they are both derived from 
oxidosqualene and depend on the cytosolic pathway that involves MVA as a key intermediate 
for isopentenyl diphosphate supply. In yeast and mammals, the activity of HMGR, encoding 
the rate-limiting enzyme in MVA biosynthesis, is regulated from the transcriptional to the 
posttranslational level. Many of the regulatory mechanisms involved have been characterized 
in these organisms, but, in plants, little is known to date. Mostly, regulation at the 
transcriptional level has been reported, for instance, in response to several environmental and 
developmental factors or to perturbations of the metabolic flux through the sterol pathway 
(Nieto et al., 2009). Accordingly, in MeJA-elicited M. truncatula cells, the MVA pathway is 
transcriptionally upregulated, as reflected by the co-activation of different isoforms of the 
HMGR gene with the known saponin-specific biosynthesis genes (Figure 1, chapter 2). 
Hence, transcriptional upregulation of the MVA pathway may indeed account for or, at least, 
contribute to the MeJA-mediated increase in saponin accumulation in legume species. 
Also in plants, mechanisms operating at the posttranslational level appear to control the 
HMGR activity, as suggested by the observation that some environmental or developmental 
factors or perturbations trigger an increase in HMGR activity but no changes in the HMGR 
transcript levels (Nieto et al., 2009). However, to our knowledge, a possible posttranslational 
regulatory mechanism of plant HMGR has been reported only once, in a study of plant SNF1-
related protein kinases (SnRKs) that phosphorylate and, thereby, inactivate Arabidopsis 
HMGR (Dale et al., 1995). Here, we showed that MeJA-modulated (transcriptional) 
elicitation of saponin biosynthesis in M. truncatula was co-regulated with the transcriptional 
induction of a RING E3 Ub ligase, MKB1, that controls the stability of HMGR through a 
mechanism analogous to the ERAD system directing the sterol-regulated destruction of the 
HMGR enzyme in yeast and mammals, but hitherto undetected in plants. 
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3.2.M. truncatula uses an ERAD system different from the one that regulates 
HMGR stability in yeast and mammals 
Remarkably, MKB1 does not belong to the HRD-type RING E3 Ub ligases known to be 
involved in the ERAD system that controls HMGR stability in both yeast and mammals, but 
instead to the RMA-type of RING E3 Ub ligases. In mammalian cells, RMA1 is involved in 
the ERAD system that targets aberrant or misfolded proteins for degradation by the 26S 
proteasome. Thus far, no evidence for an involvement of mammalian RMA1 in ERAD 
surveyed HMGR degradation has been reported, in contrast to the mammalian HRD-type E3 
ligase gp78, which, like its yeast counterpart HRD1, seems to be the sole determinant in the 
HMGR control system. Furthermore, no RMA-type ERAD ligase equivalents exist in yeast or 
fungi, suggesting that sterol-mediated feedback control of HMGR stability by HRD-type 
ligases is broadly conserved and strictly an HRD-type ERAD matter. Nonetheless, we show 
that MKB1 can complement the yeast hrd1-1 mutant, implying that RMA-type ERAD ligases 
can take over some of the functions of HRD proteins in the absence of the latter, at least in 
yeast, and likely use the same molecular machinery as HRD1. 
Furthermore, some common mechanistic principles between the yeast/mammalian HRD-type 
and the M. truncatula RMA-type ERAD ligases in the control of HMGR stability were 
apparent. In mammalian cells, coexpression of the Insig proteins is needed to restore the 
resistance of overproduced HMGR to sterol-induced ubiquitination and degradation 
suggesting that ectopic reductase saturates the endogenous ERAD machinery. Accordingly, 
RNAi against Insig or Gp78 abrogates sterol-mediated HMGR ubiquitination and degradation 
(Sever et al., 2003), whereas RNAi against the mammalian Hrd1, not involved in HMGR 
control, does not affect HMGR ubiquitination (Jo and Debose-Boyd, 2010). Similarly, in M. 
truncatula, RNAi against MKB1, the RMA-protein shown to target at least one isoform of the 
M. truncatula HMGR proteins can apparently provoke an uncontrolled flux through the 
saponin pathway, leading to the accumulation of incompletely glycosylated saponins. The 
increased and/or ectopic accumulation of partially glycosylated saponins is harmful as 
illustrated by the dramatic phenotype of MKB1
KD
 roots, which is analogous to that of an oat 
mutant deficient in avenacin A1 glycosyltransferases and accumulating incompletely 
glycosylated avenacin A1 (Mylona et al., 2008). Furthermore, the possible toxicity of 
ectopically accumulated partially glycosylated saponins is supported by structure-activity 
relationship studies that indicated that the monodesmoside derivatives of medicagenic acid 
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possessed a higher hemolytic activity, as well as a higher anti-fungal and allelopathic activity 
than the related bi- and tridesmosides (Oleszek, 1990; Voutquenne et al., 2002; Tava and 
Avato, 2006). Hemolytic activity is generally attributed to membrane bursts caused by the 
interaction between the saponins and the sterols of the erythrocyte membrane. Hence, co-
induction of MKB1 by MeJA treatment might be a safety break to prevent saturation of the 
ERAD system and to restrict the flux to the saponin pathway. This hypothesis is further 
supported by the marked co-regulation of M. truncatula HMGR1 and MKB1 observed in the 
MtGEA. 
3.3.Conservation of ERAD modifier activities and substrate sequences 
Plant SnRKs phosphorylate and inactivate HMGR, for instance Arabidopsis HMG1 at a site 
(Ser-577) equivalent to that at which the mammalian HMGR is phosphorylated by AMPK, a 
major metabolic regulator in mammals (Dale et al., 1995). Hence, the activity of the modifier 
and the primary sequence of the physiological substrate might be conserved between plants 
and mammals, although the signaling molecule that activates plant SnRKs is not AMP (Dale 
et al., 1995). For the ERAD control of HMGR stability, such a conservation of the primary 
sequence of the substrate is seemingly improbable. Point mutations within the HMGR 
membrane domain, which is also the sterol-sensing domain, at amino acid residues that are 
conserved between human, hamster, Xenopus, zebrafish, sea urchin, and, to some extent, also 
Drosophila, disrupt Insig binding and abolish sterol-accelerated degradation of the HMGR 
enzyme (Lee et al., 2007). In mammals, the HMGR transmembrane domain is also the site 
where ubiquitin is conjugated (Doolman et al., 2004). In contrast to the high conservation of 
the catalytic C-terminal domain, the N-terminal, membrane-spanning domain of plant HMGR 
proteins is highly divergent and little primary sequence conservation can be observed. For 
instance, the amino acid residues important for sterol-sensing in animal HMGR proteins are 
not conserved. Furthermore, the N-terminal domain is truncated and lacks the complex 
membrane-spanning architecture, i.e. plant HMGR proteins only possess two membrane-
spanning domains, whereas in yeast and human, they contain seven and eight transmembrane 
domains, respectively (Figure 5; Figure 9A) (Learned and Fink, 1989). Hence, recognition of 
the plant HMGR proteins by RMA-type ligases, such as MKB1, might have evolved 
alternative recognition and ubiquitination sites. Alternatively, the ERAD-regulated 
degradation of plant HMGR might depend on a „distributed degron‟, requiring structural 
features distributed over the entire transmembrane domain and not visible in primary 
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sequence motifs, as found for yeast Hmg2p (Gardner and Hampton, 1999; Hampton, 2002b). 
Although plant HMGR proteins have a truncated membrane domain, such structural features 
might have been conserved. In support of the latter hypothesis, despite the structural 
resemblance, the primary sequence resemblance between the membrane domains of yeast and 
mammalian HMGR proteins is only limited (<20% identity over 340 amino acids; (DeBose-
Boyd, 2008)). 
The discovery of MKB1 and its role in the regulation of HMGR stability generates several 
other intriguing questions. Is a role for the RMA-type E3 Ub ligases in the ERAD control of 
HMGR stability conserved in plants? Only very recently, the first putative substrates for two 
of the Arabidopsis RMA ligases, AtRMA1 (At4g03510) and AtRMA2 (At4g28270), have 
been found, namely aquaporin and the auxin receptor auxin-binding protein 1, respectively 
(Lee et al., 2009; Son et al., 2010), but the regulatory mechanisms involved have not been 
elucidated yet. Assuming a conserved role for RMA proteins in the ERAD control of plant 
HMGR stability, would it have evolved de novo and independently of the HRD system, or 
conversely, would it cooperate with plant HRD proteins in targeting HMGR for degradation? 
Like mammals, plants seem to possess both ERAD systems, in contrast to fungi with only the 
HRD system. For instance, besides at least three RMA-type proteins (Lee et al., 2009), 
BLAST searches indicate that Arabidopsis encodes two HRD-like proteins (At1g65040 and 
At3g16090; http://www.arabidopsis.org/). Similarly, at least two putative HRD proteins 
(Medtr4g106990 and Medtr5g007790; http://www.medicago.org/genome/IMGAG/) can be 
identified in the M. truncatula genome. More M. truncatula HRD homologs might exist, 
because the genome sequencing is still incomplete. The gene corresponding to MKB1 is still 
absent in the current version, but one RMA-type homolog is present (Medtr5g019250; 
http://www.medicago.org/genome/IMGAG/). Yet, several TCs with a 100% match to MKB1 
and at least five homologs could be identified in the DFCI Medicago Gene Index (Figure 6B; 
http://compbio.dfci.harvard.edu/tgi/cgi-bin/tgi/gimain.pl?gudb=medicago), confirming that 
also M. truncatula possesses several HRD- and RMA-type ligases. Conversely, in view of the 
conserved coexistence of the two ERAD systems in higher eukaryotes, could mammalian 
RMA proteins play a hitherto unnoticed role in the regulation of HMGR stability, and 
consequently the RMA-type ERAD have originated early in evolution with the capacity to 
target HMGR? Cooperation between the mammalian HRD-type gp78 ligase and RMA1 has 
been reported in the ERAD of mutant forms of the cystic fibrosis transmembrane 
conductance regulator (Morito et al., 2008). Would similar (metabolite) signals determine the 
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recognition of HMGR by the ERAD system in plants and mammals? In addition to sterols in 
mammals, both yeast and mammalian cells appear to use FPP-derived non-sterols, such as 
geranylgeraniol or geranylgeranyl pyrophosphate, to regulate HMGR stability/degradation 
(Sever et al., 2003; Garza et al., 2009). Actually, the primary sequence differences between 
the membrane domains of yeast and mammalian HMGR proteins have been postulated to 
account for the observation that HMGR degradation is triggered by non-sterol isoprenoids in 
yeast, and not by sterols, as in mammals (Hampton, 2002b; DeBose-Boyd, 2008; Garza et al., 
2009). In analogy, the divergent sequence of plant HMGR proteins might have allowed the 
generation of a plant-specific gateway to the ERAD-mediated control of HMGR stability. 
Perhaps both the general primary and the more plant-specific secondary metabolic pathways, 
such as sterol and saponin biosynthesis, respectively, in M. truncatula, can generate specific 
intermediates that can activate the ERAD control of HMGR stability and regulate the flux 
through their respective pathways. Further biochemical and protein-protein interaction studies 
will address at least some of these questions in the near future. 
4. Methods 
4.1.M. truncatula suspension cell culture maintenance and elicitation 
M. truncatula cell cultures (kindly provided by Richard Dixon, Ardmore, USA), were 
maintained as described (Suzuki et al., 2002). For elicitation, 7 days after inoculation of 
75 mL of a 14-day-old suspension culture into 175 mL fresh medium, cells were treated with 
100 μM MeJA (dissolved in EtOH) or an equivalent amount of EtOH as a control. Samples 
were harvested, vacuum filtrated, and frozen at -80°C. For transcript profiling, samples were 
taken 0, 0.5, 1, 2, 4, 8, 12, and 24 h after elicitor or mock treatments. 
4.2.Transcript profiling 
Total RNA from M. truncatula cells was prepared with TRIZol (Invitrogen, Carlsbad, CA) 
and reverse transcribed to double-stranded cDNA as described (Vuylsteke et al., 2007). After 
appropriate sample preparation, cDNA-AFLP based transcript profiling was done with all 
128 possible BstYI+1/MseI+2 primer combinations (Vuylsteke et al., 2007). Gel images were 
analyzed with the AFLP-QUANTARPRO software (Keygene, Wageningen, The 
Netherlands), allowing accurate quantification of band intensities. The intensity of all 
individual bands was determined and the obtained raw expression data were corrected for 
lane variations (due to PCR or loading differences) by dividing the raw data by a correction 
178 
 
factor. The correction factor was calculated by dividing the sum of the expression levels of all 
fragments within one lane by the highest sum of all lanes within a primer combination. 
Subsequently, the standard deviation (SD) and the average were calculated for each 
individual band. Individual gene expression profiles were variance normalized by subtracting 
the calculated average from each individual data point, after which the obtained value was 
divided by the SD. A coefficient of variation (CV) was obtained by dividing the SD by the 
calculated average. Gene tags displaying expression values with a CV ≥0.5 were considered 
as differentially expressed. Based on this cut-off value, together with visual inspection of the 
cDNA-AFLP gels, differentially expressed gene tags were selected for further analysis. 
Cluster analysis, sequencing, and BLAST analysis were done as described (Rischer et al., 
2006). 
For quantitative Real Time PCR (qRT-PCR), total RNA was extracted with the RNeasy mini 
kit (Qiagen), and cDNA prepared with SuperScript
TM
 II Reverse Transcriptase (Invitrogen). 
Primers were designed with Beacon Designer version 4.0 (Premier Biosoft International, Palo 
Alto, CA, USA). qRT-PCR was carried out with a Lightcycler 480 (Roche) and SYBR Green 
QPCR Master Mix (Stratagene). For reference genes, 40S ribosomal protein S8 (40S) 
(TC160725 of the MTGI from TIGR) and translation elongation factor 1α (ELF1α) 
(TC148782 of the MTGI from TIGR) were used. Reactions were done in triplicate and for the 
relative quantification with multiple reference genes qBase was used (Hellemans et al., 
2007). 
4.3.Generation of DNA constructs 
For hpRNAi, the 471-bp MKB1 cDNA-AFLP fragment was PCR-amplified and by 
Gateway
TM
 recombination cloned into the binary vector pK7GWIWG2D(II) (Karimi et al., 
2002). The resulting expression clone was transformed into the Agrobacterium rhizogenes 
strain LBA 9402/12 for generation of hairy roots. 
To identify the FL-ORF of MKB1, the cDNA-AFLP tag sequence was used for a BLASTN 
search against the Medicago truncatula Gene Index database 
(http://compbio.dfci.harvard.edu/tgi/). The MKB1 FL-ORF consensus sequence (TC149901; 
Genbank accession JF714982) and the M. truncatula HMGR1 sequence (Genbank accession 
EU302813) (Kevei et al., 2007) were PCR-amplified and by Gateway
TM
 recombination 
cloned into the entry vector pDONR221. To obtain entry clones with and without stop codon, 
179 
 
Gateway primers were designed according to Underwood et al. (2006). The MKB1 entry 
vector was used as a template to amplify truncated versions of the MKB1 sequence as well as 
to create point mutations with the GeneTailor Site-Directed Mutagenesis system (Invitrogen). 
All entry constructs were sequence-verified. For stable MKB1 overexpression experiments, 
Gateway recombination was carried out with the pK7WG2D binary vector (Karimi et al., 
2002), and the resulting clone transformed to A. rhizogenes. For transient MKB1 
overexpression in plant protoplasts and for MKB1 localization experiments, Gateway 
recombination was carried out with the p2GW7 and pK7WGF2 vectors, respectively (Karimi 
et al., 2002). For recombinant protein production, the MKB1 sequences were recombined in 
pDEST15 and pDEST17 expression vectors, and the resulting clones transformed to E. coli 
BL21 (DE3) cells. For the yeast complementation assays, the pAG426GPD vector (Alberti et 
al., 2007) was used as the destination vector for the MKB1 gene. For the degradation assays 
in plant protoplasts, the M. truncatula HMGR1 ORF was fused at its C-terminus with the 
firefly luciferase ORF by a fusion PCR and Gateway recombined in the p2GW7 vector. 
4.4.Generation and cultivation of transgenic M. truncatula hairy roots 
A. rhizogenes-mediated transformation of M. truncatula (ecotype Jemalong J5) hairy roots 
was done according to Boisson-Dernier et al. (2001) with modifications. After scarification 
with sulfuric acid for 5 minutes, seeds were surface sterilized with 12% sodium hypochlorite 
for 2 minutes and washed with sterile water. Subsequently, seeds were treated with 1 μM 6-
benzylaminopurine for 3 hours and thereafter allowed to germinate on wet, sterile 3 mm 
Whatman paper at room temperature in the dark. After 2 days of germination, the seedlings 
were wounded by cutting approximately 2 mm from the root tip of the radicle. The wounded 
seedlings were infected with A. rhizogenes grown on solid YEB medium, and placed on 
slanted agar plates containing Murashige and Skoog (MS) medium (pH 5.8) supplemented 
with vitamins (Duchefa). The plates were sealed with micropore tape, placed vertically, and 
cocultivation was allowed for 10 days under a 16 h/8 h light/dark regime at 22°C. After 10 
days, the plants were transferred to new plates, containing 100 mg/L cefotaxime to prevent 
Agrobacterium growth and incubated under identical conditions. Ten days later, hairy roots 
were excised from the plants and transferred to liquid MS medium (pH 5.8) supplemented 
with vitamins, 1% sucrose (w/v), and 100 mg/L cefotaxime. The hairy roots were grown for 
7 days in the dark at 24°C and shaking at 300 rpm. Subsequently, the roots were transferred 
to horizontal Petri dishes containing solid MS medium (pH 5.8) supplemented with 1% 
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sucrose (w/v) and 100 mg/L cefotaxime, grown in the dark at 24°C, and subcultured every 
3 weeks. 
4.5.Particle bombardment of onion epidermis cells 
The constructs for localization were transformed into onion epidermis cells by microparticle 
bombardment with a PDS-1000/He Biolistic® Particle Delivery System (Bio-Rad 
Laboratories, Hercules, CA, USA). To this end, 1 mg of 1.6 μm Gold Microcarriers (Bio-Rad 
Laboratories) were coated with 5 μg plasmid DNA according to the manufacturer‟s 
instructions. The coated particles were bombarded into onion epidermis slices of 
approximately 2.5×2.5 cm, placed on solid MS medium (pH 5.8) supplemented with 1% 
(w/v) sucrose, with 1100 psi rupture discs and a vacuum of 0.1 bar. Subsequently, the onion 
slices were stored in the dark for 24 hours at room temperature and analyzed by confocal 
microscopy with the FV10 ASW Olympus Confocal with a water immersion 63× objective. 
4.6.Phenotypic analysis of transgenic M. truncatula hairy roots 
Samples for SEM were prepared as described (Van Damme et al., 2006). Briefly, after the 
first fixation step in 4% paraformaldehyde, 1% glutaraldehyde in 2 mM sodium phosphate 
buffer, the root samples were fixed in 1% osmium tetroxide solution (Fluka) for 2 hours, and 
subsequently subjected to a dehydratation series to 100% ethanol. Next, the root samples 
were critical-point dried and sputter-coated with gold particles before they were examined 
with the SEM microscope (JEOL JSM-5600 LV) under an acceleration voltage of 10 kV. 
For TEM, root tips from 12-day-old M. truncatula hairy roots grown in liquid medium were 
briefly immersed in 20% (w/v) BSA and frozen immediately in a high-pressure freezer (EM 
Pact, Leica Microsystems, Vienna, Austria). Freeze substitution was carried out using a Leica 
EM AFS in dry acetone containing 0.1% uranyl acetate, 1% (w/v) OsO4 and 0.2% 
glutaraldehyde over a 4-day period as follows: -90°C for 26 hours, 2°C per hour increase for 
15 hours, -60°C for 8 hours, 2°C per hour increase for 15 hours, and -30°C for 8 hours. 
Samples were then slowly warmed up to 4°C, infiltrated stepwise over 3 days at 4°C in 
Spurr‟s resin and embedded in capsules. The polymerization was performed at 70°C for 16 
hours. Ultrathin sections were made with an ultramicrotome (Leica EM UC6) and post-
stained in a Leica EM AC20 for 40 min in uranyl acetate at 20 °C and for 10 min in lead stain 
at 20 °C. Grids were viewed with a JEM 1010 transmission electron microscope (JEOL, 
Tokyo, Japan) operating at 80 kV. 
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4.7.Saponin profiling 
M. truncatula hairy roots were grown for 21 days in liquid medium. The hairy roots were 
harvested and the medium collected from five biological repeats of three independent 
transgenic lines per transgene construct. The hairy roots were rinsed with purified water 
under vacuum filtration and ground in liquid nitrogen. Of the ground material, 400 mg was 
extracted with 1 ml methanol at room temperature for 10 minutes, followed by centrifugation 
for 10 minutes at 20,800×g. Under vacuum, 500 μl of the supernatant was evaporated to 
dryness and the residue was dissolved in 600 μl water/cyclohexane (2/1, v/v). Samples were 
centrifuged (10 minutes at 20,800×g) and 200 μl of the aqueous phase was retained for 
analysis. 
To remove salts from the samples of the medium, 1 mL of medium was brought on a 100 mg 
Extract-Clean
TM
 SPE column (Mandel, Guelph, Ontario, Canada) preconditioned with 1 mL 
100% MeOH and 1 mL water acidified with 0.1% (v/v) acetic acid. After washing with 1 mL 
acidified water, samples were eluted in 1 mL methanol. The methanol eluent was evaporated 
to dryness under vacuum and the residue dissolved in 200 μl water for analysis. 
For reversed phase LC, an Acquity UPLC
TM
 BEH C18 column (150 x 2.1 mm, 1.7 μm; 
Waters, Milford, MA) was serially coupled to an Acquity UPLCTM BEH C18 column (100 x 
2.1 mm, 1.7 μm) and mounted on an ultrahigh performance LC system consisting of a Accela 
pump (Thermo Electron Corporation, Bremen, Germany) and Accela autosampler (Thermo 
Electron Corporation). The Accela LC system was hyphenated to a LTQ FT Ultra (Thermo 
Electron Corporation) via an electrospray ionization source. The following gradient was run 
with water:acetonitrile (99:1, v/v) acidified with 0.1% (v/v) acetic acid (solvent A) and 
acetonitrile:water (99:1, v/v) acidified with 0.1% (v/v) acetic acid (solvent B): time 0 min, 
5% B; 30 min, 55% B; 35 min, 100% B. The loop size, flow, and column temperature were 
25 μl, 300 μl/min, and 80°C, respectively. Full loop injection was applied. Negative 
ionization was obtained with the following parameter values: capillary temperature 150°C, 
sheath gas 25 (arbitrary units), auxiliary gas 3 (arbitrary units), and spray voltage 4.5 kV. Full 
FT-MS spectra between m/z 120–1400 were recorded at a resolution of 100,000. For 
identification, full MS spectra were interchanged with a dependent MS
2
 scan event in which 
the most abundant ion in the previous full MS scan was fragmented, and two dependent MS
3
 
scan events of the two most abundant daughter ions. The collision energy was set at 35%. 
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Elucidation of the MS
n
 spectra was according to Pollier et al. (2011) for the saponins and 
Morreel et al. (2006; 2010) for the flavonoids and (neo-)lignans. 
The resulting chromatograms were integrated and aligned with the XCMS package (Smith et 
al., 2006) in R version 2.6.1. with the following parameter values: xcmsSet(fwhm=8, 
max=300, snthresh=5, mzdiff=0.5), group(bw=8, max=300), retcor(method=loess, 
family=symmetric). A second grouping was done with the same parameter values. Due to in-
source fragmentation, multiple m/z peaks for each compound were often observed. The 
number of compounds was estimated with “peak groups” consisting of m/z peaks with the 
same retention time (window, x s) that were correlated (Pearson; threshold, 0.85) across all 
control samples. 
4.8.Phylogenetic analysis 
The protein sequences were aligned with ClustalW and the resulting alignments were 
manually adjusted (Dataset 1). The phylogenetic tree was generated in MEGA 4.0.1 software 
(Tamura et al., 2007), by the Neighbor-Joining method, and bootstrapping was done with 
10,000 replicates. The evolutionary distances were computed with the Poisson correction 
method, and all positions containing gaps and missing data were eliminated from the data set 
(complete deletion option). 
 
>At-Rma1/AT4g03510 
DCNICLDSVQEPVVTLCGHLFCWPCIHKWLDVQSFSTSCPVCKSKVSHSTLVPLYGRGKVPKRPVGPYMVGEMVATRLFGGPRMRRRIMQADKSLGRIFFFFMCCVVLCLLLF 
>At-Rma2/AT4g27470 
DCNICLDTAHDPVVTLCGHLFCWPCIYKWLHVQL-SSVCPVCKSNITITSLVPLYGRGSIPRRPAPTGMFGDLVYTRIFGSQRM----MQREKSLNRVSIFFLCCIILCLLLF 
>At-Rma3/AT4g28270 
DCNICLDQVRDPVVTLCGHLFCWPCIHKWTYASNNSRQCPVCKSDVSEATLVPIYGRGSVPSRPTG-YVVCEMVYRRLFG-VRSRRRAMQAEESLSRVYLFLLCFMFMCLFLF 
>Ca-Rma1H1 
DCNICLDCVHEPVITLCGHLYCWPCIYKWIYFQSVSSECPVCKAEVSEKTLIPLYGRGKIPQRPPSLSMIGEVAYARIFGSPRMRRQLSQADRSLGRICFFLFCCFVTCLILF 
>Ce-RNF5 
ECNICLDAAKDAVVSLCGHLFCWPCLSQWLDTRPNNQVCPVCKSAIDGNKVVPIYGRGKVPPRPKGPGIFPLSFVASFFGSAAPGSRMAQEEEYLSNIFKYIGFFMLFWLLFV 
>Hs_RNF5/RMA1 
ECNICLETAREAVVSVCGHLYCWPCLHQWLETRPERQECPVCKAGISREKVVPLYGRGKTPPRPQGPGAFPFGFFTTVFNDLGQG---HPASSWQDSLFLFLAIFFFFWLLSI 
>MKB1 
DCNICLESANDPVVTLCGHLYCWPCIYKWLNVQS-SSVCPVCKAVISHTSLVPLYGRGNIPHRPPPTGLFGEMVSTRMFGSPRMRRQEMQIDKSLNRVSIFLLCCFILCLLLF 
>TC144757 
DCNICLDFAHEPVVTLCGHLYCWSCIYKWLFVQS-ASLCPVCKDGISHTKMVPLYGRGSIPPRPPAA-LFPQFVFG--FGSSRWRRQEMLANKSLNRISFFLFLCFLLCFILF 
>TC156053 
ECNICFDLAQDPVITLCGHLFCWPCLYRWLHHHSHSQECPVCKALVQEEKLVPLYGRGKIPRRPSGNGLMNIHFHG--FQSQATGQVQRQEDNCLKNLLMLIGFLVLLTVIFF 
>TC150776 
DCNICLDFANEPVVTLCGHLYCWPCIYKWLHVQSDDSLCPVCKENISHTTMVPLYGRGSVPPRPTAAGMFEEMIFSGVVGSSRLRRQELQTDKFLNRISNFLFCCFLLCLIVF 
>TC152655 
DCNICLECVQDPVVTLCGHLYCWPCIYKWLNFHAENQ-CPVCKSEISKSSLVPLYGRGNIPPRPLGPQVFGEMIYARIFGNPRIRRHLMRADKSLGRICFFLLCCTVLCLLLF 
>TC154271 
DCNICLDCVQDPVVTFCGHLYCWPCIYKWLDIQSGISSCPVCKSELSQSSLVPLYGRGKVPRRPTGPSIFGEMIYGRMFGNPRMRRHLMQVDKSLNRISFFLFCSLVLCVLLF 
>AT1g19310 
ECNICLDLAQDPIVTLCGHLFCWPCLYKWLHLHSQSKDCPVCKAVIEEDRLVPLYGRGKVPNRPSGPGLFNLHFHG--FPYQRHTGRQGQQDHHLR-ILLLIVFVVVVFSLFL 
>AT2g23780 
ECNICFELAQDPIVTLCGHLFCWPCLYRWLHHHSHSQECPVCKAVVQDDKLVPLYGRGKIPNRPTGPGLFNFQFHG--FHERPMARGGNQSDAFLKNILFFVGICVVIFLIW- 
Dataset 1. The amino acid alignments used to generate the phylogenetic tree presented in Figure 6. 
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4.9.Ubiquitination assay 
Recombinant GST-MKB1 fusion proteins (wildtype, truncated, or mutated) were purified 
from transformed E. coli cells, pretreated for 2 hours with isopropyl-β-D-1-
thiogalactopyranoside (IPTG), with Glutathione Sepharose
TM
 4B resin columns (GE 
Healthcare) according to the manufacturer‟s instructions. A protein refolding step to assure 
the full ion Zn charge of the GST-MKB1 fusion protein was included by incubation with 
refolding buffer (20 mM Hepes, pH 7.4, 0.02 mM ZnCl, 1.5 mM MgCl2, 150 mM KCl, 
0.2 mM EDTA, 20% glycerol, 0.05% Triton-X100) for 1 hour at 4°C. 
Ubiquitination reactions were done in a total volume of 30 μl using 15 μl of the refolded 
GST-MKB1 in a glutathione resin. The reaction contained 300 ng of GST-MKB1 fusion 
protein as E3 ligase, 250 ng of the Ub-activating Enzyme (UBE1) from rabbit 
(BostonBiochem), 400 ng of human recombinant UbcH5a protein (BostonBiochem), and 
2 μg of His6-Ub from human (BostonBiochem) in ubiquitination buffer (50 mM Hepes, 
pH 7.4, 2 mM ATP, 5 mM MgCl2, 2 mM DTT, 0.02 mM ZnCl2). The ubiquitination 
reactions were incubated for 1 hour at 30°C and stopped by adding 2X Laemmli buffer. 
Samples were resolved on 8% SDS-PAGE followed by protein immunoblot analysis with α-
penta/tetra His antibody (Qiagen) and α-GST (GE Healthcare) antibodies. 
4.10. Yeast complementation and protein degradation assays 
The S. cerevisiae strains RHY400 (a, ade2-101, his3Δ200, lys2-801, met2, hmg1::LYS2, 
hmg2::HIS3, ura3-52::6MYC-HMG2) expressing 6myc-Hmg2p and its hrd1-1 mutant 
RHY401 were used for the complementation and protein degradation assays (Hampton et al., 
1996). Transformations were carried out with the high-efficiency lithium acetate/single-
stranded carrier DNA/polyethylene glycol method. The transformed yeast strains were 
selected on minimal medium (2.67% minimal SD Base with 0.077% -Ura DO supplement; 
Clontech) supplemented with 30 mg/l adenine and methionine. 
For the hrd1-1 mutant phenotype complementation assays, minimal medium supplemented 
with 100 μg/ml lovastatin was used. A stock solution of 25 mg/ml lovastatin was prepared by 
the hydrolysis of a 100 mg/ml solution in 95% ethanol with 1 N NaOH at 55°C for 40 min, 
followed by addition of 1 M Tris-HCl (pH 8.0) and adjustment of pH to 8.0 with 1 N HCl. 
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The protein degradation assay was done by a CHX chase of log phase cells at 0 h and 4 h, 
and subsequent immunoblotting to follow the degradation of 6myc-Hmg2p (Hampton and 
Rine, 1994). Whole cell protein extracts were prepared from yeast cells by washing them 
with minimal medium containing 0.1% NaN3 followed by resuspension in 100 μl of SUTE 
buffer (8 M urea, 1% SDS, 10 mM Tris base, 10 mM EDTA, pH adjusted to 7.5) containing 
Complete protease inhibitors (Roche) at pH 6.8. The cells were lysed by vortexing at high 
speed with acid-washed 0.5 mm glass beads. The lysate was boiled for 10 min at 65°C after 
addition of 100 μl USB buffer (8 M urea, 4% SDS, 0.125 M Tris-HCl, pH 6.8, 10% β-
mercaptoethanol, pH adjusted to 6.8). Ten μl of the clear liquid lysate was loaded on SDS-
PAGE gels for protein separation, followed by immunoblotting with the 9E10 monoclonal 
anti-myc antibody. 
4.11. HMGR degradation assays in plant protoplasts 
Protoplast preparation from tobacco Bright Yellow-2 cells, automated transfection, lysis, and 
firefly luciferase assays were carried out as described (De Sutter et al., 2005). 
4.12. Accession numbers 
Sequence data from this article can be found in the EMBL/Genbank data libraries under 
accession number JF714982. 
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1. The Combinatorial Biosynthesis in Plants (COMBIPLAN) project 
This PhD project was conducted in the framework of the COMBIPLAN SBO project 
(“Strategisch Basisonderzoek” project SBO040093), with the aim to demonstrate the 
potential and technical feasibility of a platform allowing semi-rational combinatorial 
engineering of the biosynthesis of existing and novel plant secondary metabolites in plant cell 
tissue cultures, with the secondary metabolite class of the triterpene saponins as the target. 
The COMBIPLAN project was a collaboration between three research groups, and was 
coordinated by Prof. Alain Goossens, from the VIB department of Plant Systems Biology, 
Ghent University. The collaborating partners consisted of the research groups of Prof. Danny 
Geelen of the department Plant Production, Ghent University, and of Prof. Luc Pieters of the 
department of Pharmaceutical Sciences, University of Antwerp. 
1.1.Contribution to the COMBIPLAN project 
The first major deliverable of this thesis for the COMBIPLAN project was the gene discovery 
program for combinatorial biosynthesis in plants. The creation of conditions of differential 
saponin production in the target plants by elicitor treatment allowed to pinpoint relevant 
genes through a genome-wide transcriptome analysis. This transcript profiling was performed 
with cDNA-AFLP, and led to the visualization of the expression of more than 70,000 genes, 
of which around 250 were prioritized for further analysis based on their putative annotation 
and transcriptional co-regulation with known saponin biosynthesis genes (Chapter 2). To 
obtain the FL-clones of the selected genes, a medium-throughput cDNA-library screening 
strategy to convert the cDNA-AFLP tag sequences to the corresponding FL-clones was 
developed and applied (Chapter 3). This screening led to a library of 140 FL-clones, encoding 
enzymes potentially involved in saponin biosynthesis (geneset 1) and transcription factors 
that potentially regulate the saponin biosynthesis (geneset 2). 
The second major aim of this PhD project was delivering proof of concept of combinatorial 
biosynthesis of triterpene saponins in plants. To this end, more than 50 gene constructs (from 
geneset 2) leading to ectopic expression of candidate saponin biosynthesis genes were 
introduced in M. truncatula hairy roots. A method for metabolite profiling of triterpene 
saponins in M. truncatula hairy roots by liquid chromatography Fourier transform ion 
cyclotron resonance mass spectrometry was designed (Chapter 4), and employed to screen for 
novel molecules, which were detected in three different transgenic M. truncatula hairy root 
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lines. Structural elucidation of the novel molecules indicated that two of the transgenic lines 
produced novel triterpene saponins, whereas the third line produced a set of novel, non-
saponin compounds. Hence, proof of concept of combinatorial biosynthesis in plants was 
obtained. 
1.2.Are the new compounds truly novel? 
Questions may arise about the true novelty of the compounds. Indeed, they have been shown 
to be new to both the M. truncatula hairy roots and the plants of which the genes were 
derived, but, since their exact chemical structure is not know, it is still possible they are not 
new to nature. Nuclear magnetic resonance (NMR) spectroscopy is the most commonly used 
method to determine the exact chemical structure of new compounds. Especially for 
complicated molecules such as triterpene saponins, two-dimensional (2D)-NMR may be 
needed to fully elucidate the structures. 2D-NMR reveils nuclei that are spin-coupled to each 
other, and since spin-coupled nuclei are usually separated by one to three bonds only, the 
connections within the compound are revealed. Homonuclear 
1
H-
1
H correlation spectroscopy 
(COSY) reveils spin-coupled protons, whereas heteronuclear 
1
H-
13
C correlation spectroscopy 
reveals either one-bond carbon-hydrogen interactions (such as heteronculear single quantum 
coherence (HSQC) or heteronculear multiple quantum coherence (HMQC) techniques) or 
multiple-bond carbon-hydrogen correlations (e.g. heteronuclear multiple bond correlation 
(HMBC) spectroscopy). By combining the correlations reveiled by the different 2D-NMR 
experiments, the chemical structure of a compound can be determined. However, to perform 
an NMR experiment, a significant amount (>1 mg) of purified (>90%) material is required. 
Since the new compounds in the ML385 lines are highly abundant, this may prove to be 
relatively easy, however, because of the low abundance of the new saponins in the PG0408 
and BF0567 lines, to obtain enough pure compound may become quite a challenge. The 
concentration of saponins in root tissue of M. truncatula was shown to be 5.92 mg/g 
(Huhman et al., 2005), and the new saponins detected in the PG0408 lines only occur at 0.15 
to 0.66% of the highest abundant compound, soyasaponin I, which accounts for 32% of the 
total saponins in the M. truncatula roots (Huhman et al., 2005). Thus, to obtain 1 mg of pure 
compound, 80-340 g of dry roots would be required. After metabolite extraction of the roots, 
purification of the low-abundant compounds could be performed via preparative column 
chromatography. 
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It is not unthinkable, however, that after purification it turns out that the required amount of 
1 mg of pure compound for NMR analysis is not obtained for some of the lower abundant 
compounds. When lesser amounts of compound are available, the various NMR techniques 
may not be able to reveal all correlated nuclei. Nonetheless, provided that similar compounds 
as the unknown compound are available, performing NMR on lower amounts of the unknown 
compound may be still useful. By comparing the NMR spectrum that is obtained with low 
amounts of compound with the NMR spectrum of a similar compound, it may still be 
possible to identify the changes between the “standard” and the unknown compound. For 
instance, in the case of the PG0408 lines, hydroxylation on another position of the 
dammarenediol backbone will only cause the shift of a few of the peaks obtained by NMR. 
Thus, comparison of the NMR spectrum of the commercially available ginsenoside aglycones 
with the low resolution NMR spectrum of the unknown compound may still lead to structural 
elucidation of the unknown compound. 
2. Initiated follow-up research 
In this PhD project, a library of 140 FL-clones was generated comprising genes that encode 
enzymes potentially involved in saponin biosynthesis (geneset 1) and transcription factors 
that potentially regulate the saponin biosynthesis (geneset 2). During my thesis period, three 
other PhD projects that use these genesets as a basis have been started within this department. 
2.1.Biosynthesis of novel plant derived drugs in engineered yeast 
The goal of the PhD project of Tessa Moses is to create a combinatorial biosynthesis platform 
in yeast that allows the production of novel biologically active plant derived molecules. After 
engineering the yeast strains to produce the basic saponin backbone (β-amyrin, lupeol, 
dammarenediol, …), the strains will be further engineered with multiple candidate saponin 
biosynthesis genes from geneset 1, in new-to-nature combinations, in order to create yeast 
cells that produce structurally novel saponins or sapogenin precursors. This will not only 
allow for the biosynthesis of new compounds, but will also generate the opportunity to 
functionally characterize the corresponding enzymes. Thus far, yeast strains capable of 
accumulating high levels of several triterpene backbones have been generated. Furthermore, 
super-transformation of these yeast strains with some of the genes encoding CytP450 
enzymes of geneset 1 led to the identification of a novel functional M. lanceolata CytP450 
enzyme that hydroxylates the β-amyrin backbone. 
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2.2.Identification and functional characterization of jasmonate-modulated master 
switches that steer the biosynthesis of plant pharmaceuticals 
In her PhD project, Azra Gholami will try to functionally characterize some of the candidate 
regulators of geneset 2. In first instance, candidate regulators of M. truncatula will be 
overexpressed or silenced in M. truncatula hairy root lines, and the resulting transgenic lines 
will be phenotypically characterized. This will include metabolite profiling of triterpene 
saponins with the method developed within my PhD (Chapter 4) and targeted and genome-
wide transcript profiling. For a selection of lead genes an in-depth functional analysis is 
envisaged using various approaches, such as biochemical analysis, mutant and/or chemical 
genetic screens, yeast screens, bimolecular fluorescence complementation (BiFC) analysis, in 
situ expression analysis, which should allow the elucidation of their mode of action and the 
mapping of their position in the JA-signalling machineries. Finally, the utility of these genes 
as tools for metabolic engineering towards increased production of plant-derived 
pharmaceuticals will be assessed. 
2.3.Study of protein complexes involved in the elicitation of secondary metabolism in 
M. truncatula 
In his PhD project, Nathan De Geyter will set up a Tandem Affinity Purification (TAP) 
platform (Van Leene et al., 2008) in M. truncatula hairy root cultures. As baits, 11 proteins of 
the candidate regulators of geneset 2 will be used, and the proteins that are co-purified with 
the baits will be identified. As such, Nathan will try to identify new components of the 
protein complexes involved in the jasmonate signal transduction cascade that leads to the 
elicitation of secondary metabolism in M. truncatula. When the protein complexes are 
identified, their role in elicitation of secondary metabolism in M. truncatula will be 
investigated in overexpression or silencing lines of the corresponding genes. To this end, 
targeted or genome-wide transcript profiling could be performed and the effect on metabolite 
accumulation could be assessed using the method developed in this thesis (Chapter 4). 
3. Potential of the technology platform and the generated data 
Besides the initiated PhD projects, the generated data and the technology platform itself may 
be of economic and scientific importance in various research fields. 
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3.1.Drug discovery 
In this PhD project, proof of concept of combinatorial biosynthesis in plants was obtained 
with the secondary metabolite class of the triterpene saponins as target (Chapter 5). 
Triterpene saponins are a large and structurally diverse group of plant natural products that 
possess various pharmaceutical properties (Chapter 1), and are thus of considerate 
economical importance. For instance, recently a license fee of $450 million to develop and 
commercialize a chemical derivative of oleanolic acid, bardoxolone methyl, for the treatment 
of chronic kidney disease has been paid by Abbott to Reata Pharmaceuticals 
(http://www.abbott.com/global/url/pressReleases). Also ginsenosides, the dammarane-type 
saponins restricted to the genus Panax, possess a variety of pharmaceutical properties. 
Cultivation of ginseng is a slow process and productivity from ginseng tissue and cell 
cultures has been low. In this PhD project, several (novel) ginsenosides were produced in a 
plant not belonging to the genus Panax (Chapter 5), suggesting an opportunity for alternative 
production methods for ginsenosides. Hence, the application of combinatorial biosynthesis to 
increase the structural variation of triterpene saponins may result in the discovery of novel 
compounds with a significant pharmaceutical (and thus economical) impact. 
One of the major challenges in the development of plant-derived drugs is obtaining sufficient 
amounts of the compounds. In a lot of cases, the complex bioactive molecules are available at 
very low concentrations in planta. Furthermore, plant growth can be very slow, or the 
molecules are found in plant species that are rare or threatened with extinction. As such, the 
establishment of combinatorial biosynthesis programs in planta may be compromised, at least 
in some plant species. Also here, the library of 140 FL genes may offer opportunities. 
Overexpression or silencing of regulatory genes may lead to a higher accumulation of the 
desired compounds in planta. For instance, silencing of the RING E3 ubiquitin ligase 
MAKABISH1 that regulates the triterpene saponin biosynthesis in M. truncatula leads to an 
increased flux through the mevalonate pathway, with an increased accumulation of 
monoglycosylated saponins as a consequence (Chapter 6). Furthermore, also reconstitution of 
the biosynthesis pathway in a heterologous host could overcome low production amounts in 
planta, or the need to sacrifice rare or endangered species. The genes present in our FL 
library may be lead candidates for the reconstitution of the saponin biosynthesis in a suitable 
host, and thus for the development of a more robust microbial production system. 
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3.2.Gene discovery for combinatorial biosynthesis 
To exploit the full potential of plant natural products, knowledge of the genes involved in the 
biosynthesis of the metabolites is essential, but until now most, if not all, of the biosynthesis 
pathways leading to the production of plant natural products remain incompletely understood. 
With the commercialization of several next-generation sequencing techniques, the last five 
years witnessed a revolution in functional genomics. This tremendous progress now brings 
the whole genome or transcriptome of any plant species within reach and will undoubtedly 
greatly accelerate gene discovery for secondary metabolite pathways. Simultaneously, the 
enormous amount of data generated by such next generation sequencing platforms demands 
for efficient strategies to identify and select the relevant biosynthetic genes from the pools of 
thousands of sequenced genes, or at least for efficient ways to exploit them. 
Next to the use of elicitors (Chapter 1 and 2), overexpression or silencing of regulatory genes 
may allow pinpointing the desired subsets of the total gene pools as candidate genes 
responsible for the biosynthesis of the secondary metabolites. For instance, silencing of the 
the RING E3 ubiquitin ligase MAKABISH1 in M. truncatula hairy roots led to a strong 
downregulation of practically all of the hitherto known triterpene saponin biosynthetic genes, 
whereas no effects were observed on genes of the related sterol biosynthesis (Chapter 6). 
Thus, comparison of the transcriptome of MAKABISH1 silencing lines with the 
transcriptome of control hairy root lines may allow to specifically pinpoint the hitherto 
unknown genes involved in saponin biosynthesis. 
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Summary 
Combinatorial biosynthesis comprises a series of methods that establish novel enzyme-
substrate combinations in vivo, which in turn lead to the biosynthesis of new, natural product-
derived compounds that can be used in drug discovery programs. Because of the more 
complex genetic makeup of plants and the lack of tools to manipulate them, combinatorial 
biosynthesis in plants is still in its infancy. (Chapter 1). The main goal of this PhD research 
was to establish a combinatorial biosynthesis platform in plants with the secondary 
metabolite class of triterpene saponins as the target. 
Since several of the steps involved in the saponin biosynthesis were uncharacterized at the 
molecular level, a functional genomics approach to identify candidate genes involved in the 
saponin biosynthesis of five different plants was applied. The creation of conditions of 
differential saponin production in the target plants by elicitor treatment allowed to pinpoint 
relevant genes through a genome-wide transcriptome analysis. This transcript profiling was 
performed with cDNA-AFLP, and led to the visualization of the expression of more than 
70,000 genes, of which around 250 were prioritized for further analysis based on their 
putative annotation and transcriptional co-regulation with known saponin biosynthesis genes 
(Chapter 2). To obtain the FL-clones of the selected genes, a medium-throughput cDNA-
library screening strategy to convert the cDNA-AFLP tag sequences to the corresponding FL-
clones was developed and applied (Chapter 3). This screening has led to a library of 140 FL-
clones, encoding enzymes potentially involved in saponin biosynthesis and transcription 
factors that potentially regulate the saponin biosynthesis. To deliver proof of concept of 
combinatorial biosynthesis of triterpene saponins in plants, more than 50 gene constructs 
leading to heterologous expression of candidate saponin biosynthesis genes were introduced 
in M. truncatula hairy roots. A method for metabolite profiling of triterpene saponins in M. 
truncatula hairy roots by liquid chromatography Fourier transform ion cyclotron resonance 
mass spectrometry was designed (Chapter 4), and employed to screen for novel molecules, 
which were detected in three different transgenic M. truncatula hairy root lines. Structural 
elucidation of the novel molecules indicated that two of the transgenic lines produced novel 
triterpene saponins, whereas the third line produced a set of novel, non-saponin compounds. 
Hence, proof of concept of combinatorial biosynthesis in plants was obtained (Chapter 5). 
Furthermore, overexpression and silencing of a set of candidate genes involved in the 
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regulation of saponin biosynthesis has led to the identification of MKB1, a RING E3 
ubiquitin ligase that regulates triterpene saponin biosynthesis in Medicago truncatula by 
targeting 3-hydroxy-3-methylglutaryl-CoA reductase, the enzyme catalyzing the rate-limiting 
step in the mevalonate pathway (Chapter 6). 
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Samenvatting 
Combinatoriële biosynthese omvat een aanal technieken die nieuwe enzym-substraat 
combinaties genereren in vivo, welke resulteren in de biosynthese van nieuwe molecules die 
gebruikt kunnen worden in drug discovery programma‟s. Hoewel combinatoriële biosynthese 
technieken in micro-organismen regelmatig worden toegepast, is het gebruik ervan in planten 
gelimiteerd omwille van de complexere genetische structuur van planten en het ontbreken 
van technieken om planten te manipuleren (Hoofdstuk 1). Het hoofddoel van dit 
doctoraatsonderzoek was dan ook om een combinatoriële biosynthese platform in planten te 
ontwikkelen, met de triterpeen saponines, een klasse van secundaire metabolieten in planten, 
als doel. 
Daar tot op heden nog steeds verschillende stappen in de biosynthese van triterpeen 
saponines ongekend zijn, werd er in de eerste stap van dit doctoraatsonderzoek in vijf 
verschillende planten gezocht naar genen die mogelijks betrokken zijn in de biosynthese van 
triterpeen saponines. Het behandelen van de verschillende planten met methyl jasmijnzuur 
resulteerde in een verhoogde saponine accumulatie, als gevolg van de activatie van de 
saponine biosynthese genen. Het onderzoeken van de genexpressie van meer dan 70,000 
genen van de vijf verschillende planten met behulp van de cDNA-AFLP techniek stelde ons 
in staat om een set van een 250-tal genen te priorizeren voor verdere analyse. Een gen werd 
enkel beschouwd als kandidaat-gen als de expressie ervan overeen kwam met de expressie 
van de gekende saponine biosynthese genen (co-regulatie) en als het gen ook nog eens een 
geannoteerde functie had die nodig was voor de ongekende biosynthese stappen 
(hoofdstuk 2). Om de volledige coderende sequentie van de genen te bekomen werd er een 
strategie ontwikkeld voor het efficiënt screenen van cDNA bibliotheken naar cDNA clones 
die overeenkomen met de geselecteerde gentags (hoofdstuk 3). Dit resulteerde in een 
collectie van clones van een 140-tal genen, welke coderen voor enzymes die mogelijk 
betrokken zijn bij de saponine biosynthese of de regulatie ervan. Om te bewijzen dat 
combinatoriële biosynthese in planten mogelijk is werden meer dan 50 kandidaat-biosynthese 
genen tot overexpressie gebracht in M. truncatula hairy roots. Een methode voor het 
profileren van de door de hairy roots geproduceerde saponines werd ontwikkeld 
(hoofdstuk 4) en toegpast voor het opsporen van nieuwe metabolieten in de transgene hairy 
roots, welke gedetecteerd werden in drie verschillende transgene lijnen. Het gedeeltelijk 
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ophelderen van de structuur van de nieuwe componenten toonde aan dat twee van de lijnen 
nieuwe triterpeen saponines produceerden, terwijl er in de derde lijn accumulatie van nieuwe, 
niet-saponine componenten werd waargenomen. Het bewijs van combinatoriële biosynthese 
in planten werd hiermee geleverd (hoofdstuk 5). Bovendien werd er ook een set van 
kandidaat genen betrokken bij de regulatie van de saponine biosynthese onderzocht. Dit 
leidde tot de identificatie van MKB1, een RING E3 ubiquitin ligase dat de triterpeen 
saponine biosynthese reguleert in Medicago truncatula door het enzyme 3-hydroxy-3-
methylglutaryl-CoA reductase van de mevalonaat biosynthese te labelen voor degradatie 
(hoofdstuk 6). 
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Determination of saponins in Maesa lanceolata by LC-UV: development 
and validation 
 
Theunis, M.H.B.L., Foubert, K., Pollier, J., González-Guzmán, M., Goossens, A., Vlietinck 
A.J., Pieters, L.A.C., and Apers, S. 
 
Triterpene saponins are a class of plant natural products with a wide range of bioactivities, 
which makes them an interesting research subject. The small tree Maesa lanceolata, growing 
in African countries, is used in traditional medicine against various diseases. In previous 
work a triterpenoid saponin mixture was isolated from the leaves of M. lanceolata and the 
compounds were identified as closely related oleanane type triterpenes. The compounds 
showed virucidal, haemolytic, molluscicidal and antiangiogenic activity. Here we report the 
development of an extraction and quantification method to analyse saponin compounds in 
roots and leaves of M. lanceolata. After a purification step using C18 solid phase extraction 
(SPE) cartridges, the samples were analysed on a LC-UV/MS system. The identification of 
the peaks from the different saponins was confirmed based on the retention time and mass 
spectrum. The quantification was performed using the UV signals. The standard oleanolic 
acid curve was linear over a concentration range of 2.8-140.0 μg/mL. The recovery from the 
leaves was 94.5%. The precision of the method with respect to time and concentration was 
acceptable, with relative standard deviation (RSD%) values of 4.9 and 4.3, respectively. 
 
Published in: Phytochemistry (IF: 3.104), 2007, volume 68, pages 2825-2830. 
 
Contribution: Cultivation and harvesting of the M. lanceolata plants. 
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Dissection of the phytohormonal regulation of trichome formation and 
biosynthesis of the antimalarial compound artemisinin in Artemisia annua 
plants 
 
Maes, L., Van Nieuwerburgh, F.C.W., Zhang, Y., Reed, D.W., Pollier, J., Vande Casteele, 
S.R.F., Inzé, D., Covello, P.S., Deforce, D.L.D., and Goossens, A. 
 
• Biosynthesis of the sesquiterpene lactone and potent antimalarial drug artemisinin occurs in 
glandular trichomes of Artemisia annua plants and is subjected to a strict network of 
developmental and other regulatory cues. 
• The effects of three hormones, jasmonate, gibberellin and cytokinin, were studied at the 
structural and molecular levels in two different A. annua chemotypes by microscopic analysis 
of gland development, and by targeted metabolite and transcript profiling. Furthermore, a 
genome-wide cDNA-amplified fragment length polymorphism (AFLP)-based transcriptome 
profiling was carried out of jasmonate-elicited leaves at different developmental stages. 
• Although cytokinin and gibberellin positively affected at least one aspect of gland 
formation, these two hormones did not stimulate artemisinin biosynthesis. Only jasmonate 
simultaneously promoted gland formation and coordinated transcriptional activation of 
biosynthetic gene expression, which ultimately led to increased sesquiterpenoid accumulation 
with chemotype-dependent effects on the distinct pathway branches. Transcriptome profiling 
revealed a trichome-specific fatty acyl- coenzyme A reductase, trichome-specific fatty acyl-
CoA reductase 1 (TFAR1), the expression of which correlates with trichome development 
and sesquiterpenoid biosynthesis. 
• TFAR1 is potentially involved in cuticular wax formation during glandular trichome 
expansion in leaves and flowers of A. annua plants. Analysis of phytohormone-modulated 
transcriptional regulons provides clues to dissect the concerted regulation of metabolism and 
development of plant trichomes. 
 
Published in: New Phytologist (IF: 6.033), 2011, volume 189, pages 176-189. 
 
Contribution: qRT-PCR analysis of artemisinin biosynthetic genes (Figure 4). 
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Characterization of a RABE GTPase expressed during morphogenesis of 
the unicellular green alga Micrasterias denticulata (Zygnemophyceaea, 
Streptophyta) 
 
Vannerum, K., De Rycke, R., Pollier, J., Goossens, A., Inzé, D., and Vyverman, W. 
 
Rab GTPases are central regulators of cell shape in land plants by coordinating vesicle 
trafficking during morphogenesis. To date, relatively little is known about the role of these 
ubiquitous signaling proteins during cell growth of microalgae, in particular of the related 
charophyte algae. This paper identifies the first charophyte Rab GTPase, MdRABE1, in 
Micrasterias denticulata Bréb., a convenient model organism for studying morphogenesis. Its 
expression correlated with the onset of morphogenesis and structural analysis indicated that it 
belongs to the RABE subclass. Confocal fluorescence and immuno-electron microscopy of 
transiently GFP-MdRABE1 overexpressing interphase cells demonstrated that the GFP 
MdRABE1 protein was localized to the endoplasmic reticulum, dictyosomes, exocytotic 
vesicles, the cell margin, the membranes of cell organelles and in the isthmus zone around the 
nucleus. Although overexpression phenotyping of both N- and C-terminal GFP-fusions failed 
to indicate further functional evidence of the MdRABE1 protein due to mortality of those 
transgenic cells, its expression profile, bioinformatics, and its intracellular localization 
suggest a role in vesicle trafficking during morphogenesis. 
 
Submitted to: Journal of Phycology (IF: 2.270). 
 
Contribution: Screening for the RABE GTPase in a M. denticulata cDNA library via colony 
hybridization. 
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Transcriptional analysis of cell growth and morphogenesis in Micrasterias 
(Streptophyta) provides insights into the evolution of expansins in the green 
algal progenitors of land plants 
 
Vannerum, K. Huysman, M.J.J., De Rycke, R. Vuylsteke, M., Leliaert, F., Pollier, J., Lütz-
Meindl, U., Gillard, J., De Veylder, L., Goossens, A., Inzé, D., and Vyverman, W. 
 
Background 
Streptophyte green algae share several features of cell growth and cell wall formation with 
their relatives, the embryophytic land plants. The multilobed cell wall of Micrasterias 
denticulata, which rebuilds symmetrically after cell division and consists of pectin and 
cellulose, makes this unicellular streptophyte alga an interesting model system to study the 
evolution of molecular controls on cell shape and cell wall formation within the green plant 
lineage. 
Results 
By genome-wide transcript expression profiling of synchronously growing cells, 107 genes 
were identified of which the expression correlated with the growth phase. Four transcripts 
showed high similarity to expansins, genes that had not been examined previously in green 
algae. Phylogenetic analysis demonstrated that they are most closely related to the plant 
EXPANSIN A family, although their domain organization is very divergent. A GFP-tagged 
version of the expansin-resembling protein MdEXP2 localized to the cell wall and in Golgi-
derived vesicles. Overexpression phenotypes ranged from lobe elongation to loss of growth 
polarity and planarity. These results indicate that MdEXP2 can alter cell wall structure and 
thus may exert a function related to land plant expansins during cell morphogenesis. 
Conclusions 
Our results demonstrate the potential of M. denticulata as a unicellular model system, 
extended by the discovery of cell growth mechanisms similar to those in land plants. This 
study adds to growing body of evidence that the evolutionary origins of many cell wall 
components and regulating genes in embryophytes lie in an era prior to the colonization of 
land. 
Submitted to: BMC Plant Biology (IF: 3.77). 
 
Contribution: Help with screening for the FL cDNAs in a M. denticulata cDNA library via 
RACE PCR.  
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Supplementary Table S1. LC ESI FT-ICR MS analysis of MKB1
KD
 roots. 
Change and tentative identification of the 
observed compounds 
[M-H]- Formula (δ ppm) FT-ICR MSn: m/z (% base peak) 
Up ? 675.23439 C26H43O20 (-1.6) Low abundant compound, no MS
n info available 
Up pentose derivate 425.16616 C17H29O12 (-0.68) MS
2 [425.17]: 383 (100), 365 (9), 293 (17) 
MS3 [425.17→383]: 251 (100) 
Up ? 741.22494 C33H41O19 (0.25) MS
2 [741.22]: 427 (46), 313 (100) 
Up ? 473.14549 C24H25O10 (0.36) MS
2 [473.15]: 413 (1), 311 (3), 269 (100) 
MS3 [473.15→269]: 254 (85), 253 (33), 237 (100), 227 (50), 148 (6), 145 (60)  
MS3 [473.15→311]: 268 (100) 
Up ? 559.20408 C25H35O14 (1.52) MS
2 [559.20]: 407 (100) 
MS3 [559.20→407]: 365 (100) 
Up ? 165.01928 C8H5O4 (-0.32) Low abundant compound, no MS
n info available 
Up ? 670.16455 C28H32O18N (3.08) Low abundant compound, no MS
n info available 
Up naringenin + hexose + 42 Da 475.16168 C24H27O10 (1.49) MS
2 [475.16]: 433 (43), 415 (10), 271 (100) 
MS3 [475.16→271]: 239 (12), 165 (100), 137 (7) 
MS3 [475.16→433]: 271 (100) 
Up ? 1119.52638 C53H83O25 (3.12) Low abundant compound, no MS
n info available 
Up ? 597.21986 C28H37O14 (1.64) MS
2 [597.22]: 193 (100) 
Up naringenin + hexose + malonic 
acid 
519.15162 C25H27O12 (1.58) MS
2 [519.15]: 475 (100) 
MS3 [519.15→475]: 433 (18), 415 (5), 271 (100) 
MS4 [519.15→475→271]: 239 (12), 165 (100), 147 (6), 137 (12) 
Up ? 313.07184 C17H13O6 (0.25) MS
2 [313.07]: 298 (100), 151 (33) 
MS3 [313.07→298]: 283 (100), 270 (45), 226 (33) 
MS3 [313.07→151]: 107 (100) 
Up ? 606.18215 C41H24O3N3 (-0.27) MS
2 [606.18]: 562 (100) 
Up divanilloyl hexose + 280 Da 759.21685 C36H39O18 (3.507) MS
2 [759.22]: 479 (100), 311 (6), 297 (4) 
MS3 [759.22→479]: 311 (44), 297 (100) 
Up Afrormosin + malonyl hexose 1091.27251 C52H51O26 (4.678) MS
2 [1091.27]: 1047 (100), 799 (73), 500 (60) 
Up Afrormosin (297) + ??? 1113.2565 C54H49O26 (4.263) MS
2 [1113.26]: 907 (21), 865 (100), 864 (12), 863 (9), 821 (38), 820 (8), 617 (62), 567 (20), 523 (8), 
379 (3) 
MS3 [1113.26→617]: 297 (100) 
Up ? 585.38103 C35H53O7 (2.311) Low abundant compound, no MS
n info available 
Up dHex-Hex-Hex-hederagenin 941.51536 C48H77O18 (4.058) MS
2 [941.51]: 795 (100)[M-dHex-H]-, 777 (12)[M-dHex-H2O-H]
-, 633 (13)[M-dHex-Hex-H]-, 615 
(2)[M-dHex-Hex-H2O-H]
- 
MS3 [941.51→795]: 633 (100)[M-dHex-Hex-H]-, 615 (5)[M-dHex-Hex-H2O-H]
-, 471 (20)[Agly-H]- 
MS3 [941.51→633]: 471 (100)[Agly-H]-, 393 (3) 
Up Hex-Bayogenin 649.39774 C36H57O10 (3.108) MS
2 [649.40]: 487 (100)[Agly-H]-, 469 (15), 441 (28), 409 (36) 
Up Hex-Medicagenic acid 663.37701 C36H55O11 (3.051) MS
2 [663.37]: 645 (5)[M-H2O-H]
-, 501 (13)[M-Hex-H]-, 439 (100)[Agly-CO2-H2O-H]
- 
MS3 [663.37→439]: 393 (83), 391 (100) 
217 
 
Up Malonyl-Hex-malonyl-Hex-
Bayogenin 
983.45391 C48H71O21 (4.654) (MS): 983 (21)[M-H]
-, 895 (21)[M-CO2-CO2-H]
-, 734 (11)[M-CO2-CO2-Hex-H]
-, 691 (100)[M-
malonyl-Hex-CO2-H]
-, 649 (18)[M-malonyl-Hex-malonyl-H]-, 631 (62)[M-malonyl-Hex-malonyl-
H2O-H]
-, 487 (39)[Agly-H]- 
Up Malonyl-Hex-malonyl-Hex-
Medicagenic acid 
997.4345 C48H69O22 (5.918) MS
2 [997.43]: 953 (51)[M-CO2-H]
-, 909 (100)[M-CO2-CO2-H]
-, 733 (6), 705 (24)[M-malonyl-Hex-
CO2-H]
-, 691 (26) 
MS3 [997.43→909]: 891 (4)[M-CO2-CO2-H2O-H]
-, 865 (6)[M-CO2-CO2-CO2-H]
-, 849 (3)[M-CO2-
CO2-malonyl-H2O-H]
-, 703 (4)[M-CO2-CO2-CO2-Hex-H]
-, 661 (6)[M-CO2-CO2-malonyl-Hex-H]
-, 643 
(15)[M-CO2-CO2-malonyl-Hex-H2O-H]
-, 439 (100)[Agly-H]- 
Up Hex-Hederagenin 633.40242 C36H57O9 (2.547) MS
2 [633.40]: 615 (33)[M-H2O-H]
-, 513 (15), 471 (100)[Agly-H]-, 453 (24), 405 (24), 393 (39) 
Up Hex-Aglycone A 647.38233 C36H55O10 (3.489) MS
2 [647.38]: 485 (100)[Agly-H]- 
Up Malonyl-Hex-malonyl-Hex-
Hederagenin 
967.45877 C48H71O20 (4.498) MS
2 [879.47]: 861 (2)[M-CO2-CO2-H2O-H]
-, 819 (6)[M-malonyl-CO2-H2O-H]
-, 777 (5)[M-malonyl-
malonyl-H2O-H]
-, 717 (27)[M-Hex-CO2-CO2-H]
-, 675 (100)[M-Hex-malonyl-CO2-H]
-, 657 (3)[M-
Hex-malonyl-CO2-H2O-H]
-, 615 (72)[M-Hex-malonyl-malonyl-H2O-H]
- 
Up ? 981.43761 C48H69O21 (2.545) Low abundant compound, no MS
n info available 
Down ? 863.24545 C36H47O24 (-0.96) Low abundant compound, no MS
n info available 
Down kaempferol + pentose + 
deoxyhexose + 2 hexoses 
887.24717 C38H47O24 (1.01) MS
2 [887.25]: 725 (100)[M-Hex-H]- 
MS3 [887.25→725]: 593 (68)[M-Hex-Pen-H]-, 575 (100)[M-Hex-Pen-H2O-H]
-, 327 (11), 285 
(49)[Kaempferol-H]- 
Down ? 782.20754 C41H36O15N1 (-1.92) MS
2 [782.21]: 764 (10)[M-H2O-H]-, 739 (6), 461 (100) 
MS3 [782.21→461]: 299 (9), 281 (100) 
MS4 [782.21→461→281]: 266 (100) 
Down ? 595.16713 C27H31O15 (0.48) MS
2 [595.17]: 505 (44), 475 (100), 385 (69), 355 (51) 
Down ? 773.22731 C32H41O20N2 (1.93) MS
2 [773.23]: 730 (13), 705 (100) 
MS3 [773.23→705]: 429 (100) 
Down ? 435.12997 C21H23O10 (1.4) MS
2 [435.13]: 417 (13)[M-H2O-H]
-, 345 (31), 315 (100) 
MS3 [435.13→315]: 297 (100), 271 (23), 243 (20), 209 (91), 191 (71), 190 (25), 163 (11), 151 (13) 
MS3 [435.13→345]: 327 (100), 299 (9), 283 (18), 239 (55), 221 (52), 219 (36), 181 (10), 163 (6) 
Down ? 995.34649 C39H63O29 (0.44) MS
2 [995.35]: 935 (100) 
MS3 [995.35→935]: 875 (100) 
Down naringenin + hexose 433.11434 C21H21O10 (0.74) MS
2 [433.11]: 327 (79), 271 (49)[M-Hex-H]-, 253 (100), 243 (40) 
MS3 [433.11→253]: 225 (84), 211 (12), 209 (53), 197 (15), 181 (10), 135 (100), 133 (15), 117 (17) 
MS3 [435.13→327]: 281 (6), 221 (6), 219 (13), 207 (14), 191 (64), 179 (12), 167 (25), 165 (100), 164 
(9), 163 (15), 151 (5), 137 (53) 
Down ? 328.12025 C18H18O5N (3.67) MS
2 [328.12]: 241 (100), 223 (3) 
MS3 [328.12→241]: 223 (100), 207 (14), 205 (6), 195 (23), 177 (10) 
Down naringenin + hexose + ? 637.17872 C29H33O16 (2.31) MS
2 [637.18]: 595 (5), 531 (23), 475 (13)[M-Hex-H]-, 253 (100) 
MS3 [637.18→253]: 235 (17), 225 (100), 209 (39), 197 (15), 180 (9), 135 (78), 133 (11) 
MS3 [637.18→531]: 369 (15), 351 (100), 333 (14), 321 (76), 263 (27), 219 (11), 207 (14), 179 (5) 
Down carboxybenzoic acid (Phthalic 
acid or isomer) 
165.01929 C8H5O4 (-0.26) MS
2 [165.02]: 121 (100)[M-CO2-H]
- 
MS3 [165.02→121]: 77 (100)[M-CO2-CO2-H]
- 
Down hydroxymethoxybenzoic acid + 
hydroxybenzoic acid + 276 Da 
581.15228 C26H29O15 (1.87) MS
2 [581.15]: 413 (100), 167 (2) 
MS3 [581.15→413]: 137 (100) 
MS3 [581.15→167]: 152 (72), 123 (100), 108 (10) 
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Down naringenin + hexose + malonic 
acid 
519.1152 C24H23O13 (1.5) MS
2 [519.12]: 475 (100)[M-CO2-H]
- 
MS3 [519.12→475]: 433 (7)[M-malonyl-H]-, 369 (45), 271 (43)[M-malonyl-Hex-H]-, 253 (100)[M-
malonyl-Hex-H2O-H]-, 243 (43), 165 (5) 
MS4 [519.12→475→253]: 225 (100), 211 (5), 209 (39), 208 (4), 197 (4), 185 (9), 181 (3), 135 (59), 
133 (16) 
Down ? 695.18495 C31H35O18 (2.97) MS
2 [695.18]: 607 (100), 519 (9), 413 (11) 
Down pentose + hexose derivate 367.16127 C15H27O10 (0.82) MS
2 [367.16]: 235 (100)[M-Pen-H]-, 161 (15) 
MS3 [367.16→235]: 161 (100), 101 (22) 
MS3 [367.16→161]: 101 (100) 
Down ? 521.13069 C24H25O13 (1.2) MS
2 [521.13]: 503 (24), 477 (90), 459 (59), 435 (100) 
MS3 [521.13→435]: 417 (12), 345 (32), 315 (100) 
MS3 [521.13→477]: 459 (10), 387 (15), 357 (100) 
MS4 [521.13→435→315]: 297 (100), 271 (20), 243 (24), 209 (87), 191 (65), 190 (27), 163 (10), 151 
(12), 123 (3) 
Down ? 993.25443 C44H49O26 (2.69) Low abundant compound, no MS
n info available 
Down malonic acid + pentose + 
hexose derivate 
453.16205 C18H29O13 (1.51) MS
2 [453.16]: 409 (100)[M-CO2-H]
- 
MS3 [453.16→409]: 367 (100)[M-malonyl-H]-, 349 (11), 235 (5)[M-malonyl-Pen-H]- 
MS4 [453.16→409→367]: 235 (100), 161 (13) 
Down ? 629.21054 C28H37O16 (2.91) Low abundant compound, no MS
n info available 
Down ? 879.31497 C40H55O14N4S2 (-1.37) Low abundant compound, no MS
n info available 
Down ? 699.23788 ? Low abundant compound, no MSn info available 
Down hexose derivate + 
hydroxymethoxybenzoic acid + 
hydroxybenzoic acid + 276 Da 
891.22321 C40H43O23 (3.53) MS
2 [891.22]: 753 (47), 729 (10)[M-Hex-H]-, 581 (100), 477 (44), 413 (96) 
MS3 [891.22→581]: 413 (100) 
MS3 [891.22→413]: 137 (100) 
Down ? 597.12626 C29H25O14 (2.16) MS
2 [597.13]: 553 (71)[M-CO2-H]
-, 491 (81), 287 (38), 269 (100), 259 (57)  
Down ? 305.11427 C15H17O5N2 (0.25) MS
2 [305.11]: 287 (6)[M-H2O-H]
-, 277 (33), 233 (6), 229 (16), 203 (100), 189 (61), 135 (6) 
MS3 [305.11→203]: 185 (83), 175 (100) 
Down ? 271.06125 C15H11O5 (0.38) MS
2 [271.06]: 256 (100)[M-•CH3-H]
-, 243 (49)[M-CO-H]-, 227 (12)[M-CO2-H]
-, 212 (14)[M-•CH3-
CO2-H]
-, 148 (3), 123 (4), 108 (2) 
MS3 [271.06→256]: 241 (7)[M-2•CH3-H]
-, 228 (67)[M-•CH3-CO-H]
-, 227 (100), 212 (10)[M-•CH3-
CO2-H]
-, 108 (8) 
MS3 [271.06→243]: 228 (100)[M-•CH3-CO-H]
-, 225 (70)[M-CO-H2O-H]
- 
Down ? 783.3852  Low abundant compound, no MSn info available 
Down ? 599.14158 C29H27O14 (1.59) MS
2 [599.14]: 493 (100), 463 (52), 449 (32), 273 (40), 269 (44), 259 (31) 
Down ? 695.25791 C33H43O16 (3.24) MS
2 [695.26]: 673 (2), 665 (100), 653 (2), 635 (4) 
MS3 [695.26→665]: 647 (12), 623 (100), 605 (59), 587 (4), 533 (6), 329 (40) 
MS4 [695.26→665→623]: 605 (56), 459 (10), 329 (100), 315 (29), 311 (12) 
MS4 [695.26→665→605]: 587 (77), 575 (12), 329 (100), 315 (25) 
Down Similar Rt 9,7 515.17784 C23H31O13 (1.6) MS
2 [515.18]: 413 (100) 
MS3 [515.18→413]: 137 (100) 
Down ? 863.28541 C37H51O23 (3.18) MS
2 [863.29]: 845 (48), 725 (49), 449 (24), 431 (100), 387 (72) 
Down naringenin + rhamnose + 581.13109 C29H25O13 (1.76) MS
2 [581.13]: 537 (100)[M-CO2-H]
-, 475 (27), 431 (4), 415 (5), 271 (19), 253 (44), 243 (15) 
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pentose? MS3 [581.13→537]: 431 (34), 271 (34), 253 (100), 243 (42), 165 (4) 
MS3 [581.13→253]: 225 (100), 211 (6), 209 (43), 135 (68) 
Down ? 428.18085 C22H26O6N3 (-4.34) Low abundant compound, no MS
n info available 
Down ? 975.28121 C45H51O24 (3.73) Low abundant compound, no MS
n info available 
Down pinoresinol + hexose + pentose 651.2314 C31H39O15 (3) MS
2 [651.23]: 633 (85), 621 (17), 487 (10), 357 (100), 343 (10), 339 (37), 327 (13) 
MS3 [581.13→357]: 339 (63), 151 (100) 
MS3 [581.13→633]: 339 (100) 
Down lariciresinol + hexose + pentose 
+ malonic acid? 
739.2483 C34H43O18 (3.8) MS
2 [739.25]: 695 (100) 
MS3 [739.25→695]: 653 (93), 635 (100), 563 (4), 359 (8), 329 (33) 
MS3 [739.25→437]: 305 (100), 161 (20) 
Down malonic acid + pentose 
derivate? 
523.2041 C22H35O14 (1.66) MS
2 [523.20]: 479 (100) 
MS3 [523.20→479]: 437 (100), 419 (8), 305 (6), 297 (4) 
Down lariciresinol + hexose + malonic 
acid? 
563.21454 C28H35O12 (2.02) MS
2 [563.21]: 503 (6), 359 (80), 329 (100) 
MS3 [563.21→329]: 314 (17), 299 (56), 284 (11), 193 (26), 192 (21), 178 (100), 175 (11), 161 (12), 
160 (15) 
Down dihydroxyflavone or 
hydroxyflavonol derivate? 
583.14668 C29H27O13 (1.66) MS
2 [583.15]: 477 (100), 459 (5), 449 (8), 433 (31), 431 (14), 297 (35), 271 (26), 255 (10), 253 (45), 
243 (24) 
MS3 [583.15→253]: 225 (100) 
Down ? 1027.33379 C46H59O26 (3.68) MS
2 [1027.33]: 613 (25), 595 (29), 431 (100), 413 (7) 
MS3 [1027.33→413]: 137 (100) 
Down ? 503.1204 C24H23O12 (1.79) Low abundant compound, no MS
n info available 
Down pinoresinol + hexose + pentose 
+ malonic acid 
737.23297 C34H41O18 (4.25) MS
2 [737.23]: 693 (100) 
MS3 [737.23→693]: 675 (37), 663 (8), 651 (100), 633 (71), 615 (5), 357 (58), 339 (9), 327 (6) 
MS4 [737.236→693→651]: 633 (100), 621 (26), 519 (8), 487 (14), 357 (87), 343 (26), 339 (36), 327 
(16), 313 (5),  
MS4 [737.236→693→357]: 342 (11), 327 (10), 311 (15), 151 (100), 136 (32) 
Down hydroxybenzoic acid + pentose 
+ hexose derivative 
613.21538 C28H37O15 (2.59) MS
2 [613.22]: 431 (100) 
MS3 [613.22→431]: 299 (38), 137 (100) 
Down ? 923.28627 C42H51O23 (3.86) Low abundant compound, no MS
n info available 
Down ? 919.40594 C39H67O24 (3.4) MS
2 [919.41]: 901 (100), 857 (27), 757 (22), 743 (83), 725 (11), 669 (47), 651 (20) 
MS3 [919.41→901]: 857 (51), 743 (100), 669 (21), 651 (30) 
MS3 [919.41→743]: 669 (100), 651 (75) 
Down ? 785.2327 C38H41O18 (3.86) MS
2 [785.23]: 767 (100), 755 (18), 413 (8) 
MS3 [785.23→767]: 413 (100), 353 (98) 
Down ? 997.24566 C50H45O22 (4.88) MS
2 [997.24]: 743 (19), 725 (5), 683 (4), 623 (13), 581 (100) 
MS3 [997.24→581]: 537 (100), 475 (27), 271 (19) 
MS3 [997.24→743]: 581 (100) 
Down ? 1083.45469 C54H71O21N2 (-0.73) Low abundant compound, no MS
n info available 
Down malonic acid derivative 1015.29832 C55H51O19 (-4.61) MS
2 [1015.29]: 971 (100) 
MS3 [1015.29→971]: 929 (48), 911 (74), 621 (38), 579 (100), 557 (97) 
Down ? 993.34472 C50H57O21 (4.97) MS
2
 [993.34]: 975 (100) 
Down ? 1035.35403 C34H67O35 (6.95) Low abundant compound, no MS
n info available 
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Down ? 461.20364 C21H33O11 (1.745) Low abundant compound, no MS
n info available 
Down ? 1051.33501 C48H59O26 (4.761) MS
2 [1051.34]: 991 (9), 973 (12), 949 (100), 907 (57), 889 (34), 725 (27) 
MS3 [1051.34→949]: 889 (48), 767 (78), 725 (100), 707 (34) 
MS3 [1051.34→907]: 725 (100), 707 (27) 
Down pentose + malonic acid 
derivative 
539.23538 C23H39O14 (1.58) MS
2 [539.24]: 495 (100)[M-CO2-H]
- 
MS3 [539.24→495]: 453 (100)[M-malonyl-H]- 
MS4 [539.24→495→453]: 321 (100)[M-malonyl-Pen-H]- 
Down G(8-O-4)FA + 2 G? 781.29551 C37H49O18 (3.932) MS
2 [781.30]: 739 (16), 585 (100), 389 (70), 371 (23), 341 (26) 
MS3 [781.30→389]: 371 (100), 341 (59), 193 (55) 
Down malonic acid + pentose 
derivate? 
507.2092 C22H35O13 (1.746) MS
2 [507.21]: 463 (100)[M-CO2-H]
- 
MS3 [507.21→463]: 421 (100)[M-malonyl-H]-, 403 (10), 331 (3), 289 (4)[M-malonyl-Pen-H]- 
MS4 [507.21→463→421]: 289 (100), 161 (35), 159 (5) 
MS5 [507.21→463→421→289]: 161 (100), 159 (11) 
Down malonic acid + pentose 
derivate? 
507.20895 C22H35O13 (1.25) MS
2 [507.21]: 463 (100)[M-CO2-H]
- 
MS3 [507.21→463]: 421 (100)[M-malonyl-H]- 
Down dHex-Hex-HexA-Aglycone D 973.50386 C48H78O20 (2.56) MS
2 [973,50]: 955 (100)[M-H2O-H]
-, 929 (10)[M-CO2-H]
-, 911 (53)[M-H2O-CO2-H]
-, 827 (3)[M-
dHex-H]-, 809 (7)[M-dHex-H2O-H]
-, 783 (6)[M-dHex-CO2-H]
-, 765 (19)[M-dHex-H2O-CO2-H]
-, 665 
(2)[M-dHex-Hex-H]-, 647 (26)[M-dHex-Hex-H2O-H]
-, 629 (14)[M-dHex-Hex-H2O-H2O-H]
-, 603 
(7)[M-dHex-Hex-H2O-CO2-H]
-, 557 (13)[M-dHex-Hex-H2O-C3H6O3-H]
-, 489 (11)[Agly-H]- 
MS3 [973.50→955]: 911 (100)[M-H2O-CO2-H]
-, 765 (21)[M-dHex-H2O-CO2-H]
-, 679 (9), 629 
(49)[M-dHex-Hex-H2O-H2O-H]
-, 557 (55)[M-dHex-Hex-H2O-C3H6O3-H]
-, 489 (7)[Agly-H]- 
Down ? 397.14851 C19H25O9 (-4.77) MS
2 [397.15]: 371 (100), 289 (7) 
MS3 [397.15→371]: 289 (100) 
MS3 [397.15→289]: 161 (100), 159 (9), 143 (4), 113 (12), 101 (22) 
Down ? 961.4853 C43H77O23 (-0.85) Low abundant compound, no MS
n info available 
Down ? 397.14853 C19H25O9 (-4.72) MS
2 [397.15]: 353 (100) 
MS3 [397.15→353]: 311 (100), 183 (30) 
Down ? 773.32414 C36H53O18 (0.52) Low abundant compound, no MS
n info available 
Down ? 1165.57122 C55H89O26 (5.546) Low abundant compound, no MS
n info available 
Down Hex-Hex-Hex-Bayogenin 973.50407 C48H77O20 (2.776) MS
2 [973.50]: 955 (10)[M-H2O-H]
-,811 (100)[M-Hex-H]-, 649 (20)[M-Hex-Hex-H]-, 631 (7)[M-Hex-
Hex-H2O-H]
-, 487 (8) [Agly-H]- 
MS3 [973.50→811]: 649 (100)[M-Hex-Hex-H]-, 631 (42)[M-Hex-Hex-H2O-H]
-, 487 (86) [Agly-H]- 
MS3 [973.50→649]: 487 (100) [Agly-H]- 409 (1), 393 (1), 391 (1) 
Down Hex-Hex-Hex-Medicagenic 
Acid 
987.48516 C48H75O21 (4.584) MS
2 [987.49]: 825 (100)[M-Hex-H]-, 781 (5)[M-Hex-CO2-H]
-, 711 (3), 663 (4)[M-Hex-Hex-H]-, 601 
(4)[M-Hex-Hex-CO2-H2O-H]
-, 439 (53)[Agly-CO2-H2O-H]
- 
MS3 [987.49→825]: 439 (100)[Agly-CO2-H2O-H]
- 
Down ? 756.35992 ? MS2 [756.36]: 738 (79), 712 (100), 694 (18), 641 (72), 640 (36), 597 (19), 596 (26) 
MS3 [756.36→712]: 694 (53), 597 (83), 596 (100) 
MS3 [756.36→738]: 720 (12), 694 (45), 640 (100), 623 (52), 622 (31), 596 (33) 
Down ? 1121.52513 C49H85O28 (1.645) Low abundant compound, no MS
n info available 
Down ? 1149.57585 C55H89O25 (5.227) MS
2 [1149.58]: 1069 (100), 1025 (62), 941 (7), 879 (30), 761 (27), 743 (22), 671 (26) 
Down Hex-Hex-Bayogenin 811.45241 C42H68O15 (4.763) MS
2 [811.45]: 649 (100)[M-Hex-Hex-H]-, 631 (8)[M-Hex-Hex-H2O-H]
-, 487 (62) [Agly-H]- 
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MS3 [811.45→649]: 487 (100) [Agly-H]- 
MS3 [811.45→487]: 409 (100), 403 (21), 393 (38), 391 (74) 
Down ? 840.32397 C46H50O14N (0.347) MS
2 [840.32]: 711 (100), 649 (18) 
MS3 [840.32→711]: 667 (100), 610 (48), 562 (23) 
MS3 [840.32→649]: 619 (89), 605 (57), 575 (36), 564 (100), 432 (18), 415 (26) 
Down Malonyl-Hex-HexA-Bayogenin 911.43371 C45H67O19 (6.041) MS
2 [867.44]: 825 (34)[M-malonyl-H]-, 807 (25)[M-malonyl-H2O-H]
-, 705 (9)[M-CO2-Hex-H]
-, 645 
(77)[M-malonyl-Hex-H2O-H]
-, 601 (100)[M-malonyl-Hex-H2O-CO2-H]
- 
MS3 [867.44→601]: 583 (3), 529 (100), 487 (7)[Agly-H]- 
Down ? 711.28055 C24H47O20N4 (2.302) MS
2 [711.28]: 693 (23), 681 (12), 667 (100), 610 (47), 592 (14), 562 (21), 375 (7), 358 (4) 
MS3 [711.28→667]: 649 (74), 637 (100), 619 (29), 562 (21), 416 (15), 375 (14) 
Down Hex-HexA-Aglycone A 823.41492 C42H63O16 (3.352) MS
2 [823.41]: 661 (100)[M-Hex-H]-, 617 (33)[M-Hex-CO2-H]
-, 599 (52)[M-Hex-H2O-CO2-H]
-, 485 
(15)[Agly-H]- 
MS3 [823.41→661]: 585 (5), 485 (100)[Agly-H]-, 467 (34) 
MS3 [823.41→599]: 527 (100), 485 (3)[Agly-H]-, 467 (2) 
Down ? 591.20735 C29H35O13 (-1.631) MS
2 [591.21]: 477 (64), 403 (100), 385 (20), 331 (21), 259 (33), 247 (24), 187 (73) 
MS3 [591.21→403]: 385 (17), 331 (100)  
MS3 [591.21→187]: 143 (100), 121 (62) 
Down ? 1073.52242 C52H81O23 (4.665) Low abundant compound, no MS
n info available 
Down ? 563.21203 C28H35O12 (-2.432) Low abundant compound, no MS
n info available 
Down dHex-Hex-HexA-
soyasapogenol A 
957.51003 C48H77O19 (3.735) MS
2 [957.51]: 939 (100)[M-H2O-H]
-, 895 (50)[M-H2O-CO2-H]
-, 811 (8)[M-dHex-H]-, 767 (3)[M-
dHex-CO2-H]
-, 749 (29)[M-dHex-H2O-CO2-H]
-, 649 (1)[M-dHex-Hex-H]-, 631 (29)[M-dHex-Hex-
H2O-H]
-, 613 (15)[M-dHex-Hex-H2O-H2O-H]
-, 541 (23)[M- dHex-Hex-H2O-C3H6O3-H]
-, 473 
(8)[Agly-H]- 
MS3 [957.51→939]: 895 (100)[M-H2O-CO2-H]
-, 749 (14)[M-dHex-H2O-CO2-H]
-, 613 (61)[M-dHex-
Hex-H2O-H2O-H]
-, 541 (62)[M- dHex-Hex-H2O-C3H6O3-H]
- 
MS3 [957.51→895]: 749 (100)[M-dHex-H2O-CO2-H]
-, 587 (5)[M-dHex-Hex-H2O-CO2-H]
-, 473 
(13)[Agly-H]- 
Down ? 641.35192 C24H53O17N2 (-3.916) MS
2 [641.35]: 623 (5), 597 (100), 480 (6), 327 (3) 
MS3 [641.35→597]: 579 (30), 553 (24), 535 (14), 480 (48), 327 (100), 309 (19) 
Down ? 835.34199 C41H55O18 (3.115) MS
2 [835.34]: 793 (22), 639 (100), 389 (73), 371 (15), 341 (28) 
MS3 [835.34→639]: 597 (31), 463 (36), 445 (15), 403 (15), 193 (100) 
Down Malonyl-Hex-HexA-
Hederagenin 
851.44613 C45H67O18 (3.136) MS
2 [851.45]: 809 (29)[M-malonyl-H]-, 791 (27)[M-malonyl-H2O-H]
-, 689 (82)[M-Hex-CO2-H]
-, 629 
(84)[M-malonyl-H2O-H]
-, 585 (100)[M-malonyl-CO2-H2O-H]
-, 471 (4)[Agly-H]- 
MS3 [851.45→585]: 513 (100), 471 (13)[Agly-H]- 
MS3 [851.45→629]: 629 (100)[M-malonyl-H2O-H]
-, 513 (54), 471 (78)[Agly-H]-, 453 (45), 405 (64), 
393 (74), 387 (22) 
Down Vanillic acid + unknown 613.25165 C29H41O14 (2.399) MS
2 [613.25]: 445 (100)[M-Vanillic acid-H]- 
MS3 [613.25→445]: 403 (100) 
Down Malonyl-Hex-HexA-Aglycone 
A 
865.42579 C44H65O17 (3.543) MS
2 [865.43]: 823 (3)[M-malonyl-H]-, 821 (4)[M-CO2-CO2-H]
-, 805 (28)[M-malonyl-H2O-H]
-, 761 
(4)[M-malonyl-CO2-H2O-H]
-, 703 (8)[M-CO2-Hex-H]
-, 643 (100)[M-malonyl-Hex-H2O-H]
-, 599 
(35)[M-malonyl-Hex-CO2-H2O-H]
-, 485 (1)[Agly-H]- 
MS3 [865.43→643]: 509 (100), 485 (64)[Agly-H]-, 467 (41), 421 (41) 
Down ? 1135.5037 C49H83O29 (1.013) Low abundant compound, no MS
n info available 
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Down Vanillic acid + unknown 613.25278 C29H41O14 (4.241) MS
2 [613.25]: 445 (100)[M-Vanillic acid-H]- 
MS3 [613.25→445]: 403 (100) 
Down Hex-Pen-hederagenin 765.44543 C41H65O13 (3.088) MS
2 [765.45]: 603 (100)[M-Hex-H]-, 585 (7)[M-Hex-H2O-H]
-, 471 (6)[Agly-H]- 
MS3 [765.45→603]: 471 (100)[Agly-H]-, 423 (14) 
Down Ferulic acid? + unknown 639.26765 C31H43O14 (2.848) MS
2 [639.27]: 463 (21), 445 (22), 403 (11), 193 (100) 
MS3 [639.27→193]: 178 (97), 149 (100), 134 (60) 
Down ? 809.43631 C42H65O15 (4.22) Low abundant compound, no MS
n info available 
Down ? 712.37007 C39H54O11N (-0.231) MS
2 [712.37]: 668 (100), 650 (11), 593 (8) 
MS3 [712.37→668]: 650 (24), 624 (100), 593 (20), 549 (14), 527 (13), 439 (33) 
Down Hex-dHex-Malonyl-
Medicagenic acid 
895.43821 C45H68O18 (5.496) MS
2 [851.45]: 809 (49)[M-malonyl-H]-, 791 (8)[M-malonyl-H2O-H]
-, 689 (37)[M-Hex-CO2-H]
-, 629 
(48)[M-malonyl-Hex-H2O-H]
-, 585 (100)[M-malonyl-Hex-H2O-CO2-H]
-, 439 (9)[Agly-CO2-H2O-H]
- 
Down ? 817.33168 C41H53O17 (3.495) MS
2 [817.33]: 799 (100) 
MS3 [817.33→799]: 353 (100) 
HexA, uronic acid, such as glucuronic acid or galacturonic acid; Hex, hexose, such as glucose or galactose; dHex, 6-deoxyhexose, such as rhamnose or 
fucose; Pen, pentose, such as arabinose or xylose. 
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